Tuning ribosomal elongation cycle by mutagenesis of 23S rRNA by Saarma, Urmas
DISSERTATIONES BIOLOGICAE UNIVERSITATIS TARTUENSIS
30
TUNING RIBOSOMAL 
ELONGATION CYCLE BY 
MUTAGENESIS OF 23S rRNA
URMAS SAARMA
TARTU 1997
DISSERTATIONES BIOLOGICAE UNIVERSITATIS TARTUENSIS
30
DISSERTATIONES BIOLOGICAE UNIVERSITATIS TARTUENSIS
30
TUNING RIBOSOMAL 
ELONGATION CYCLE BY 
MUTAGENESIS OF 23S rRNA
URMAS SAARMA
TARTU UNIVERSITY
PRESS
Department of Molecular Biology, Institute of Molecular and Cell Biology, 
University of Tartu, Estonia
Dissertation is accepted for the commencement of the degree of Doctor 
Philosophy (in Molecular Biology) on October 17, 1997 by the Council of the 
Institute of Molecular and Cell Biology, University of Tartu
Opponents: Prof. Paul Pumpens (Latvian University, Biomedical Research 
and Study Center)
Dr. Mart Speek (Institute of Molecular and Cell Biology, Tartu, 
Estonia)
Commencement: December 15, 1997
Publication of this dissertation is granted by the Estonian Science Foundation
© Urmas Saarma, 1997 Tartu Ülikooli Kirjastuse trükikoda 
Tiigi 78, EE 2400 Tartu 
Tellimus nr. 315
Vend Pri idule
CONTENTS
LIST OF ORIGINAL PUBLICATIONS ........................................................  8
LIST OF ABBREVATIONS.................... ........................................................ 9
INTRODUCTION............................................................................................. 10
1. LITERATURE OVERVIEW...................................................................... 13
1.1. Ribosomal elongation cycle................................................................  13
1.1.1. The ‘hybrid site model’ ............................................................  14
1.1.2. The ‘oc-e model’ .........................................................................  14
1.2. Genesis of peptidyltransferase centre during ribosome biosynthesis 15
1.2.1. Processing..................................................................................  16
1.2.2. Posttranscriptional modification..............................................  16
1.2.3. Assembly .............................................................. ..................... 17
1.3. Molecular mechanism of peptide bond formation............................  19
1.3.1. Ribosome as a ‘template’ ..........................................................  19
1.3.2. Ribosome as an enzyme............................................................  19
1.4. Catalytic flexibility of the ribosomal peptidyltransferase centre.....  20
1.5. Ionic conditions for peptidyltransferase .............................................  20
1.6. 23S rRNA topography.........................................................................  21
1.6.1. Primary structure ....................................................................... 22
1.6.2. Secondary structure ........................... ....................................... 23
1.6.3. High-order structure................................................................... 23
1.7. Functional centres of the 50S subunit................................................. 26
1.7.1. Cross-linking..............................................................................  26
1.7.2. Foot-printing..............................................................................  30
1.8. Ribosomal substrate binding sites ...................................................... 32
1.9. Probing ribosomal peptidyl transferase by mutagenesis of 23S 
rRNA ....................................................................................................  35
1.10. Antibiotics and peptide bond formation ...........................................  39
1.11. Translational accuracy........................................................................ 42
1.12. Ribosomal proteins and peptidyl transferase....................................  45
1.13. Other modulators of peptide bond formation ................................... 47
1.14. Elongation factor cycles and 23 S rRNA ..........................................  48
2. RESULTS AND DISCUSSION.................................................................  51
2.1. Functional analysis of E. coli 23S rRNA mutants   51
2.1.1. Peptidyl transferase.................................................................... 51
2.1.2. Translational accuracy..............................................................  53
2.1.3. Ribosomal elongation factor cycles.........................................  58
CONCLUSIONS ...............................................................................................  62
REFERENCES ................................................................................................... 64
KOKKUVÕTE (Summary in Estonian)..........................................................  76
ACKNOWLEDGEMENTS ............................................................................  78
7
LIST OF ORIGINAL PUBLICATIONS
Current dissertation is based on the following original publications referred to in
the text by their Roman numerals:
I Saarma, U. & Remme, J. 1992. Novel mutants of 23S RNA: characte­
rization of functional properties. Nucl. Acids Res 20: 3147-3152.
II Saarma, U., Lewicki, B. T. U., Margus, T., Nigul, S., and Remme, J. 
1993. Analysis of mutations in the 23 S rRNA. In The Translational 
Apparatus: structure, function, regulation, evolution. Edited by Nierhaus, 
K. H., Franchesci, F., Subramanian, A. R., Erdmann, V. A., and 
Wittmann-Liebold, B. Plenum Press, New York, pp. 445-454.
III Saarma, U., Remme, J., Ehrenberg, M., and Bilgin, N. 1997. An A to U 
transversion at position 1067 of 23 S rRNA from Escherichia coli impairs 
EF-Tu and EF-G function. J Mol Biol 272: 327-335.
IV Saarma, U., Spahn, C. M. T., Nierhaus, K., and Remme, J. 1997. Muta­
tional analysis of the donor substrate binding site of the ribosomal 
peptidyltransferase centre. (Manuscript submitted to RNA).
8
LIST OF ABBREVATIONS
PTase — peptidyl transferase
PTC — peptidyltransferase centre
GTP — guanosine triphosphate
GDP — guanosine diphosphate
r-protein — ribosomal protein
EF-Tu —  elongation factor Tu
EF-G — elongation factor G
aa-tRNA — aminoacyl-tRNA
pep-tRNA — peptidyl-tRNA
3 9
INTRODUCTION
Protein synthesis is a vital process for all living creatures on Earth. It is the last 
phase of gene expression that culminates with the translation of mRNA se­
quence into protein language. The responsibility for the efficiency and accuracy 
of this process lies on ribosomes. Ribosomes are large ribonucleoprotein parti­
cles that consist of one large and one small subunit. In eubacterium Escherichia 
coli these subunits have sedimentation coefficients 50S and 30S, respectively. 
Most important ribosomal enzymatic activity — peptidyl transferase (PTase), is 
an integral part of the large subunit (Monro, 1967). 50S subunit contains also 
another functionally significant region where ribosomal elongation factors 
bind— the factor centre (Fig. 1). The smaller subunit is accountable for the 
mRNA decoding process. Both subunits consist of a large number of ribosomal 
proteins and the following RNAs: in 30S subunits there is 16S rRNA, while 50S 
subunits contain two rRNA molecules, 23 S and 5S rRNA. Remarkably, the pri­
mary and secondary structure of ribosomal RNAs are highly conserved through­
out evolution. In contrast, ribosomal proteins exhibit a comparatively low level 
of sequence conservation.
CENTRAL
PROTUBERANCE
Figure 1. The outline of large ribosomal subunit with its attributes: LI and L7/L12 
arms plus the central protuberance which holds primarily 5S rRNA with its 
proteins. PTC is for peptidyltransferase centre and FC for factor centre where 
elongation factors Tu and G bind.
As soon as one realizes that the ribosome is an enzyme, the following 
question arises — why does it contain the RNA that is so highly conserved in 
evolution? Here the most likely explanation is that the remarkable uniformity of 
rRNA structure is a reflection of its functional conservation. Hence it could be
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asked — are ribosomes ribozymes? Suggestions that in the development of life 
on Earth evolution based on RNA replication preceded the appearance of 
protein synthesis were made nearly 30 years ago (Crick, 1968; Orgel, 1968; 
Woese, 1967). Discovery of RNA catalysis approximately 15 years ago has 
injected a new vigor into the evolutionary theories of catalytic molecules 
(Guerrier-Takada et al, 1983; Kruger et al., 1982). From the RNA world 
viewpoint, the ribosome is an RNA catalytic machine that aligns the anticodons 
of tRNAs to the codons of messenger RNA in a complementary fashion and 
promotes a peptidyl transferase reaction between an aminoacyl tRNA and the 
adjacent peptidyl tRNA. During the decoding process and peptidyl transferase 
reaction, the regions of tRNA and rRNA that interact with each other are 
relatively compact. Codon recognition appears to involve no more than 15 
nucleotides of the tRNA structure and a small subdomain of 16S rRNA. The 
peptidyl transferase centre involves only three nucleotides, the conserved CCA 
in 3’ terminus of tRNA and, apparently, only a small region of 23 S rRNA. 
Thus, these two functional domains are small enough to be within RNA world 
ribozyme size.
The biological role of RNA is limited by its reactivity. A single RNA mole­
cule can catalyze chemical reactions through its ability to fold into complex 
three-dimensional structures and to bind specifically other molecules and metal 
ions. The reactivity of RNA is determined by its 2’-hydroxyl groups located in 
ribose moieties. The range of activities exhibited by natural ribozymes may not, 
however, reflect the true catalytic potential of RNA, and this possibility has 
triggered attempts to develop ribozymes with new catalytic activities. Bearing 
its potential for functioning, both as a genome and as a gene product, RNA is 
suitable for in vitro evolution experiments enabling the selection of molecules 
with new properties. The development of in vitro selection and in vitro evo­
lution methodologies will provide a large number of RNAs with new and im­
proved properties. Using these strategies, ribozymes have been selected that can 
cleave amide bond (Dai et al, 1995), ligate RNA (Bartel & Szostak, 1993; 
Wright & Joyce, 1997), catalyze RNA polymerization (Ekland & Bartel, 1996), 
accelerate aminoacyl group transfer in a way similar to protein aa-tRNA 
synthetases (Illangasekare et al., 1995) and bind CCdA-puromycin, a high- 
affinity ligand of ribosomal peptidyl transferase designed as a transition state 
analogue of peptide bond formation (Welch et al., 1997). The in vitro selected 
RNA binding site for CCdA-puromycin shows an eight-base sequence simi­
larity to the highly conserved nucleotides of the peptidyl transferase loop do­
main of 23S rRNA (positions 2448-2455 according to E. coli numbering). Al­
though this structure is apparently not an absolute requirement for binding, it 
suggests that these 23 S rRNA nucleotides might be part of the ancient peptidyl 
transferase. In principle, a step further, selection of RNA with the ability to 
catalyze peptidyl transfer would be a nice way to prove that with some 
probability, ancient peptidyl transferase could have been composed of RNA.
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Several classes of ribozymes catalyze reactions not only at phosphorus 
centres but also at a carbon centre. For example, Cech and colleagues en­
gineered a group I intron by changing its internal guide sequence to base-pair 
with the P-site peptidyl transferase substrate CAACCA(fMet). Essentially, an 
ester bond was placed into the active site of a group I intron by tethering an 
amino acid to an oligoribonucleotide sequence that would normally position a 
phosphodiester bond into the active site. The authors found that this ribozyme 
catalyzes the hydrolysis of the aminoacyl ester bond (Piccirilli et al, 1992). 
Conversely, it has been shown that ribosomal peptidyl transferase can catalyze 
transfer of aminoacyl groups to a phosphate centre (Krayevsky & Kukhanova,
1979). The demonstration of catalysis at a carbon centre performed by an RNA 
enzyme suggests that prior to the involvement of proteins the RNA world could 
have expanded to include reactions of amino acids and other non-nucleic acid 
substrates. That is to say, RNA may have acted as an aminoacyl tRNA 
synthetase (Illangasekare et al, 1995). With tRNAs, mRNA, and ribozymes as 
tRNA synthetases and peptidyl transferases, it is possible to imagine of 
information-driven protein synthesis being carried out solely by RNA.
Investigations of specifying functional domains of the ribosomal RNAs have 
given us an important information to understand how the large rRNA structures 
could have evolved from a world were the largest RNAs were most likely an 
order of magnitude smaller than contemporary ribosomal RNAs. The applica­
tion of site-directed mutagenesis and other genetic approaches has strenghtened 
the idea of functional importance of rRNA. Mutations have been mapped that 
impair EF-Tu and EF-G functions, subunit association, initiation, antibiotic 
sensitivity, tRNA binding, translational accuracy and peptidyl transferase 
activity.
In this thesis I will concentrate on reviewing the current knowledge how 23 S 
rRNA tunes ribosomal peptidyltransferase, translational accuracy and elon­
gation factor dependent reactions and summarize our contribution to this field.
Roots of this dissertation can be traced back for more than 30 years, when 
Estonian molecular biology was founded by late Dr. Artur Lind and his 
colleagues. Their very first interests were structural and functional aspects of 
protein biosynthesis. This tradition has been successfully followed and kept 
alive in the laboratory of molecular biology.
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1. LITERATURE OVERVIEW
1.1. Ribosomal elongation cycle
The first round of elongation is unique in that the aminoacyl-tRNA-IF-2«GTP 
ternary complex is bound to the ribosome with the initiator tRNA (in proka­
ryotes fMet-tRNA^6') at the P-site, while the E-site is empty. All the other 
cycles are beginning with a peptidyl-tRNA (pep-tRNA) bound to the ribosomal 
P-site and the deacylated tRNA to the ribosomal E-site. Aminoacyl-tRNA (aa- 
tRNA) molecule is delivered to the ribosomal A-site in an active complex with 
the protein elongation factor Tu*GTP complex, concurrent with the release of 
the E-site bound deacyl-tRNA. After the GTP hydrolysis on EF-Tu and the re­
lease of EF-Tu*GDP complex, aa-tRNA and pep-tRNA are ready for peptidyl 
transfer, which is the transfer of growing peptide chain from pep-tRNA in the 
ribosomal P-site to the amino acid of the aa-tRNA. The quality of decoding of 
the genetic information is warranted by selection of correct codon-anticodon 
interaction before and after GTP hydrolysis on EF-Tu. In addition, proper 
interaction of the CCA 3 ’ end of aa-tRNA with the ribosomal peptidyl transfe­
rase centre plays also a role in tRNA selection process. Continuation of the 
ribosomal elongation cycle is guaranteed by the active protein translocase com­
plex EF-G*GTP, which binds to the ribosome after peptide bond formation and 
translocates tRNA substrates together with mRNA by three nucleotides in 
respect of the ribosome. After the EF-G*GDP leaves the ribosome and tRNA’s 
are positioned to the P- and E-sites, next round of peptide elongation can take 
place (Fig. 2).
Figure 2. Schematic representation of the ribosomal elongation cycle. Ribosomes are 
depicted as ellipses. Letters E, P and A are for tRNA binding sites.
l j !  p e p - tR N A
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Up to this point, “ribosome community” has no principle disagreement, 
while the details of ribosomal elongation cycle are matter of ongoing discus­
sions. Different experimental approaches have led to the establishment of 
“hybrid site model” and “a-e model” of the ribosomal elongation cycle.
1.1.1. The “Hybrid site model” of ribosomal elongation cycle
The “hybrid site” concept is based on the chemical footprinting of 16S and 23 S 
rRNA during different steps of elongation (Noller et al, 1990). According to 
the footprinting data, tRNA anticodon loop shields a distinct set of nucleotides 
in 16S rRNA from chemical modificaton when bound either to A- or P-sites, 
whereas the CCA 3’ end of the tRNA located in A-, P- or E-sites protects a 
distinct set of bases in the 23 S rRNA. Beginning with a peptidyl-tRNA in the 
P/P state (first letter for the 30S and second for the 50S subunit), an aminoacyl- 
tRNA is brought in as a ternary complex and binds initially in the A/T state (T- 
site is for incoming aa-tRNA, where only the anticodon is interacting with ribo­
somal decoding centre). After departure of the EF-Tu «GDP complex, the 
peptidyl-tRNA and aminoacyl-tRNAs are in P/P and A/A states, respectively, 
ready for peptidyl transfer. When peptidyl transfer is over, tRNAs shift from 
P/P to P/E and from A/A to A/P state, respectively. Here the two tRNAs move 
independently on the two ribosomal subunits — maintain their locations on the 
small subunit but move with respect of the large subunit. At the end, translocase 
EF-G moves the anticodon ends of both tRNAs, together with mRNA, relative to 
small subunit (P/E and E states are established). According to this model, at least 
six distinguishable binding states for tRNA can be brought forth: A/T, A/A, A/P, 
P/P, P/E and E. Interestingly, E-site is located entirely in the 50S subunit.
The hybrid site model emphasizes the role of rRNA in protein synthesis and 
unlike the two-site ribosomal elongation cycle model it uncouples the tRNA 
movement on the large and small ribosomal subunit.
1.1.2. The “a-£ model” of ribosomal elongation cycle
When protection of the tRNA sugar-phosphate backbone by ribosomes was 
studied, it was found that only 6 of 64 investigated nucleotides of AcPhe- 
tRNAphe and 1 of 63 investigated nucleotides of deacyl-tRNA show a significant 
change in the protection upon translocation, indicating that contacts between 
tRNA and ribosome are essentially the same in pre- and posttranslocational 
states (Nierhaus et al, 1996). The “a-e model” replaces the classical tRNA 
binding sites by positions, named a  and e. These are movable domains, a  pre­
ferentially for peptidyl-tRNA and e for deacylated tRNA. In the pretranslo- 
cational ribosome the a-£ domain is located at the A and P positions to create
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the A a and Pe sites. In the posttranslocational ribosome the a-e domain is 
located at the P and E positions, creating the P a  and Ee sites. Nonmovable 
decoding domain is marked by a letter 8. When ribosomal elongation cycle 
begins, the peptidyl-tRNA is bound to the P a and deacylated tRNA to the Ee 
site. Now the ternary complex enters the low-affmity A-site, the 8 domain at the 
A position. If codon-anticodon interaction has occurred, it triggers the allosteric 
transition and a-£ domain moves without the bound tRNAs from the P and E 
positions to the A and P positions, deacylated tRNA from the Ee site is expelled 
and ternary complex binds with high affinity. GTP is hydrolysed on EF-Tu and 
EF-Tu*GI)P complex rapidly leaves the ribosome. After the peptide bond is 
formed, the pretranslocational ribosome is the substrate for EF-G*GTP. During 
translocation, the a-e domain is moving together with both tRNA’s from the A 
and P positions to the P and E positions, GTP is hydrolysed and EF-G*GDP 
leaves the ribosome. Thus, according to the “a-e model” ribosomal pre- and 
posttranslocational states alternate by simultaneous movements of domains a  
and e together with the tRNAs, allowing proper positioning of the anticodon 
region, needed to maintain the reading frame and also a precise movement and 
docking of the CCA 3’ ends, which is important for the peptidyl transfer.
Largely, the hybrid site model and the a-e model are compatible with and 
also complement each other. The main discrepancy concerns the A/P hybrid 
state, which does not exist accordingly to the a-e model.
1.2. Genesis of peptidyltransferase centre 
during ribosome biosynthesis
Ribosome formation in Escherichia coli involves coordinated synthesis and 
folding of three ribosomal RNAs and 54 ribosomal proteins, processing and 
modification of the rRNAs, and assembly of both rRNA and r-proteins into 
functional subunits. All these processes are tightly connected to each other and 
therefore, despite decades of studies, we are still far from drawing final conclu­
sions, although significant portion of knowledge has already been accumulated 
(Condon et al., 1995).
Escherichia coli rRNA genes are organized into seven independent operons 
that are under the control of two strong tandem promoters. A single transcrip­
tion unit includes the rRNA coding and its leader, spacer, and trailer sequences. 
The latter have been demonstrated to possess the regulatory function necessary 
for efficient ribosome formation. The common order of rRNA genes in operons 
is 16S — spacer (containing either tRNAAIa and tRNAIle or tRNAGlu) — 23 S — 
spacer — 5S. Although small differences in primary structure are known to 
exist between the genes in different transcriptional units, the sequences are vir­
tually (>99%) identical. rrnB operon serves as a model for the ribosomal RNA
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gene organisation (the first operon that was cloned and sequenced). Formation 
of functional ribosomes is strongly dependent of RNA polymerase type, im­
plying the significance of cotranscriptional events during ribosome assembly 
(Lewicki et al., 1993). The requirement for a highly coordinated synthesis of 
rRNA and r-proteins is particulary demanding under the fast growth conditions 
of bacteria in which ribosomes contribute significantly to the dry mass of the 
cell. In bacteria the ribosomes can amount to more than 30% of the dry mass 
(Tissieres et al., 1959), whereas in eukaryotes they represent not more than 5% 
(Blobel & Potter, 1967). Transmission electron microscopy images of exponen­
tially growing E. coli show that the cells are filled with ribosomes. According to 
some calculations, up to 40% of total energy production is consumed by ribo­
some biogenesis. It follows that coordinated synthesis is not only a prerequisite 
for an effective assembly, but also a necessity for an economical consumption 
of the cell energy.
1.2.1. Processing
Processing begins before transcription of an rrn operon is finished (Apirion & 
Gegenheimer, 1984). Thus, the directional processing is coupled with
transcription. RNase III is a major nuclease responsible for cleaving the pre­
cursor RNA into pre-16S and pre-23S (unprocessed ‘30S precursor’ is found in 
wild type cells in very small quantities ~ 1%). RNase E and RNase P are re­
quired to process 5S and tRNAs, respectively. Intriguingly, RNase III cleavages 
are not of vital importance — E. coli mutants lacking the enzyme can survive, 
albeit with significantly prolonged generation time (Srivastava & Schlessinger,
1990). 50S subunits containing pre-23S RNA are shown to be active in protein 
synthesis, though their activity is decreased compared to mature 50S subunits 
(Sirdesmukh & Schlessinger, 1985). Final trimming of 23S rRNA takes place in 
polysomes (Srivastava & Schlessinger, 1988). Enzymes involved in this step are 
not yet identified.
1.2.2. Posttranscriptional modification
rRNA modification starts during its transcription and completes in late stages of 
ribosome assembly. Prompted by their distribution in regions of rRNA im­
plicated in the various functions of the ribosome, such as subunit association, 
tRNA binding and peptidyl transfer (Brimacombe et al, 1993), posttranscrip­
tional modifications are considered to be essential for ribosome functions. The 
importance of modifications is further emphasized by the fact that none of the 
23 S rRNA homologues have been found without posttranscriptional modifi­
cations. However, the degree of rRNA modification varies between different 
organisms. In general, the more ancient the organism is, the less modifications
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its rRNAs contain. The least modified tend to be mitochondrial rRNA se­
quences (for example yeast mitochondrial 23 S rRNA homologue has only three 
modifications, while E. coli 23S rRNA has 23). In boldest speculation, authors 
have attributed to the pseudouridine residues a direct role in catalysis of the 
peptidyltransferase reaction, clustered around the peptidyltransferase centre of 
the 50S subunit (Lane et al, 1992). In addition, it has been proposed that di­
hydrouridines might function to enhance the conformational flexibility required 
for dynamic translation and methylated 2’ hydroxyls might prevent undesired 
hydrogen bonding interactions (Kowalak et al, 1995). However, these propo­
sals are without experimental verification.
Current experimental evidence has given a ground to the belief that modi­
fications are simply “fine tuning” of the ribosome functions. Active 50S su­
bunits can be formed by using 50S proteins and in vitro transcribed 23S RNA 
lacking all the modifications, though their PTase activity is severely inhibited 
(Green & Noller, 1996). Similarly, active 30S subunits can be reconstituted 
from in vitro transcribed 16S RNA (Krzyzosiak et al, 1987). tRNAs are rich in 
postranscriptional modifications; yet, in vitro transcripts of these molecules are 
readily aminoacylatable and are active in protein synthesis under in vitro 
conditions (Sampson & Uhlenbeck, 1988). Although the consequences of the 
absence of posttranscriptional modifications in rRNA and tRNA may be 
substantial in vivo, it appears that they are not fundamental. From evolutionary 
perspective, nonfundamental role of posttranscriptional modifications is 
consistent with the idea of their late acquisition during evolution and can be 
explained as “fine tuning” of an already functional translational apparatus 
(Noller & Woese, 1981).
To identify the region of 23 S rRNA were the presence of modified nucleo­
tides has substantial impact on ribosomal peptidyltransferase activity, an in vitro 
complementation analysis was carried out with ribosome-derived 23 S rRNA 
fragments combined with the complementary in vitro transcript in a chimeric 
reconstitution reaction. Using this approach, segment of 23S rRNA extending 
from positions 2445 to 2523 and containing six posttranscriptional modifica­
tions was found to contribute most to the assembly of the ribosomal peptidyl 
transferase centre (Green & Noller, 1996).
1.2.3. Assembly
E. coli 50S subunit with a mass of ca. 1.85 million Da is composed of two 
RNAs, 5S (120 nt) and 23S (2904 nt) and 34 r-proteins. Assembly of 50S 
subunit from these components is a process of an ordered series of RNA-RNA, 
RNA-protein and protein-protein interactions. Even though the structure of the 
ribosome is very complex, functionally active ribosomes can be reconstituted 
from purified components in vitro demonstrating that all information necessary 
for correct assembly is contained in the structure of the mature ribosomal com­
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ponents. Both, 50S reconstitution in vitro and 50S assembly in vivo have shown 
to occur via three precursor particles. Optimal 5OS reconstitution from purified 
natural 23S rRNA, 5S rRNA and TP-50 requires two steps: (1) an initial 
incubation for 20 minutes at 44°C and 4mM Mg2+ followed by (2) 90 minutes 
incubation at 50°C and at 20mM Mg2+. Under these conditions, intermediates 
with sedimentation coefficients 33S, 41S and 48S are consequtively formed. 
Similarly, the in vivo assembly has shown to occur via three precursor particles, 
sedimenting at 34S, 43S and ‘near 50S\ In both cases, protein analysis revealed 
that the first and the second particle contained very similar complement of 
rRNA and r-proteins in spite of the drastic difference in their respective S- 
values. The ‘near 50S’ particles contained all the components of the active 50S 
subunit, but like the first two, they were found to be totally inactive. Thus, 
structural transitions in the final stage of assembly are crucial to activate 
ribosomes. It is likely that in vitro reconstitution of the 50S subunit reflects 
basic principles of the in vivo assembly. The only difference is considerably 
slower kinetics of the in vitro process. It has been speculated that in vivo 
assembly may involve some unique mechanisms which would help to decrease 
the kinetic barrier for the assembly reaction. For example, assembly may take 
place in association with membrane or some extraribosomal protein could be 
involved. Recently, several nonribosomal auxiliary factors SrmB, DeaD, DbpA 
and DnaK have been found to affect the cellular assembly of ribosomal 
subunits, most likely by facilitating rRNA folding (Fuller-Pace et al, 1993; 
Nicol & Fuller-Pace, 1995; Nishi et al, 1989; Toone et al, 1991). Participation 
of nonribosomal proteins might be one of the reasons, why ribosome formation 
within E. coli cells occurs in few minutes at 37°C, while the succesfull reconsti­
tution in vitro needs 1.5 hours incubation at 50°C under nonphysiological ionic 
condition. Another reason could be that the in vivo assembly is a highly ordered 
cooperative process, starting with a relatively short 5’ sequence of the rRNA 
and proteins essential for the early assembly, whereas in reconstitution the 
mature 23S rRNA is exposed to all TP-50 proteins.
In spite of the large number of proteins (20) which can bind to the naked 23 S 
rRNA in vitro, only two of them, L24 and L3 can initiate the assembly process 
(Nowotny & Nierhaus, 1982). Surprisingly, a temperature-sensitive mutant has 
been described which lacks r-protein L24 (Dabbs, 1986). L20 was identified as 
a protein able to replace L24 and initiate 50S subunit formation (Franceschi & 
Nierhaus, 1988). This finding serves as example of certain degree of flexibility 
during 50S assembly.
It would be significant to know whether any form of truncated 23 S ribo­
somal RNA is capable of forming active particles? To study this possibility, 
Liiv and coauthors have made a series of overlapping deletions covering the 
entire 23 S rRNA. They found that all deletions, except those lacking 5’ or 3’ 
end of the molecule, were able to form stable particles together with a specific 
set of ribosomal proteins, though none of them exhibited any peptidyltrans-
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ferase activity (Liiv et al, 1996). In a very recent paper, experimental evidence 
was provided that helix 1, formed between the 5’ and 3’ ends of 23 S rRNA, is 
an important determinant for the ribosomal large subunit assembly (Liiv & 
Remme, 1997, submitted).
Taken together, it appears that the genesis o f functional peptidyl transferase 
is a very late assembly event. Not only a complete set o f ribosomal components 
guarantees the formation o f functional subunits, but ordered series o f structural 
transitions are o f high significance. The final transition seems to be essential 
for the creation o f active peptidyltransferase centre.
1.3. Molecular mechanism of peptide bond formation
Although we know the basic scheme of the ribosomal peptidyl transferase, 
transfer of the growing peptidyl group from the CCA terminus of one tRNA 
molecule to aminoacyl group attached to the CCA terminus of another tRNA 
molecule, the nature of catalysis is not clear. Is the PTase an enzymatic activity 
of a specific ribosomal component or does ribosome work as a template, 
bringing the ends of two tRNAs into proper juxtaposition to allow spontaneous 
peptide bond formation?
1.3.1. Ribosome as a ‘template9
According to the ‘template hypothesis’, ribosome serves as a template for 
proper alignment of the substrates of the peptidyl transferase reaction, which in 
this case is simply the aminolysis of the activated ester bond of peptidyl-tRNA 
by the a-amino group of aa-tRNA via the formation of tetrahedral intermediate 
(Krayevsky et al, 1975). The ribosome is not involved catalytically in the 
reaction. Nierhaus and coworkers argued that the required rate of peptide bond 
synthesis in vivo (15-20 amino acids per second) could be achieved by appro­
priately positioning the a-amino group of aminoacyl-tRNA for nucleophilic 
attack on the ester linkage of peptidyl-tRNA, excluding the functional groups of 
the ribosome in the catalysis of the PTase reaction (Nierhaus et al, 1980a).
1.3.2. Ribosome as an enzyme
The second model attributes the catalytic properties of the PTase reaction to the 
ribosome. The idea was inspired by the mechanism of action of serine proteases. 
These enzymes operate via general nucleophilic or acid-base catalysis (Nierhaus 
et al., 1980a). Three amino acid residues participate directly in the covalent 
events at the active centre: serine, histidine and aspartic acid. The same amino
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acids have been found to be universally conserved in ribosomal protein L2. As a 
variation of the action of serine proteases, an ordered catalysis mechanism for 
the ribosome was proposed: deprotonation and activation of the nucleophilic a- 
amino group of the aa-tRNA by histidine-carboxyl system. The deprotonation 
of the a-amino group is considered here as the ‘catalysed’ reaction. Next steps 
are the stabilization of the tetrahedral intermediate, produced by the nucleo­
philic attack of the a-amino group on the ester carbonyl, and enhancement of 
breakdown of the tetrahedral intermediate by proton donation from the 
histidine-carboxyl system. Garrett and Woolley critisized some aspects of the 
model. The most important remark was that the catalytic group which enhances 
the nucleophilicity of the the a-amino group of the acceptor substrate does not 
necessarily have to be confined to ribosomal protein; it could be also provided 
by the phosphates of an RNA molecule (Garrett & Woolley, 1982).
None of the models are neither proved nor rejected.
1.4. Catalytic flexibility of the ribosomal 
peptidyltransferase centre
Under normal circumstances ribosomes are the catalysts of peptide bond syn­
thesis, while under extrordinary conditions in vitro, they are capable of cata­
lysing the formation of several types of chemical bonds. Generally, the peptide 
acceptor in the ribosome is the amino group of an amino acid residue in 
aminoacyl-tRNA, whereas the carbonyl group at the C-terminus of the peptidyl 
residue of the peptidyl-tRNA serves as the peptide donor. Chemical alterations 
in the nature of both substrates can be tolerated. E. coli ribosomes have been 
demonstrated to be able to catalyse the formation of amide, ester, thioester, 
thioamide and phosphinamide bonds (Krayevsky & Kukhanova, 1979). Such a 
high degree of flexibility could have resulted from the specific character of the 
PTase centre — it must adopt many different amino acids, attached to struc­
turally different tRNAs.
1.5. Ionic conditions for peptidyl transferase
The PTC of E. coli ribosomes can exist in active or inactive state. One of the 
requirements for activity is the presence of monovalent and divalent ions. Re­
moval of NH4+ ions from E. coli ribosomes completely inactivates them. One 
K+ or NH4+ ion per ribosome must be bound for efficient catalysis of PTase 
reaction. Eukaryotic ribosomes use K+ or Na+ ions (Na+ is known to inhibit 
PTase in prokaryotes) rather than K+ or N H /. Inactivated ribosomes can be re­
activated by heating them at 40°C in the presence of necessary ions. Antibiotics 
like streptomycin, neomycin, erythromycin, lincomycin and chloramphenicol
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inhibit both inactivation and activation of the ribosomes. Kasugamycin prevents 
only inactivation and kanamycin only activation (for review, see Krayevsky and 
Kukhanova, 1979). Divalent ions are also required. The presence of Mg2+ ions 
is a prerequisite for efficient acceptor and donor substrate binding. The role of 
ions is most probably to maintain the structure of rRNA. If PTase activity 
indeed belongs to rRNA, there is a possibility that the reaction is catalysed by 
metal ions. All RNA catalysed reactions, characterized so far, involve metal 
ions in their catalytic mechanism (Pan et al, 1993). It has been proposed that by 
coordinating RNA, the divalent metal ions are involved in the catalysis of 
peptidyl transfer (Winter et al, 1997). Three possibilities of how metal ions 
may aid peptide bond formation have brought out: 1) the developing negative 
charge on the leaving group (tRNA ribose) could be stabilized by a directly 
coordinated metal ion; 2) or metal ion coordination to the oxygen of the carbo­
nyl group of the amino acid may render the carbon centre more susceptible to 
nucleophilic attack; 3) metal ion which coordinates hydroxyl group could act as 
a general base on the amino group, enhancing the nucleophilicity of the amine 
nitrogen. Pb2+ induced cleavage of the sugar-phosphate backbone has been used 
to probe the metal binding sites in rRNA. Two prominent cleavage sites were 
found in 23S rRNA: A505 and C2347. At high lead concentration, cleavage at 
position C2440 was observed. All cleavages occur in the regions that are un­
paired in the secondary structure model of 23 S rRNA and can be competed for 
by high concentrations of Mg2+, Mn2+, Ca2+ans Zn2+ ions, suggesting that lead is 
bound to the general metal binding sites (Winter et al, 1997). Similar results 
have been obtained for group I introns (Streicher et al, 1993) and RNase P 
(Zito et al, 1993).
1.6. 23S rRNA topography
To understand the nature of an enzyme is to understand its functional structure. 
An ultimate goal would be to know all structural transitions and movements of 
active groups during the action of an enzyme. The most powerful physico-che­
mical technique that gives a detailed atomic resolution picture is the x-ray 
crystallography. The evolution of our understanding of how the ribosome does 
its job is currently in a ‘low-resolution phase’. At the moment, when we do not 
have an atomic map of the structure and we are nowhere near to the functional 
structure of the ribosome (the ‘high-resolution phase’), our knowledge is limited 
to data created with a number of low-resolution methods. These methods can 
describe three-dimensional folding of rRNAs, rRNA-protein and protein-protein 
interactions in the ribosome. High-resolution structures are available for several 
ribosomal proteins and segments of rRNA (Uhlenbeck et al, 1997).
Ribosomes are big enough (250Ä in diameter) to obtain some useful infor­
mation about them from electron microscopy images. In 1970s and 1980s, the
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approximate shape of the ribosomal subunits was deduced. Using antibodies 
against specific ribosomal components and several staining strategies, the loca­
tions of several landmarks on the surface of the ribosome were mapped (Oakes 
et al., 1986; Stöffler & Stöffler-Meilicke, 1986). These investigations have es­
tablished the overall morphology of the 50S ribosomal subunit, which exhibits 
three distinct features: LI protuberance, central protuberance, L7/L12 stalk and 
the body of 50S (Fig. 1). In 1990s, Frank’s and van Heel-Brimacombe’s groups 
took one step further and developed the strategy called “image reconstitution”. 
Two independent 20-25Ä resolution reconstitutions of the E. coli 70S ribosome 
(Franck et al, 1995; Stark et al, 1995). The results of both groups were very 
similar, elucidating many structural details, such as extensive system of 
channels within the 50S subunit and an intersubunit gap ideally shaped to 
accommodate two transfer RNA molecules. Agrawal et al., (1996) and Stark et 
al, (1997), extended their work to analyze the movements of ribosome-bound 
tRNAs during protein synthesis. The first group imaged ribosomes with 
deacylated tRNAs bound simultaneously to all three sites of the ribosome, while 
the other visualised two tRNAs bound to both pre- and posttranslocational 
ribosomes. Earlier data have positioned the decoding region as well as the 
peptidyltransferase centre to the interface of the two ribosomal subunits. Electron 
microscopy studies confirmed these observations. Both groups detected an extra 
density, attributed to tRNAs. From van Heel’s group images, it is clearly seen 
that tRNAs move relative to each other during translocation. The direction of 
tRNA movements during translocation from A to P and from P to E sites is 
from L7/L12 side towards LI binding region. Interestingly, the shapes of the 
pre- and posttranslocational ribosomes were indistinguishable at this resolution 
(20Ä).
1.6.1. Primary structure
Determination of the primary structure of 23S rRNA and cloning the whole 
E. coli rrnB operon by Brosius and colleagues (Brosius et al, 1980) has been a 
landmark of the new era in ribosomology, because many useful methods to 
study the ribosome and ribosomal RNA are not applicable without the pos­
sibility to manipulate with rRNA genes. E. coli 23 S rRNA consists of 2904 
nucleotides and has multiple posttranscriptional modifications. Analysis of phy­
logenetic conservation of 23S rRNA sequences has brought forth functionally 
important regions of the molecule. The occurrence of posttranscriptional modi­
fications in regions with highly conserved features suggests that they might be 
also functionally important (see also section 1.2.2).
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1.6.2. Secondary structure
With sufficiently extensive collection of homologous sequences, one can 
through comparing them, define the range of their similarities and differences, 
and the patterns that characterize evolutionary changes in the molecules primary 
structure. By means of phylogenetic sequence comparisons the secondary struc­
ture model of 23S rRNA has been proposed (Noller et al, 1981). The secondary 
structure of 23S rRNA (Fig. 3A and 3B) is composed of six large domains, ra­
diating out from a central ring and formed by helices, defined by their re­
spective long-range interactions: domain I (16-25/515-524), domain II (579- 
585/1255-1216), domain III (1295-1298/1642-1645), domain IV (1656- 
1664/1997-2004), domain V (2043-2054/2615-2625), and domain VI (2630- 
2637/2781-2788). The most conserved region in the secondary structure is the 
central ring of domain V and its surrounding (Fig. 4). This region could be 
considered as the ‘heart’ of the 50S subunit — changes in this region often lead 
to inhibition or block of the central ribosomal reaction, the peptidyl transfer 
(Table 1; section 1.10). Evidence for the existence of each helix was derived 
also from structure probing analysis (Egebjerg et al, 1990). About 40% of the 
23S rRNA is single-stranded and as discussed below, a vast majority of 
experimental data points lie in single-stranded regions. It is noteworthy that 
long, regular helices do not exist in the 23 S rRNA. Instead, the structure is 
formed by joining together many short helices, the junctions of which tend to 
create a variety of structural irregularities.The reason for this kind of architec­
ture has been rationalized in two ways (Noller & Woese, 1981). First, multiple 
small helices allow a much more complex three-dimensional structure and 
second, the long and stable helices would create kinetic ‘traps’, interfering with 
ribosome assembly.
1.6.3. High-order structure
Comparisons among 23 S rRNA sequences reveal a number of positions that 
covary in composition, suggestive of high-order structural elements. A number 
of long-range tertiary structural interactions have been predicted, bringing to­
gether areas that are distant in the secondary structural diagram (Gutell & Fox, 
1988).
Based on various types of topographical information, mostly such as intra- 
RNA crosslinking, RNA-protein cross-linking, protein footprinting as well as 
the classical binding-site data and computational analysis, preliminary models 
for three-dimensional folding of 23 S rRNA have been proposed (Brimacombe, 
1995; Mitchell et al, 1990; Nagano et al, 1988). The most comprehensive 23S 
rRNA model is the one established by Brimacombe and coworkers. It sum­
marizes a majority of structural data currently available that are relevant to
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Figure 3A. 5’ half secondary structure diagram for Escherichia coli 23 S rRNA 
(adapted from Gutell, 1993). Tertiary interactions are connected by 
thicker solid lines. Every 10th position is labeled by a tick mark, every 
50th is numbered. Thiostrepton binding structure (TBS) of 23S rRNA is 
rectangled and magnified above. Position 1067 is encircled.
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Figure 3B. 3’ half secondary structure diagram for for Escherichia coli 23 S rRNA 
(adapted from Gutell, 1993). Tertiary interactions and numbering are the 
same as in Figure 3A. Peptidyltransferase centre (PTC) of 23 S rRNA is 
magnified above.
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three-dimensional interactions of 23 S rRNA. Taking into account that the RNA 
component is two-third of the mass of the ribosome, autors believe that the 
overall shape of the 23 S rRNA should at least approximately correspond to the 
morphological shape of the ribosomal large subunit, observed by electron 
microscopy. The three-dimensional model of 16S rRNA serves as a good 
example to endorse this expectation — it resembles very well the image of 3 OS 
subunit (Mueller et al, 1995). The starting point of the models is the phylo- 
genetically established secondary structure of the 23 S rRNA. Some features of 
the three-dimensional model are supported with experimental data while some 
are highly speculative. Relatively large number of structural elements are im­
plicated in beeing close to, or part of the functional core, being consistent with 
the obseravation that the PTC is rich in RNA (Picking et al, 1992).
1.7. Functional centres of the 50S subunit
A cascade of methods has been developed to determine functionally significant 
regions of rRNA. Three regions of 23 S rRNA have shown to be involved in 
ribosome functions. The thiostrepton binding sequence in domain II (Fig. 3A, 
bases 1052-1108) and a-sarcin stem loop structure in domain VI (Fig. 3B, bases 
2647-2673) are implicated in elongation factor EF-Tu and EF-G dependent 
reactions (for details, see section 1.13). Ribosomal peptidyltransferase centre 
involves primarily nucleotides in domain V (Fig. 4).
A few classical methods are outlined below that have aided to get insight 
into the ribosomal peptidyl transferase centre.
1.7.1. Cross-linking
In the site-directed cross-linking approach, a photoreactive group is introduced 
at a certain position within a functional ligand, which is bound to the ribosome 
under specific conditions. The following photoactivation of the reactive group 
leads to crosslink(s) between ribosomal component(s) and the functional ligand. 
The crosslinked complex could be isolated and the site of cross-link determined, 
providing us information about the proximity of the functional ligand to a spe­
cific functional entity of the ribosome. The approach has demonstrated its value 
in a series of experiments were the bound ligands have retained their functional 
activity (see below). Photo-reactive groups could be attached to different places 
in tRNA, mRNA or the nascent peptide, enabling to gain insight into a variety 
of contacts between ribosomal ligands, rRNA or ribosomal proteins.
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Figure 4. Central ring of domain V of Escherichia coli 23S rRNA. Mutations cha­
racterized in these thesis are encircled. tRNA protections and crosslinks are 
represented by arrowheads; antibiotic protections, crosslinks and resistance 
mutations by smaller symbols (for review see Spahn & Prescott, 1996). MLS 
is for macrolide-lincosamide-streptogramin type B antibiotics.
Introduction of the photoreactive base analogues like 2-azido- or 8-azido- 
adenosine (photoactivated azidoadenosines form very short cross-links, about 
2-4 A) into 3 ’ end of tRNA at positions 73 or 76 of tRNAphe gives additional 
information about the structure of the PTC. 2-azido-A73 derivatives reacted 
only with the protein L27, but both the 2-azido-A76-tRNA and 8-azido-A73- 
tRNA reacted with several proteins (mainly L27, with minor cross-links to L2, 
L I5 and L,16) and with 23S rRNA. G1945 of 23S rRNA was cross-linked by 
P-site bound [2N3A76]tRNAPhe (Wower et al., 1989), but the data were ques­
tioned later and the authors suggested that the labeling of G1945 takes place in 
the ribosomal A-site. 2-azido-A76-tRNAs bound to ribosomal A-, P- and E-site
label five segments whithin domains IV and V of 23S rRNA (Wower et al,
1995). p-azido derivative of puromycin (an analogue of the 3’ end of aa-tRNA) 
has been cross-linked to the universally conserved residues G2502 and U2504 
(Hall et al, 1988).
Upon irradiation with UV light at 320 nm, BP-Phe-tRNAplie (BP — bensoyl- 
propionyl) bound to poly(U)-programmed ribosomes, cross-links exclusively to 
23 S rRNA (despite of the potential reactivity of BP moiety, attached to the 
amino group of the Phe towards both protein and RNA). The fact that the cross- 
linked Phe-tRNA derivative retains the ability to form a peptide bond is an 
indication that the cross-linked region of the 23 S rRNA can be an integral part 
of PTC (Barta & Kuechler, 1983). When RNA was isolated from the ribosomes 
specifically labeled with BP-[3H]Phe-tRNAphe from either A- or P-site, and was 
used as a template for the primer extension analysis with reverse transcriptase, 
three labeled regions of domain V of 23S rRNA were identified (Steiner et al, 
1988). A-site bound tRNA cross-links to nucleotides U2584 and U2585 as the 
major affinity labeling sites plus A2503 and U2504 as the minor sites. For P- 
site bound tRNA, nucleotides C2452 and A2453 became labeled. Similarly with 
A-site experiments, some minor sites were also observed: U2504, G2505 and 
U2506. However, when BP-Phe-tRNAphe was bound to ribosomes in which P- 
site binding was blocked by the excess of deacylated tRNA, the cross-links 
obtained were across the loop at residues U2584 and U2585. Here, the results 
seem to be in controversy, which could be eliminated by the ‘hybrid site’ mo­
del — under the excess of deacylated tRNA, the tRNA is probably bound in the 
A/P-state, where it is simultaneously in the 30S A-site and 50S P-site. This is a 
puromycin unreactive state and has been previously thought to represent A-site 
binding. When bound in the P/P-state, the BP-tRNA crosslinks mainly to A2451 
and C2452, coinciding with the observed protection of the 3’ CCA terminus of 
tRNA at A2451 (see also section 1.1.1).
When an aromatic azide is attached to the amino acid of Phe-tRNAPhe, it 
labels nucleotide A2493 from both A- and P-sites (Mitchell et al, 1993). More 
recently, the study has been extended to map the cross-linking sites of peptides 
with various lenght, synthesized in situ on the ribosome in the presence of a 
synthetic mRNA analogue coding for methionine, lysine, phenylalanine and 
glutamic acid (Stade et al, 1994). The peptides, carrying diazirino derivatives 
attached either to the a-amino group of the N-terminal methionine residue, or to 
the 6-amino group of an immediately adjacent lysine residue, were cross-linked 
to 23S rRNA positions 2062, 2506, 2585 and 2609. These positions are 
probably very close to the PTC. However, when the peptide was three or four 
residues long, a new cross-link was observed at position 1781 (helix 65) which 
is several hundreds of nucleotides away in another secondary structural domain. 
The data show that the exiting peptides are directed towards helix 65 in domain 
IV of 23 S rRNA and it is noteworthy that nucleotides 1782 and 2609 are among 
several pairs of nucleotides which have been identified to connect domains IV 
and V (Mitchell et al, 1990). Using intra-RNA cross-linking method, helices
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35, 40, 72 of 23S rRNA and helix IV of the 5S rRNA have been found to be 
adjacent to the central ring of domain V (Döring et al., 1991). With pro­
gressively longer peptides, cross-links to nucleotide 750 at the loop end of helix 
65 and to nucleotide 1614 at the loop end of helix 59A have been observed 
(Stade et al, 1995). The first occured from peptides of 6 residues or longer, 
whereas the second revealed onself when the peptide reached a lenght of 25 
amino acids. Again, the proximity of the position 750 in helix 35 to the PTC is 
corroborated by earlier data of direct UV-cross-link between positions 746 and 
2614 (Mitchell et al, 1990) as well as by the protection of position 752 by 
antibiotic vernamycin B (Moazed & Noller, 1987). Helix 59A, the cross-link 
site from 25-26 amino acid residues long peptides is close to the binding site for 
protein L23 (Vester & Garrett, 1984). L23 together with L29 have been 
identified to contact the 23 S rRNA region embracing nucleotides between 
positions 60 and 140 in domain I. Immuno-electron microscopy studies have 
located this site at the rear of the 50S subunit (Bernabeu & Lake, 1982). 
Peptides of 29-33 amino acids that are the longest peptides that should approach 
the peptide exit site, cross-link to the position 91 (helix 7) of 23S rRNA (Stade 
et al., 1995). Taking the data together it becomes evident that the growing 
peptide makes contacts with remarkably widely separated regions of 23 S rRNA. 
The peptide is directed from the PTase ring in domain V to domain IV (helix 
65), then to domain II (helix 35), and to domain III (helix 59A), and finally to 
domain I (helix 7). Due to the absence of experimental data for peptides with 
lenght of 15-25 amino acids, some significant points on the pathway for the 
nascent peptide are likely to be missing. Another interesting phenomenon has 
been emphasized by Brimacombe and coworkers — during the peptide growth 
in the ribosome, the specific cross-links for the very first amino acids disappear 
at some lenght of the peptide and appear again when the peptide has become 
longer. It is a very likely indication of the folding events that occur already 
within the ribosome and preclude the existence of a tunnel, wide enough to 
allow the peptide to fold back on itself and reach a sub-set of the ‘earlier’ cross­
links. The role of the 50S subunit in protein folding has also brought into 
prominence by Hardesty and colleagues (Hardesty et al, 1993) and by Das- 
gupta’s team (Das et al, 1996). The latter work has demonstrated a protein-fol- 
ding activity in vitro in ribosomes from bacterial, plant and animal sources: 
ribosomes can refold a number of enzymes which are denatured with guani- 
dine/HCl. After closer inspection, the protein-folding activity was attributed to 
the 50S subunits and the active site for folding of denatured protein to the 23S 
rRNA. Disruption of the tertiary structure of 23 S rRNA inhibited its protein- 
folding activity. Neither the 30S particle nor the 16S rRNA were shown to be 
involved.
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1.7.2. Footprinting
The method is based on an idea that binding of functional ligand to the 
ribosome must limit or prevent the access of chemical or enzymatic probes to 
the rRNA if the ligand and rRNA interact. Earlier, mostly single- and double­
strand specific nucleases have been exploited to follow the interactions between 
ribosome and its substrates. Nowadays, the most successful method has been 
the use of chemical probes that attack the bases, ribose, or phosphate groups in 
the rRNA, allowing identification of the sites of ligand interaction by primer 
extension technique. Importantly, the changes in reactivities could be induced 
also by conformational changes in the ribosome due to the ligand attachment 
(referred in literature as class III sites), giving us the major shortcoming of the 
method and making interpretation of the data difficult. Both, the RNA-ligand 
contacts and ligand induced conformational changes, would be valuable to 
know. Unfortunately, the method does not allow to distinguish one from 
another.
Small chemical probes are especially good due to their high specificity, 
permitting localization of individual atoms in the rRNA: diethyl pyrocarbonate 
(N7 of A), kethoxal (N1 and N2 of G), dimethyl sulfate (N1 of A, N3 of C and 
N7 of G), CMCT (N3 of U and N1 of G), hydroxyl radical generated by Fe2+ 
(C45 of ribose) and ethylnitrosourea (phosphate oxygen). The precise positions 
of the modifications as well as the relative extent of modification can be 
identified by primer extension analysis. Reverse transcriptase either stops or 
pauses at modified nucleotides. In case of chain scission (hydroxyl radical 
attack of ribose, ethylnitrosourea attack at phosphate and dimethyl sulfate modi­
fication of G at N7) reverse transcription terminates.
One of the first indications of the importance of rRNA in translation came 
from modification studies with kethoxal, showing that modificaton of a few 
guanines in 16S rRNA results in a loss of tRNA binding to 30S subunits (Noller 
& Chaires, 1972). Later on, this approach has been extensively used to map the 
binding sites of tRNAs, and for various type of antibiotics. tRNAs bound to the 
ribosomal A-, P- and E-sites were found to protect specific set of bases in the 
rRNA. A- and P-site bound tRNAs protect bases of 16S and 23S rRNA. When 
tRNA is in the E-site, it is shown to shield bases in 23 S rRNA, exclusively.
Most of the bases protected by tRNA in 23 S rRNA are found in domain V, 
but few are also found in domains II and IV (Moazed & Noller, 1989).
A-site specific bases are A2254, A2439, A2451, G2553, U2555, A2602 and 
U2609 in domain V, C l941 in domain IV and G1041, G1068 and G1071 in 
domain II. Among those, A2439, A2451, U2555, A2602 and U2609 depend on 
acyl moiety, whereas protection of G2553 requires 3’ terminal A.
P-site bound tRNA gives specific footprints at bases A1916, A 1918 and 
U1926 in domain IV, G2252, G2253, A2439, A2451, G2505, U2506, U2584, 
U2585 and A2602 in domain V. Acyl moiety is necessary to protect bases
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A2439, A2451 and A2602. U2506, U2584 and U2585 depend on 3’ terminal A 
and G2552 and G2553 on 3’ CA.
The protection of G2112, G2116, A2169 and C2934 can be assigned to the 
binding of deacylated tRNA to the E-site. All these protections depend on the 3’ 
terminal A.
The only overlap between A- and P-sites occurs at nucleotides A2439 and 
A2451, both protections were demonstrated to be dependent on the presence of 
acyl group. A2451 is one of the nucleotides within the selected eight base-pair 
sequence that interacts with CCdApPuromycin, a high-affinity ligand of 
peptidyl transferase (Welch et al., 1997). Puromycin is a structural and functio­
nal analogue of the 3’ aminoacyl-A of aa-tRNA. Thus, the region around A2451 
may be involved in interaction with puromycin or 3’ terminus of aa-tRNA. The 
protection experiments by Moazed and Noller lead to another important con­
clusion — the integrity of the universally conserved 3 ’ CCA terminus of tRNA 
is responsible for most of the contacts between tRNA and 23 S rRNA. Pro­
gressive removal of 3’ terminal A and penultimate C eliminates most of the 
protections observed. The role of tRNA 3’ end in establishing necessary con­
tacts with 23 S rRNA was further emphasised by a complementary study, where 
the protection pattern of tRNA 3’ oligonucleotide fragments (CACCA-AcPhe, 
UACCA-AcLeu and CAACCA-fMet) was elucidated. All three oligonucleo­
tides protect 23S rRNA bases G2552, G2553, A2439, A2451, U2506 and 
U2585 (Moazed & Noller, 1991). These account for most of the bases that are 
protected also by the full-lenght P-site specific tRNA and correspond precisely 
to those bases whose protection is abolished by the changes in the 3 ’ terminal 
CCA of the bound tRNA.
Correlating the tRNA “footprints” with the state of ribosomal elongation 
cycle the binding mimics, Moazed and Noller suggested the ‘hybrid site model’, 
which serves to explain the mutual movements of tRNA and ribosomal RNA in 
the ribosome. The model emphasizes the kinetic aspect of tRNA and rRNA 
interactions and firms the functional role of rRNA during elongation (see also 
section 1.1.1).
A. Mankin and colleagues have taken a step further and identified 23 S rRNA 
nucleotides that are necessary for tRNA binding to the ribosomal P-site by 
using so-called ‘damage selection’ approach. By binding biotinylated tRNA 
substrates to randomly modified large ribosomal subunits and capturing 
resulting complexes on the avidin resin, four nucleotides of 23 S rRNA: G2252, 
A2451, U2506, and U2585 were identified whose modifications prevent 
binding of pep-tRNA analog to the ribosomal P-site (A. Mankin, personal 
communication). This finding is in good agreement with RNA footprinting and 
affinity labeling results mentioned above, which also suggest that these four 
residues reside in the vicinity of the pep-tRNA 3’ terminus.
31
1.8. Ribosomal substrate binding sites
Every working ribosome binds simultaneously two tRNAs, either in A- and P- 
sites or in P- and E-sites. A- and P-sites, or alternatively acceptor and donor 
substrate sites, are of fundamental importance for PTase, while E, alias exit site 
is for departuring tRNA.
During the course of translation, the ribosome recognizes and adopts at its 
acceptor and donor site 3’ ends of over 60 different tRNAs with their attached 
amino acids. Free a-amino group of the aa-tRNA is a common determinant for 
acceptor substrates in binding to the A’- site (acceptor site in the PTC). The 
binding of substrates to the P’-site (donor site in the PTC) requires the presence 
of the carbonyl group of the first C-terminal peptide bond. Common deter­
minants in both the A’ and P’ substrate sites may include the aminoacyl ester 
linkage, the very similar but by no means identical three-dimensional shape of 
the invariant CCA 3’ sequence of tRNAs.
The acceptor activity of aa-tRNA depends on the nature of attched amino 
acid. Phe and Tyr are the best acceptors, while Gly and Trp are with the lowest 
reactivity. For efficient activity, amino acid must be located at the 3’ hydroxyl, 
it has to be in L-configuration and in form of a-amino acid. It is likely that there 
is a hydrophobic pocket in the acceptor substrate site, since aromatic amino 
acids (except tryptophan) bind more strongly than most of their aliphatic 
equivalents (Harris & Symons, 1973). Footprinting experiments provide addi­
tional support to the hydrophobic pocket hypothesis, showing that specific 
nucleotides in rRNA are protected by aromatic amino acids (see also Section 
1.11). The relatively strong binding of pA-Lys suggests that there might exist 
also an adjacent hydrophilic centre, possibly involving phosphate groups where 
the side chains of lysine and arginine bind (Harris & Symons, 1973; Rychlik et 
al, 1970). However, these binding differences could reflect conformational 
changes induced by amino acid at the acceptor site rather than the existence of 
specific centres (Krayevsky et al, 1975).
All known mature tRNAs have in common a 3’ single stranded CCA end 
that interacts with acceptor and donor sites of peptidyltransferase during the 
peptide chain elongation process on the ribosome (Sprinzl et al, 1989). During 
the course of protein synthesis, the 3’ end of a tRNA must interact with several 
components of the translational machinery. The universal 3’ CCA is essential 
for aminoacylation of tRNA, though the selection of which amino acid to 
incorporate is made by features of tRNA other than the universal CCA. None of 
the changes in CCA sequence could abolish the aminoacylation, only the 
reaction efficiency was severely reduced for G76 and G75 mutant tRNAs (Liu 
& Horowitz, 1994). The integrity of the 3’ CCA end of the tRNA appears to be 
crucial for peptide bond formation — 3’ ends of two adjacent tRNAs must 
come into close proximity to allow the peptidyl transfer. Chemical and nuclease 
protection studies indicate that the 3’ CCA sequence also functions in formation
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of ternary complex between aa-tRNA, EF-Tu and GTP, and in the binding of 
tRNA to 23 S rRNA at the ribosomal A-, P- and E-sites of the 50S ribosomal 
subunit during the elongation phase of translation. Thus, interactions between 
the 3’ end of the tRNA and the ribosome may occur at all stages of the transla­
tion cycle (Noller et al., 1990). Although peptide bond formation is normally 
integrated in the sequence of reactions during protein synthesis, there is evi­
dence that only the terminal moieties of tRNA interact with the PTC. By using 
substrate analogs of the tRNA that lack certain functional parts but retain others, 
it is possible to separate the peptidyl transfer reaction from the other reactions. 
An aminoacylated CCA trinucleotide alone can interact with the large ribosomal 
subunit and donate its attached amino acid to an acceptor molecule located in 
the ribosomal A-site (Monro & Marcker, 1967). Even more truncated versions 
like aminoacylated A and CA can participate in PTase reaction in vitro, albeit 
with reduced efficiency.
Compounds such as puromycin (analog of the terminal aminoacyl ade­
nosine), and other modified nucleosides (like ethenoadenosine-Phe or etheno- 
cytidine-Phe) that cannot undergo Watson-Crick base pairing, bind effectively 
to the acceptor site (Chladek et al., 1976). The 3’ terminal adenosine of tRNA 
can also be replaced by formycin without loosing the binding to the acceptor 
site (Bakhst et al., 1976). These results suggest that base pairing between ulti­
mate A and rRNA is not is required for acceptor activity. Interaction of ribo­
some with cytosines of the CCA end of tRNA is demonstrated to be of impor­
tance for acceptor activity. When A-Gly and UpA-Gly do not react with poly- 
lysyl-tRNA in the P-site, CpA-Gly was found to be reactive, albeit with reduced 
efficiency compared to puromycin (Rychlik et al, 1967). It has also been ob­
served that replacement of the Cp moiety in the position C75 with other nucleo­
tides has more profound negative effects than that of analogous replacements in 
the third position. It has been demonstrated that UCA-Phe is more active than 
CUA-Phe, or analogically, GCA-Phe is better acceptor than CGA-Phe or GGA- 
Phe. Similarly to the ultimate A in the 3’ end of tRNA, universal cytosines at 
positions 75 and 74 of tRNA are unlikely to make Watson-Crick base pairing 
with rRNA in the ribosomal A’-site. Replacement of these natural cytidylic acid 
residues in CCA-Phe with guanylic acid moieties resulted only a small decrease 
of acceptor binding activity (Tezuka & Chladek, 1990). It appears that the 
stacked ordered structure of the CCA terminus is important for recognition by 
the A’-site. Disruption of the stacking geometry, coincides with the loss of 
acceptor activity (Chladek & Sprinzl, 1985). The nucleotides beyond the CCA 
sequence most probably do not interact with the 50S subunit. When binding and 
acceptor activities increase in order A-Phe<CA-Phe<CCA-Phe, pentanucleotide 
fragments exhibit no further improvement compared to trinucleotide fragments. 
This suggests that the CCA trinucleotide of the tRNA contains most, if not all, 
of the structural elements required for the interaction with the PTC.
Most of the donor site specificity has been investigated by means of the 
‘fragment reaction’. Monro and coworkers have found that the 3’ terminal frag­
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ments of fMet-tRNAflvIet (from CAACCA- to pA-fMet) bound to the ribosomal 
P’-site undergo a ribosome-catalysed reaction with the ribosomal A-site placed 
acceptor puromycin to yield fMet-puromycin (Monro & Marcker, 1967). The 
reaction takes place in the presence of limited number of translational com­
ponents: the large ribosomal subunit, A- and P-site substrates and alcohol plus 
magnesium and potassium ions. No mRNA, 30S subunit, translation factors or 
cofactors, or even intact tRNA is required. Instead, 3’ end fragments of tRNA or 
its analogs that interact directly with the PTC could be used as acceptor or 
donor substrates. The authenticity of the ‘fragment reaction’ as a true model for 
PTase was verified by demonstrating, that PTase inhibitors such as chloram­
phenicol, lincomycin, carbomycin, amicetin inhibit the ‘fragment reaction5 as 
well (Celma et al, 1967). The ‘fragment reaction’, with its limited number of 
components and truncated tRNAs, refers to a small structural region of the large 
ribosomal subunit that is necessary for the PTase activity.
The formyl group of fMet-tRNA, which could be replaced by an acetyl 
group, provides strong specificity for binding to the donor and not to the 
acceptor substrate site (Monro et al., 1968). pA-fMet is known as the smallest 
donor substrate, though not the efficient one (Cerna et al., 1973b). The presence 
of cytidines increases its donor activity significantly, pA-fMet<CA-fMet<CCA- 
fMet. Similarly to acceptor activity, there is no further increase in donor activity 
comparing trinucleotide and pentanucleotide derivatives (Chladek & Sprinzl, 
1985). The donor activity of pA-fMet could be significantly enhanced by pC 
(Cerna, 1975). However, pC fails to stimulate the donor activity of CpA-fMet. 
It has been suggested that pC can stack on the A and pair to adjacent G on the 
rRNA, thereby stabilizing the complex (Krayevsky et al, 1976). CN(AcMet) 
that is unable to undergo Watson-Crick base pairing has found to be completely 
inactive (Quiggle et al., 1981). It can be concluded that CCA terminus of the 
tRNA plays a crucial role in the binding of peptidyl-tRNA. The peptidyl- 
transferase P’-site requires also the L configuration of the amino acid portion of 
the substrate and the integrity of the 2’-OH group (Quiggle et al., 1981). The 
donor activity varies, depending on the amino acid bound to the tRNA, in order 
Met>Leu>Phe...>Gly (Krayevsky & Kukhanova, 1979).
To examine the role of the universal CCA terminal sequence of tRNA in the 
process of peptidyl transfer, all possible CCA mutants of valine tRNA were 
constructed. PTase activity monitored in the ‘fragment reaction’ was severely 
repressed by majority of tRNA mutations. Three mutations UCA, CUA and 
CCG have shown to retain low level activity (Tamura, 1994).
Ribosomal acceptor and donor substrate sites are conformational ly inter­
dependent. Peptidyl-tRNA bound to the P-site stimulates the binding of aa- 
tRNA to the A-site and vice versa (Chladek & Sprinzl, 1985). Peptidyl-tRNA 
has stimulatory effect only as the 3’ isomer, 2’ isomer is inactive (Bakhst et al., 
1976). Binding of an acceptor substrate to the A’-site is also stimulated by P’- 
site bound tRNA (Ulbrich et al, 1978). Antibiotics sparsomycin and chlo­
ramphenicol, known to inhibit acceptor substrate binding, have an opposite
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effect on donor substrate docking (Lazaro et al, 1991; Ulbrich et al., 1978). 
fMet-tRNA^61 bound in the P-site undergoes alcoholysis only when the ac­
ceptor substrate site is filled (Scolnick et al, 1970). The ribosomal acceptor site 
could be largely dependent on r-proteins. Ribosomes, treated with RNase T1 
retain their acceptor substrate binding activity, whereas donor activity is 
completely abolished (Cerna et al., 1973a). Thus, despite of the closeness be­
tween CCA ends of both acceptor and donor site tRNAs in the PTC, archi­
tecture of the sites seems to be rather different.
1.9. Probing ribosomal peptidyl transferase 
by mutagenesis of 23S rRNA
Mutagenesis has proven a valuable technique to put functional capacities of 
biologically important molecules on the test. The methodology is best applied 
when the model system is sufficiently well developed. A majority of ribosomal 
studies have been performed on Escherichia coli, which is genetically and bio­
chemically one of the best understood organisms. E. coli has seven rRNA 
operons, presenting a major challenge for studying rRNA by mutagenesis — 
expression of mutant RNAs from a plasmid is accompanied by host genome 
encoded homologs. Thus, both mutant rRNAs and wild type rRNAs are as­
sembled into ribosomes. To evaluate the influence of mutation on ribosome 
functions, wild type ribosomes have to be repressed. Recently, one operon 
model system, based on Halobacterium halobium, has become available (Man- 
kin et al., 1992). However, it is limited from the aspect that phenotypically 
lethal ribosomal mutations cannot be subjected to further biochemical analysis. 
As it has been expected and demonstrated even before the appearance of one 
operon system, cells that bear mutations affecting ribosomal peptidyl transferase 
function are usually not viable (Table 1). In order to isolate ribosomes with 
poisonous mutant rRNAs, a methodology based on multioperon organism like 
E. coli has been developed. It uses expression plasmid, where ribosomal 23S 
RNA gene is under the control of an inducible promoter. For the isolation of 
‘poisonous’ ribosomes, cells are grown to a certain density allowing to express 
only the wild type rRNAs. Then, synthesis of mutant rRNA molecules is 
induced and the culture is grown further for a certain time period. Next, cells are 
harvested and ribosomes isolated. As the result, we have a mixed population of 
mutant and wild type ribosomes (the ratio is usually 1:1, if PL-cIte857 system is 
used). Several experimental ‘tricks’ have been developed to distinguish between 
activities of mutant and wild type ribosomes. Mutations, conferring resistance 
to antibiotic thiostrepton, base substitution A1067U (Paper I) and to erythro­
mycin/clindamycin, base change A2058G (Leviev et al., 1995) have been 
exploited to discriminate wild type ribosomes. Recently, additional opportunity 
has emerged, called ‘chimaeric reconstitution’. A RNase H fragment of mature
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23 S rRNA is combined with complementary in vitro transcript in reconstitution 
reaction with large subunit proteins and 5S rRNA to yield catalytically active 
50S subunits (Samaha et al, 1995). However, none of these methods is capable 
to yield the results with 100% unambiguity. Despite of the fact that A1067U 
mutation has no influence on the ribosomal PTase, it is shown to increase the 
generation time of bacteria, possibly due to a perturbed EF-Tu cycle (Paper III). 
There is strong evidence indicating that functional connection might exist 
between domains II and V (Douthwaite, 1992a; Mankin et al., 1994). Position 
A2058 lies in the peptidyl transferase ring at the secondary structure model and 
the mutation at A2058 could interfere with the influence of PTase mutation. 
Moreover, erythromycin is thought to block the entrance of the channel for the 
growing peptide. ‘Chimaeric reconstitution’ analysis suffers from excluding 
several posttranscriptional modifications that might be important for PTase, 
though they have been shown not to be fundamental (Green & Noller, 1996).
Based on the results of structure probing experiments with peptidyl 
transferase substrates and inhibitors (for details, see Section 1.5.4 and 1.11), 
23 S rRNA domains V and in a much lesser extent domain IV have been 
subjected to site directed or random mutagenesis with a hope to specify 23S 
rRNA nucleotides involved in peptide bond formation. The effects of the first 
mutations in the domain V were published by Vester and Garrett in 1988. Cells 
with A2060C and A2450C mutations were shown to be nonviable and the 
mutant rRNA was strongly underrepresented in 70S ribosomes, but not in 50S 
subunits. In addition, G2502C and G2503C transversions caused a decreased 
growth rate and the latter mutation was found to confer resistance against 
chloramphenicol. Most surprisingly, A2503C RNA was demonstrated to be 
preferred over chromosome encoded natural 23 S rRNA (more than 90% ribo­
somes contained mutant RNA), implying to the importance of this region for 
50S assembly. Furthermore, in an attempt to gain insight into the structural 
alterations induced in the domain V, part of the domain (from position A2051 to 
G2603) was probed with various chemical and enzymatic probes. As a result, 
only minor structural changes were observed (Vester & Garrett, 1988). How­
ever, no connection was made in this work between the growth phenotypes and 
ribosomal peptidyl transfer function.
The first 23 S rRNA mutations demonstrated to affect PTase were base sub­
stitutions at positions G2505 and G2583. Using thiostrepton to discriminate be­
tween wild type and mutant ribosomes under in vitro conditions (puromycin 
reaction), all three substitutions at position G2583 and G to C replacement at 
position 2505 were demonstrated to inhibit NAcPhe-puromycin formation 
(Paper I; see also Section 2).
Recently, Porse and colleagues have performed an extensive mutagenesis of 
23 S rRNA domain V and analysed the mutants with respect to their influence 
on cell growth, ribosome assembly and PTase. Secondary mutation A2058G 
was introduced and the ability of mutant ribosomes to carry out peptidyl 
transfer reaction was measured in the presence of clindamycin (Porse & Garrett,
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1995; Porse et al, 1996). Extreme effects on cell growth were observed for 
mutants U2506A, U2506C, U2506G, ¥2580C, G2583U, U2584G, U2585A, 
U2585C and U2585G, which all exhibited dominant lethal phenotype (they 
were not able to grow even in the presence of 60 to 70% wild type ribosomes 
encoded by host chromosome). In general, dominant lethality correlates with 
severely affected PTase activity in vitro. A decrease in activity in the ‘fragment 
reaction’ could be a consequence of weakened binding of either PTase 
substrates: puromycin or peptidyl-tRNA fragment or impairment of peptide 
bond formation. 23 S rRNA mutations U2506C, U2584G and U2585G that are 
dominant lethal, express significant activity in forming peptide bonds. 
Therefore, severe growth deficiency of these mutants can not be explained 
solely by impaired peptidyl transferase, but some other translational process(es) 
must be affected. Mutants G2583A and U2584C were extraordinary in that their 
growth rate was close to wild type but their ribosomes exhibited low activities. 
When Ac-Phe-tRNAphe was used as a donor instead of the fragment, ribosomes 
from mutants U2584A, U2584C and to a lesser extent U2585C and U2585G 
displayed enhanced peptidyl transferase activity, suggesting that the whole 
tRNA helps to compensate for defective interaction between the CCA end of the 
tRNA and the ribosome. In general, mutant RNAs incorporated readily into 5OS 
and 70S particles, implying to unaltered 50S subunit assembly and subunit 
association. There are few exceptions: G2505C, G2550A, ¥25800, U2584A 
and U2584G mutants were severely reduced in 70S ribosomes.
Two mutations, namely G2550A and A2565U, are rather peculiar — they 
incorporate extensively into 50S subunits, but are underrepresented in 70S 
monosomes. Incorporation into ribosomal particles was found to be adversely 
correlated with the PTase activity. 50S particles from these mutants are with 
very low PTase activity, but the activity is drastically elevated after association 
with 30S subunits. Thus, G2550A and A2565U mutations seem to weaken the 
subunit-subunit interaction. In a single case, for mutant U2528C, the authors 
have noticed an increased PTase reaction rate for 5 OS subunits; 70S ribosomes 
with the same mutation were not different from wild type ribosomes.
Two phylogenetically invariant sequences, UGG2251 and ¥GG2582, can be 
found in 23 S rRNAs that could have the potential to interact via Watson-Crick 
base pairing with the universal CCA 3 ’ end of the tRNA at the ribosomal PTC 
(Gutell, 1993). When base changes were introduced into the first two positions 
of these sequences, no assembly or polysome formation defects were detected. 
While the mutations on the helix-loop 80 region (UG2250) hardly affected 
bacterial growth and peptide bond formation, the helix 90 mutants (¥02581) 
caused severe growth effects and were seriously inhibited in poly(Phe) synthesis 
(Spahn et al, 1996a) and in PTase assay (Spahn et al., 1996b). Cells with 
G2581A mutation in their 70S ribosomes were unable to grow and exhibited no 
PTase activity. The influence of ¥25800 mutation was rather mild on bacterial 
growth. Notably, ribosomes with the same mutation were shown to have lost
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about half of their efficiency in the PTase assay. Intriguingly, ribosomes with 
G2581A and ¥25800 mutants did not response to addition of CMP in reaction 
between pA-fMet and Phe-tRNAPhe (the same was also observed for G2582A 
and C, see Section 2.1.1). CMP is known to stimulate this reaction by a factor of 
four, but has no stimulatory effect with the CA-fMet. The result has been 
interpreted that the universal C75 of tRNA is essential for the correct docking of 
the donor substrate to the PTC (see above). Accordingly, the whole ¥002582  
sequence could be, either directly or indirectly, involved in binding of the C75 
of the peptidyl-tRNA to the donor site.
Among the bases of 23S rRNA that are protected from chemical probes by 
P-site tRNA and by CCA containing oligonucleotide analogues of P-site tRNA 
are the universally conserved nucleotides G2251, G2252 and G2253. Therefore, 
these nucleotides are possible candidates to interact with the tRNA C74C75 at 
the ribosomal donor site. Lieberman and Dahlberg were the first to analyze this 
region. Double mutant G2252C/G2253C was found to severely compromise 
cell growth. Mutant RNA assembled into 50S and 70S particles but was 
discriminated against in polysomes. The PTase activity, assayed in the ‘puro- 
mycin reaction’, was decreased, but the effect was rather moderate (influence of 
this double mutation on peptide bond formation could be underestimated, since 
the formation of AcPhe-puromycin was judged in the presence of wild type 
ribosomes). To test whether this effect derives from disruption of base pairing 
with the invariant cytidines of tRNA 3’ end, a mutant tRNA gene was 
constructed with the GGA sequence instead of CCA. Mutant tRNA was ready 
to accept amino acid but failed to react as a P-site substrate, with either wild 
type or mutant ribosomes.Although these results support a role for G2252 and 
G2253 of 23S rRNA in the peptide bond formation, they fail to provide 
evidence supporting canonical base pairing between these residues and the 3’ 
end of peptidyl-tRNA (Lieberman & Dahlberg, 1994). However, recent work of 
Samaha and coworkers disproves this observation to some extent. Using 
chimaeric reconstitution strategy to obtain pure population of mutant 50S su­
bunits in combination with highly sensitive ‘fragment reaction’ they were able 
to demonstrate that compensatory mutation at position 74 (C to G) of tRNA 
restores the PTase activity of G2252C mutant ribosomes. Thus, interaction of 
tRNA in the 50S donor site involves Watson-Crick base pairing between C74 of 
tRNA and G2252 of 23 S rRNA. The role of this interaction is probably to 
position the acceptor end of peptidyl-tRNA in the PTase site. Additionally, it 
was found that G75 mutation of tRNA cannot undergo Watson-Crick base 
pairing with G2253 in the same experimental system (Samaha et al, 1995). The 
results are in good correlation with the observed effects of these mutations: 
G2252 mutations were dominant lethal, while G2253A and U mutants were 
only slightly affected in growth rate and PTase activity. G2253C mutation was 
found to confer recessive slow growth phenotype and was deficient in PTase 
assay in vitro (Porse et al., 1996). The G2252 mutants were determined to be 
underrepresented in polysomes, which could be the consequence of impaired
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PTase activity that impedes the rate of movement of ribosomes along mRNA 
(Samaha et al, 1995). The requirement for canonical base pairing between 
tRNA and 23 S rRNA that is so important for peptide bond formation under in 
vitro conditions, seems to be less stringent in vivo, at least with the tRNA]Val. 
Substitution of the tRN A ^31 3’ terminal CCA sequence to UCA had little or no 
effect on tRNA-ribosome interaction while the GCA and ACA mutations 
significantly increased the level of frame shifting and stop codon readthrough 
(O’Connor et al, 1993). It seems therefore that Watson-Crick base pairing 
between C74 of tRNA and G2252 of 23 S rRNA is not fundamental for peptide 
bond formation but is required for maintaining the accuracy of translation.
When another candidate for the interaction with C75 of tRNA, G2251 of 23 S 
rRNA, was subjected to analysis, it was found that mutations G2251A and U 
confer dominant lethal phenotype and are severely deficient in PTase activity. 
No suppression of this decrease was observed using C75 mutant tRNA 
fragments (Green et al, 1997). The absence of Watson-Crick suppression does 
not rule out the possibility of existence of non-canonical base pairing (Porse et 
al, 1996) or that other moieties like phosphate or ribose of the RNA backbone 
are involved in direct interaction between 23 S rRNA and tRNA (Hiittenhoffer 
& Noller, 1992).
1.10. Antibiotics and peptide bond formation
The majority of antibiotics inhibit cell growth by binding to functionally 
essential regions of the ribosome. Correlating antibiotic binding site with its 
mode of action provides a valuable source of information to understand the 
structure-function relationship of the ribosome. In general, antibiotics are 
produced by micro-organisms to inhibit the growth of others. One of the earliest 
indications that rRNA could be target for antibiotic action came from studies on 
Staphylococcus aureus. This organism was shown to protect itself from the 
attack of MLS antibiotics (macrolides, lincosamides and streptogramin type B 
compaunds) by methylating its 23S rRNA (Lai et al, 1973). Later, several 
Streptomyces species being producers of many known antibiotics have been 
demonstrated to use similar strategy. The producer of erythromycin, Strepto­
myces erythraeus dimethylates A2058 of its own 23S rRNA (Skinner et al., 
1983) and Streptomyces azureus, the producer of thiostrepton, exploits similar 
self-defence by methylating nucleotide A 1067 of its 23 S rRNA (Thompson et 
al, 1982). Thus, antibiotics seem to use rRNA as the primary target. The only 
example of antibiotic interaction with r-proteins is erythromycin, that binds 
weakly in solution to the ribosomal protein L I5 (Teraoka & Nierhaus, 1978). 
The fact that rRNA-antibiotic contacts are the basis for the act of inhibition is 
reinforced by the observations, that group I self-splicing introns and hammer­
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head ribozymes are inhibited by aminoglycoside antibiotics (Stage et al, 1995; 
von Ahsen et al, 1991).
Using the chemical footprinting method, a large proportion of antibiotics that 
interfere with PTase reaction have been shown to protect specific bases in 23 S 
rRNA (Spahn & Prescott, 1996). Chloramphenicol is a classical inhibitor of 
PTase that inhibits peptide bond synthesis both in vivo and in vitro. It is known 
to affect A’-site binding, while P’-site binding remains unaffected (Harris & 
Pestka, 1977). The drug protects 23S rRNA nucleotides A2059, A2062, A2451, 
G2505 and enhances the reactivity of A2058 in the central ring of domain V 
(Moazed & Noller, 1987). Mutations at positions 2032, 2057, 2058, 2447, 2451, 
2452, 2503 and 2504 confer resistance to chloramphenicol (Garrett & Rodri- 
guez-Fonseca, 1995). Alterations of 23S rRNA nucleotides G2505 to C and 
G2583 to A or U lead ribosomes to hypersensitivity towards chloramphenicol 
(Paper I). Proteins L I6 and L27 yielded cross-links to chloramphenicol 
(Cooperman et al, 1990) and L16 enhances binding of the drug to the ribosome 
(Nierhaus & Nierhaus, 1973).
Lincosamide antibiotics (lincomycin and its derivative clindamycin) together 
with macrolides (like erythromycin and carbomycin) are known to compete 
with chloramphenicol for the ribosome binding. They all, except erythromycin, 
inhibit the ‘puromycin reaction’. Erythromycin appears to block entrance of the 
tunnel for the growing peptide (Arevalo et al., 1988), thereby stimulating 
premature dissociation of the peptidyl-tRNA from the ribosome (Menninger & 
Otto, 1982). In the same paper, carbomycin and spiramycin, and quite recently 
also lincosamide antibiotics were shown to have the same effect (Menninger & 
Coleman, 1993). Chloramphenicol instead, prevents the displacement of 
peptidyl-tRNA (Menninger, 1976). Lincomycin and clindamycin protect 23 S 
rRNA bases A2058, G2061, A2451 and G2505 from chemical modifications 
and the patterns of modification differ in that A2059 is protected by clinda­
mycin but not by lincomycin (Douthwaite, 1992b). Both erythromycin and 
carbomycin alter chemical reactivities of bases A2058, A2059 and G2505, 
while only carbomycin protects also A2062. Mutations G2505C, G2583U and 
G2583C led to increased sensitivity to lincomycin in ‘puromycin assay’ (Paper 
I; see also Section 2). Base changes at positions G2032, A2058 and A2059 
render ribosomes resistant to lincomycin. Clindamycin resistance involves 
rather close set of bases, positions G2032, G2057 and A2058. Deletion of bases 
1219-1230 in the domain II as well as mutations at positions G2057 and A2058 
give resistance to erythromycin, but alterations of nucleotide G2032 make ribo­
somes hypersensitive to erythromycin (Garrett & Rodriguez-Fonseca, 1995). 
Thus, the binding sites for macrolides, lincosamides and chloramphenicol are 
largely overlapping, while their mode of action is not identical.
Puromycin is a structural analogue of the 3’ end of Tyr-tRNAXyr. It is known 
as an effective A-site competitor and while bound, it can accept the growing 
peptidyl residue from the ribosomal donor site (Vazquez, 1979). After the 
complex between peptidyl-tRNA and puromycin has been formed, no further
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peptidyl transfer can take place, since the amide bridge cannot be cleaved by the 
ribosome and peptidyl-tRNA-puromycin complex falls off the ribosome. Azido- 
puromycin has been cross-linked to nucleotides G2502 and G2504 of 23S 
rRNA and to ribosomal proteins L I5, L I8 and L23 (Cooperman et al, 1990). 
As a minimized substrate of the ribosomal A-site, puromycin has been exploited 
as a classic tool for investigating ribosomal peptidyltransferase reaction.
Sparsomycin and amicetin are also powerful inhibitors of PTase. Sparsomy- 
cin enhances binding of the donor substrates to the ribosomal P-site and com­
petitively inhibits the acceptor substrate binding to the ribosomal A-site (Vaz­
quez, 1979). Chloramphenicol and lincomycin have been shown to compete 
with sparsomycin for binding to the ribosomes, suggesting that the binding 
takes place close to the ribosomal PTC. In contrast to most of the PTase in­
hibitors, sparsomycin and amicetin do not ‘leave any strong footprints behind’. 
However, mutants of Halobacterium halobium and Halobacterium salinarium 
were isolated that exhibit resistance to sparsomycin. Mutations at positions 
C2471, C2518, and U2519 (C2452, C2499, and U2500 accordingly to E. coli 
numbering) for the first, and the absense of modification at U2603 for the 
second archeon, have demonstrated to confer resistance against the drug (La- 
zaro et al, 1996; Tan et al., 1996). In a similar manner, amicetin resistant mu­
tant, carrying U to C mutation at position corresponding to 2438 in E. coli 23 S 
rRNA has been isolated (Leviev et al, 1994).
Integrating protection patterns of PTase antibiotics on 23 S rRNA with the 
knowledge of their structure and mode of action, Garrett and coworkers have 
constructed a map for the ribosomal PTC (Porse et al., 1995; Rodriguez-Fon- 
seca et al, 1995). The region A2451-C2452 has been implicated as a 
hydrophobic site for the side chains of aromatic amino acids. The photoreactive 
benzoylphenyl derivative, linked to the 3’ end of the P/P site bound tRNA, 
crosslinks to A2451-C2452 (Steiner et al, 1988). A2451 is deprotected on 
excision of amino acid residues from both A/A- and P/P-site bound tRNAs 
(Moazed & Noller, 1989). Single site mutations at these positions in archeal 
rRNAs produce resistance to celesticetin, anisomycin and chloramphenicol 
(Hummel & Böck, 1987; Mankin & Garrett, 1991). Narciclascine, anisomycin 
and chloramphenicol alter reactivities of this region (Moazed & Noller, 1987; 
Rodriguez-Fonseca et al, 1995). All these antibiotics contain aromatic groups 
which are important for their inhibitory action (Vazquez, 1979).
Donor substrate site is proposed to involve nucleotides U2506, U2585, 
A1787 and G2252. Reactivity of nucleotides A2506 and U2585 is shown to be 
enhanced on removal of the 3’-terminal adenosine of P-site bound tRNA. 
Peptidyl-tRNA analogues protect bases G2252-G2253 from chemical modi­
fications (Moazed & Noller, 1989). Recently, a possibility to form a basepair 
between G2252 of 23 S rRNA and C74 of P-site bound peptidyl-tRNA has 
demonstrated (Samaha et al., 1995). Protection effects were observed for 
griseoviridin and virginamycin M, both thought to interfere with P-site substrate 
binding (Vazquez, 1979). A nucleotide covariance study predicted that nuc-
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leotides U I782 and U2586 interact (Larsen, 1992) and cross-link was identified 
between nucleotides U1782 and G2608/G2609 (Mitchell et al, 1990). Griseo- 
viridin induced an enhanced chemical reactivity of A 1787 in addition to pro­
tecting U2585 (Rodriguez-Fonseca et al., 1995).
C2394 is one of the three sites that is protected by E-site bound deacylated 
tRNA (Moazed & Noller, 1989) but protection by virginamycin M and toxin T2 
was observed exclusively on eukaryotic 28S rRNA at this position. Macrolides 
yield footprints at A2508, A2509 and U2609 (Rodriguez-Fonseca et al, 1995). 
Nucleotides at the A2058-A2062 region and U2609 supposedly constitute part 
of an entrance of the nascent peptide channel. The A2058 to A2062 region is 
also easily accessible to chemical probes in the ribosome (Egebjerg et al.,
1990). Methylation of A2058 has been demonstrated to give resistance against 
erythromycin in its producing organism (Skinner et al, 1983). Recently, Tenson 
and coworkers have found that erythromycin resistance could be mediated by a 
specific interaction of the 23 S rRNA-encoded pentapeptide (E-peptide) with the 
ribosome (Tenson et al, 1996). E-peptide is assumed to interact with the large 
ribosomal subunit in the vicinity of the peptidyltransferase centre at the site of 
erythromycin binding (Tenson et al, 1997).
1.11. Translational accuracy
Translation is a relatively rapid and accurate process, proceeding at a rate of 
about 20 amino acids per second with an average of 5x 10-4 missense events per 
codon. The process is well balanced in respect to speed and accuracy. For 
example, if the ribosome selects tRNA with maximum accuracy, then trans­
lation is exceedingly inefficient and vice versa (Kurland & Ehrenberg, 1987). 
Therefore, deviations in tRNA selection could be very costly or even lethal for 
the cell.
How is the translational accuracy ‘kept in frame’ and what are the com­
ponents and mechanisms involved in this process?
Ribosomal mutations and universal inhibitors of protein synthesis that alter 
ribosome functioning have been useful tools to answer these questions. In 1961 
Gorini with colleagues noticed the peculiarity that an arginine auxotroph that 
contained also mutation rendering it resistant to streptomycin could be restored 
to prototrophy by addition of streptomycin to the growth medium (Gorini et al, 
1961). After careful inspection, evidence was presented that streptomycin was 
altering the specificity of translation via an interaction with the ribosome 
(Gorini, 1964). This was the first time when the importance of ribosomal struc­
ture was recognized to influence reading of the code during translation — up 
until that time, it was thought that all the specificity of translation of the genetic 
code depends on the interaction between transfer RNA and messenger RNA.
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Streptomycin and other aminoglycoside antibiotics have been demonstrated 
to induce misreading of the genetic code, whereas kasugamycin appears to 
increase the accuracy of translation. Many fidelity mutants of tRNA have been 
isolated (Murgola, 1985). Mutations in ribosomal proteins S4, S5, L7/L12, 
elongation factor Tu and release factor 1 and 2 decrease the accuracy of protein 
synthesis, while mutant r-proteins S I2, S17 and L6 increase it implying that 
accuracy tuning depends on components other than codons and anticodons 
(Yarns & Thompson, 1983).
During the course of translation, tRNAs contact a number of bases in 16S 
and 23 S rRNA. The anticodon end of tRNA and mRNA associated to it interact 
with the decoding centre of 30S subunit and the CCA 3 'end of the tRNA 
interacts with the PTC of the 50S subunit. Residues in both 16S and 23 S rRNAs 
have the potential to influence the interaction between tRNAs and the ribosome 
and, consequently, the selection of correct tRNA. Base changes in 16S rRNA 
were demonstrated to suppress nonsense mutations, frameshift mutations, and 
cause increased translational misreading (Noller, 1991; Lieberman & Dahlberg,
1996).
To date, 23 S rRNA is also included into the list of components that control 
the precision of translation. At first, it would seem to be a little surprising, since 
the codon-anticodon interaction on 30S subunit is known to be responsible for 
choosing the right aa-tRNA during the decoding process. However, according to 
the current knowledge, establishment of a codon-anticodon interaction is not the 
final stage for correct docking of the whole tRNA that would be properly de­
coded and ready for peptidyl transfer. After the ternary complex enters the ribo­
somal A-site, the anticodon part of the tRNA makes contact with mRNA and 
the decoding centre of the 3OS subunit. This is the moment for initial selection. 
The ternary complex, cognate or non-cognate, may either establish the codon- 
anticodon interaction by hydrolyzing GTP or dissociate from the ribosome. 
When the initial selection is over and tRNA-mRNA interaction is firm, EF-Tu- 
GDP leaves the ribosome and aa-tRNA is positioned into the proof-reading site. 
At this site, the CCA 3’ end of the tRNA is not yet fixed. Aminoacyl-tRNA may 
now be discarded from the ribosome or become docked into the peptidyl 
transfer site of the 50S subunit. When docking of the CCA end occurs, then the 
selection is over and peptidyl transfer can take place. For efficient peptide bond 
formation, the CCA ends of both aa-tRNA and pep-tRNA need to be properly 
positioned. 23S rRNA and several r-proteins have been shown to be involved in 
binding of both substrates (see Section 1.9). Thus, experimental evidence 
indicates that 23S rRNA could actually participate in tuning translational 
accuracy.
The first 23S rRNA mutants that affect translational accuracy were disco­
vered in our laboratory. We checked the misreading properties of mutant ribo­
somes and found that mutations at position G2583 (to C and U) lead to in­
creased translational accuracy in vitro (Paper I). The same mutations attributed
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error restrictive character to the ribosomes also in vivo (Nigul et al, unpub­
lished; Paper II; for details, see Section 2).
Another 23 S rRNA mutant with a G to C transversion at position 2661 in the 
universally conserved a-sarcin loop that interacts during ribosomal elongation 
cycle with elongation factors Tu and G, has been shown to confer ribosomes an 
error restrictive phenotype in vitro (Bilgin & Ehrenberg, 1994). The gain in ac­
curacy was attributed to the improved initial selection rather than proof-reading, 
correlating with a loss in kcat/KM for the ternary complex-ribosome interaction. 
This agrees with the expectation that when the accuracy in a certain step 
approaches its maximum then the kcat/KM must drop considerably. Combining 
the 23S rRNA mutation with error restrictive mutation of r-protein SI2, even lo­
wer error rate was observed. The G2661C mutation causes a loss of viability in 
combination with a hyperaccurate rpsL mutation (Tapprich & Dahlberg, 1990). 
Viability can be restored by introduction of a tufA mutation (Tapio & Isaksson,
1991) or by addition of antibiotic streptomycin to the media (Bilgin & Ehren­
berg, 1994).
In addition to hyperaccurate mutants, multiple error prone 23 S rRNA mu­
tants have been obtained. The fidelity of decoding is decreased by mutations at 
position U2555, a base protected by the aminoacyl residue of A-site bound 
tRNA (O’Connor & Dahlberg, 1993) and by mutations at positions 
G2252/G2253 (Gregory et al., 1994), bases protected by the CCA end of pep- 
tRNA (Moazed & Noller, 1989). Moreover, G2252 and C74 of tRNA have 
shown to base-pair (Samaha et al., 1995). Eight different 23S rRNA mutants 
(and none of 16S rRNA) were recovered by isolating rRNA mutants that in­
crease frameshifting (O’Connor & Dahlberg, 1995). One group of mutations 
(U2460G, U2492C, U2493C and deletion of U2493) was located in helix 89, 
close to the central loop of domain V. No tRNA or antibiotic dependent pro­
tection was observed in helix 89 in chemical footprinting experiments. In 
eukaryotic 28S rRNA, bases in the region equivalent to the loop end of helix 89 
became hypersensitive to chemical modification reagents upon association of 
subunits into 80S ribosomes (Holmberg et al., 1994). These data indicate that 
this 23S rRNA region undergoes structural rearrangements during subunit 
association. Mutations at position U2493 result in a drastic decrease in pepti- 
dyltransferase activity (Porse & Garrett, 1995). The other group of mutations 
lies in a small single-stranded loop in domain IV: C1914U, insertion of an extra 
A between A1916 and U1917 and deletion of A1916. Bases A1916, A 1918 and 
U1926 are protected from chemical modification by the 3OS subunit (Noller,
1991) and several intra-RNA cross-links have been obtained between domain
IV and V (Mitchell et al, 1990). Mutations at several positions in domain IV, 
close to position 1916, greatly reduce the peptidyltransferase activity of the 
mutant ribosomes (Leviev et al, 1995). These data place the CCA end of the 
tRNA close to both the 1916 region and the peptidyltransferase loop in domain 
V. Another mutant isolated during these experiments contains substitution of
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C2666 to U in 23 S rRNA. Position 2666 is close to position 2661 mentioned 
above that is involved in tRNA selection. All the mutations that change the 
accuracy of translation are in highly conserved or invariant elements of 
ribosomal RNA.
Conclusively, changes in the interaction o f the CCA end o f the tRNA due to 
mutations in the putative peptidyltransferase centre have serious impact on 
overall accuracy o f translation (Table 1).
1,12. Ribosomal proteins and peptidyl transferase
The question ‘Which protein is the peptidyl transferase?’ has been asked for 
more than two decades. In early days, isopycnic CsCl gradient and high mag­
nesium concentration was used to “strip” the 50S subunit, and three discrete 
particles with increasing protein content were found. The transition coincided 
with the loss of both a small group of proteins and peptidyltransferase activity. 
The activity was restored by replacing the proteins L6, LI 1 and L I6 (Staehelin 
et a l, 1969). Similar results were obtained by other groups. Stripping proteins 
with LiCl (Moore et a l, 1975; Nierhaus & Montejo, 1973), a single split protein 
L I6 was found to restore the catalytic activity (as discussed below, L I6 is not 
crucial for PTase). Single omission tests, where 50S subunits lacking one 
ribosomal protein were reconstituted and tested in the fragment reaction for 
peptidyltransferase activity, have pointed to a larger set of proteins necessary 
and sufficient for the activity: L2, L3, L4, L I5 and L I6 (Schulze & Nierhaus, 
1982). Although the reconstitution technique does not answer, whether the 
ribosomal component is essential for the assembly of the whole active centre or 
part of it, it certainly defines the group of possible candidates. Since the 
peptidyltransferase takes place in close proximity to acceptor ends of A- and P- 
site bound tRNAs, the crosslinks between 3’ terminals of such tRNAs and 
ribosomal components must refer to the closeness to the catalytic centre. 
Ribosomal components identified by this approach are the proteins L2, L I5, 
LI 6, L27 and L33, plus 23S rRNA (Wower et a l, 1993). Photoaffinity labeling 
by antibiotics that inhibit peptidyl transferase provided evidence for the 
presence of L2, L I5, L I6, L I8, L22, L23 and L27 as well as the central loop of 
domain V of E. coli 23 S rRNA at or near the peptidyltransferase centre 
(Cooperman et a l, 1990). L15, L16 and L27 were later exluded from the list of 
possible candidates — viable E. coli mutants lacking L I5 and L27 could be 
isolated (Dabbs, 1986; Wower et a l, 1995). L16 was found dispensable for both 
catalytic activity and poly(Phe) synthesis (Francheschi & Nierhaus, 1990; 
Remme et a l, 1983; Tate et a l, 1987). Hence, proteins L2, L3, L4 together with 
23S rRNA are the main suspects for being crucial for the ribosomal PTase.
It has been proposed that peptidyl transferase operates via a charge-relay 
system similarly to serine proteases, though the serine proteases cleave the pep-
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tide bond, while ribosome forms it (Nierhaus et a l, 1980b; Rychlik & Cerna,
1980). The catalytic core of serine proteases consists of three amino acids: 
serine, histidine and aspartic acid. The involvement of histidine in peptide bond 
formation is supported by several observations: the pH dependence of peptidyl 
transferase correlates with the involvement of an imidazole residue of histidine, 
or the N-terminal a-amino group of peptide (Maden & Monro, 1968); histidine- 
modifying agents inhibit the peptidyltransferase activity of the 50S subunit 
(Rychlik & Cerna, 1980). An involvement of serine or aspartic acid in the 
peptidyltransferase reaction has never been demonstrated. Among r-protein 
candidates for peptidyltransferase, evolutionally the most highly conserved 
protein is L2. Similarly to serine proteases, L2 has universally conserved histi­
dine, serine and aspartic acid. It has been shown that the modification of one 
histidine residue of L2 is sufficient for the loss of PTase activity (Wan et a l, 
1975). In addition, antibodies raised against L2 block the fragment reaction 
(Nag et a l, 1986; Olsen et a l, 1991). Furthermore, L2 is capable of binding to a 
portion of domain IV of 23S rRNA (Beauclerk & Cundliffe, 1988) that is 
structurally and functionally linked to the central loop of domain V. The latter 
region of 23 S rRNA was clearly identified as a part of the peptidyltransferase 
centre (Cooperman et a l, 1990; Garrett & Rodriguez-Fonseca, 1995; Noller,
1993). 50S subunits depleted of L2 were shown to be inactive in puromycin 
reaction as well as in dipeptide formation assay (Dietrich, G., personal com­
munication). The results indicate that at least one of the following reactions is 
dependent on L2: binding of A-site acceptor tRNA and/or P-site donor tRNA or 
the PTase. Yet another likely explanation is that protein L2 might be necessary 
for the structural stability of the catalytic centre. Interestingly, L2 has also a 
significant affinity to tRNA (Remme et a l, 1985). Ribosomes with His229Arg 
mutation in protein L2 have shown to be inhibited (five-fold) in the ‘puromycin 
reaction’ (Dietrich, G., personal communication). In another study, when the 
same histidine was mutagenized to Gin a complete loss of PTase activity was 
observed (Cooperman et al., 1995).
In addition to L2, another 5OS subunit protein, namely L27, has been made 
responsible of modulating ribosomal PTase (Wower et a l, 1995). In this study, 
a constructed minus L27 mutant exhibited an impaired PTase activity, as tested 
by ‘puromycin reaction’. As noted above, L27 has thought to reside in close 
proximity to PTase substrates or the PTase inhibitors.
The importance of L3 and L4 in peptidyltransferase reaction remaines enig­
matic.
As a potential catalyst, RNA has its own apparent deficiencies when com­
pared with proteins. The common amino acids provide a much wider array of 
functional groups than the four major RNA nucleotides. Therefore, proteins 
seem to be much more adaptable to substrate binding and chemical catalysis 
than RNA. The inherent versatility of proteins as enzymes is shown by their 
ability to catalyze more comprehensive range of chemical processes that is 
known for ribozymes.
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Using aa-tRNA and pep-tRNA in mRNA directed polypeptide formation, 
Nitta and coworkers found that the PTase reaction is promoted by a tertiary 
amine, pyridine. Tertiary amines appear to accelerate the PTase by means of its 
catalytic character on the nucleophilic substitution reaction. In 1995 M. Shimizu 
published a paper, where the catalysis of peptidyl transfer reaction was shown 
to occur without the aid of ribosome. A dipeptide, alanylhistidine, was de­
monstrated to act as a catalyst for the peptidyl transfer reaction between the 
amino acid moieties of phenylalanyl, lysyl, prolyl and glycyl tRNAs in the ab­
sence of ribosomes. This reaction was strictly dependent on their model temp­
lates: poly U, poly A, poly C and poly G, respectively. Histidine, that is tertiary 
amine like pyridine has no catalytic activity unless complexed with alanine. 
Interestingly, amongst 18 different dipeptides, only alanylhistidine exhibited 
significant catalytic properties, while histidylalanine did not (Shimizu, 1996).
1.13. Other modulators of peptide bond formation
A nonribosomal protein factor termed as EF-P is known to enhance both the 
affinity of acceptor substrate binding and peptide bond formation (Chung et a l,
1990). EF-P does its job by an unknown mechanism, possibly by ‘fine-tuning’ 
the catalytic centre.
Both, 5S rRNA and 30S subunit can be neglected when PTase is considered 
from the fundamental point of view. However, for efficient protein biosynthesis 
both 5S rRNA and 3OS subuinit are required. 5S rRNA is a component of the 
large ribosomal subunit of cytoplasmic ribosomes from all living organisms, 
with the exception of fungi and animal mitochondria. Particles lacking 5S 
rRNA possess only 8-10% of the activity of mature 50S subunit as judged by 
puromycin reaction. The same particles were unable to bind aa-tRNA-EF- 
Tu*GTP ternary complex (Dohme & Nierhaus, 1976).
As already mentioned above, the PTase reaction occurs at the subunit inter­
face. 30S subunit shields the catalytic centre against ribonuclease and protease 
attack and both subunits protect most of the P-site bound tRNA from hydroxyl 
radical attack (Hiittenhoffer & Noller, 1992). Ribosomal protein L2, that is 
known to modulate the rate of PTase reaction in E. coli, crosslinks to several 
proteins of the 30S subunit (Lambert & Traut, 1981). 30S subunit may in­
directly participate in peptide bond formation by influencing the conformation 
of both tRNAs and the 50S subunit. In the fragment reaction between C-A-C-C- 
A-fMet and puromycin, which can occur without 30S subunit, the rate of fMet- 
puromycin formation is increased by a factor of two when 70S ribosomes are 
used (Monro, 1967).
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1.14. Elongation factor cycles and 23S rRNA
During each round of ribosomal elongation cycle, elongation factors Tu (EF- 
Tu) and G (EF-G) interact alternately with the ribosome at overlapping, 
mutually exclusive sites. Both factors are members of the family of G-proteins, 
the activity of which is regulated by the binding of GTP or GDP (Bourne et al.,
1991). Binding of GTP activates both proteins, while GDP bound factors are in 
their inactive state. Like most essential processes during protein synthesis, the 
cyclic performance of Escherichia coli translational elongation factors is linked 
with specific regions in the rRNA. Two structural motifs of E. coli 23 S rRNA 
have been established that are in control of the fluent action of elongation 
factors during ribosomal elongation cycle. One such motif has been situated in 
the domain II on the secondary structure model of E. coli 23S rRNA (Fig. 3A). 
According to the site of binding for thiopeptide antibiotic thiostrepton it is 
termed as “thiostrepton binding structure”, TBS (nucleotides between positions 
1051 to 1108). Another structural element, known as the site of action of cyto- 
toxin a-sarcin (the “a-sarcin stem-loop structure”) is lying in the domain VI 
(Czworkowski & Moore, 1996; Thompson, 1996). These two regions are distant 
from each other on the primary and secondary structure of E. coli 23 S rRNA. 
However, on a higher structural level in the ribosome, they might reside in close 
vicinity. Immuno electron microscopy, footprinting and cross-linking expe­
riments have demonstrated, that both elongation factors share partially 
overlapping binding sites On the ribosome (Thompson, 1996). EF-G has been 
cross-linked to the TBS (Sköld, 1983). It also shields several nucleotides against 
chemical modification in the same domain, as well as in the a-sarcin loop. EF- 
Tu protects nucleotides in the a-sarcin loop, but no shielding was detected in 
the TBS (Moazed et al., 1988). Mutational analysis has shown that E. coli 
ribosomes with G to C transversion at position 2661 in 23 S rRNA have EF-Tu 
and EF-G cycles kinetically impaired (Bilgin & Ehrenberg, 1994). Similarly, an 
A to U transversion at position 1067 impairs the cyclic action of both elongation 
factors (Paper III, see also Section 2). These data are implying to the orche­
strated performance between the TBS and a-sarcin loop during ribosomal elon­
gation cycle.
Computer simulated secondary structures of the TBS from organisms re­
presenting different kingdoms are universally conserved (de Rijk et al., 1996). 
In support to phylogenetic data, experimental evidence has demonstrated the 
possibility of heterologous interaction between E. coli protein LI 1 and the TBS 
from archaebacteria, yeast and mouse (Beauclerk et al., 1985; El-Baradi et al., 
1987; Stark et a l, 1980). Successful exchange of the TBS between E. coli and 
yeast without the loss of ribosome functions (Musters et a l, 1991; Thompson et 
a l, 1993) provides an evidence for functional conservation of this rRNA region.
Originally, the importance of the TBS in the ribosome function was deduced 
from experiments, where the mode of action of two antibiotics, thiostrepton and
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micrococcin, was studied. These antibiotics inhibit a variety of reactions in the 
ribosome cycle, among them are EF-Tu and EF-G dependent activities 
(Vazquez, 1979). For both antibiotics, the only established binding site lies in 
the TBS (Rosendahl & Douthwaite, 1995). Thiostrepton producing organism 
Streptomyces azureus has been shown to protect himself from the action of the 
antibiotic by specifically methylating the ribose of nucleotide A at position 
1067 (E. coli numbering) of 23S rRNA (Thompson et al., 1982). The modifi­
cation simply restricts the binding of thiostrepton to the ribosome. Micrococcin 
and thiostrepton, although structurally related to each other, have diametric 
influence on EF-G dependent GTPase: micrococcin stimulates this reaction, 
while thiostrepton inhibits it (Cundliffe & Thompson, 1981). This phenomenon 
correlates with their different binding to the ribosome — structural probing of 
23S rRNA has revealed, that binding of micrococcin enhances and thiostrepton 
reduces the accessibility of the chemical modificator DMS to N 1 position of the 
base A 1067 (Egebjerg et al., 1989). When A at position 1067 in 23S rRNA was 
replaced by U or C, ribosomes became highly resistant to both antibiotics 
(Thompson et al., 1988). Structural probing data suggest that direct interaction 
may exist between A 1067 and thiostrepton or micrococcin (Rosendahl & 
Douthwaite, 1995). Nucleotide A at position 1067 of 23 S rRNA is conserved 
among prokaryotic, archaebacterial and chloroplast 23 S rRNAs, but eukaryotes 
have mostly G at this position (de Rijk et al., 1996). The fact is coinciding with 
the observation, that prokaryotic ribosomes are sensitive to thiostrepton, while 
their eukaryotic counterparts remain totally insensitive. However, the difference 
in the antibiotic binding is only partially attributable to the nucleotide change. 
Eukaryotes are thiostrepton resistant possibly due to the exchange of protein 
L ll with the eukaryotic homologue (Thompson et al., 1993; Uchiumi et al., 
1995). Thiostrepton binding is modulated by the ribosomal protein L ll 
(Thompson et al., 1979), which also binds to the TBS (Ryan & Draper, 1989). 
Comprehensive analysis of the interaction between L ll  and its binding region 
has demonstrated, that L ll  stabilizes tertiary structure of the TBS and is 
therefore important factor for accurate folding of this structure (Draper, 1996). 
L ll and ribosomal protein complex L10(L7/L12)4, often named as L8, have 
been shown to promote EF-Tu and EF-G dependent functions (Beauclerk et al., 
1984). Importance of the TBS has also become evident in etiology of human 
diseases. An anti-28S autoantibody was found in sera of patients with systemic 
lupus erythematosus (Uchiumi et al., 1991). This antibody binds to the euka­
ryotic 28S rRNA (but not to its eubacterial homologue) and inhibits EF-2 de­
pendent GTP hydrolysis. Specificity of the antibody binding is dependent on the 
nature of position 1159 (1067 by E. coli numbering). G il 59 has the binding 
ability, but when substituted to A, the binding is lost. Substitution of A 1067 to 
G in E. coli 23S rRNA confers the antibody binding (Uchiumi & Kominami,
1994). Thus, various types of data imply to the central role of position 1067 for 
ribosome performance.
13 49
Taking together, all the date establish that the TBS together with the a- 
sarcin stem-loop structure o f 23S rRNA, several r-proteins and elongation 
factors are involved in sophisticated interplay to implement the ribosome cycle.
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2. RESULTS AND DISCUSSION
2.1. Functional analysis of E. coli 23S rRNA mutants
2.1.1. Peptidyl transferase
For a long period, when enzymatic activity was considered to be solely the 
property of proteins, the search for the ribosomal peptidyltransferase con­
centrated mainly on ribosomal proteins of the 5OS subunit. The other and more 
objective reason was the absence of adequate methods for analysis of rRNA and 
existence of powerful techniques for detection of ribosomal proteins (like two- 
dimensional electrophoresis and immunoassays, allowing a straightforward 
identification of affinity-labeled proteins). By using derivatives of aa-tRNAs 
and antibiotics that inhibit ribosomal peptidyl transferase, proteins like L2, L I5, 
L I6 and L27 were most often found to be affinity labeled. Mapping by im- 
munoelectron microscopy has shown that L2, L I5 and L27 are clustered at the 
subunit interface, where the interaction of peptidyl transferase substrates is 
thought to occur. However, no single ribosomal protein has been found to 
possess the peptidyltransferase activity.
Our interest has been to specify the components of the ribosomal peptidyl­
transferase centre and to reveal the role of 23S rRNA in this reaction. As judged 
from the review of previously published papers, several nucleotides in domain 
V of 23S rRNA were already suspected to be part of or located in the close 
neighbourhood of the peptidyltransferase centre. Importantly, some of them are 
also universally conserved throughout evolution. As a further step toward the 
understanding of 23 S rRNA functional role in PTase reaction, we chose the site- 
directed mutagenesis approach to change the nucleotide sequence in the putative 
PTase centre of E. coli 23S rRNA. In order to determine the effects of base 
substitutions on peptidyl transfer reaction, 23S rRNA nucleotides G2505, 
G2582, G2:583, G2607 and G2608 were subjected to mutagenesis and further 
analysis. So far, the absence of methods which could discriminate between 
wild-type (chromosome born) and mutant ribosomes (plasmid born) was a 
major obstacle in scoring the effect of 23S rRNA mutations to the peptidyl­
transferase reaction. Therefore, the first task was to find a way to repress 
selectively the influence of wild-type ribosomes. For this purpose, we intro­
duced the second mutation, an A to U transversion at position 1067 into the 
gene of 23S rRNA (Paper I). This base substitution renders ribosomes resistant 
to antibiotic thiostrepton (a powerful inhibitor of translocation) under in vitro 
translation conditions.
Mutant ribosomes were analyzed in respect of their influence on bacterial 
growth and in the following series of in vitro reactions: for their ability to direct
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poly(U) dependent translation, sensitivity to peptidyltransferase inhibitors and 
impact on missense error frequency.
By using thiostrepton based selection between wild type and mutant ribo­
somes in puromycin reaction (Fig. 5), we demonstrated that all three possible 
substitutions of G2583 and G to C replacement at position 2505 inhibit poly(U) 
translation and the NAcPhe-puromycin formation. 23 S rRNA mutants at 
positions G2505 and G2583 are the first rRNA mutants demonstrated to affect 
ribosomal peptidyl transferase. These mutants exhibited also an increased sen­
sitivity to peptidyl transferase inhibitors such as chloramphenicol and linco- 
mycin. While enhanced chloramphenicol sensitivity was observed in poly(U) 
translation, the effect was not seen in puromycin reaction (Paper I). In the same 
paper, an error restrictive phenotype was attributed to the mutations at the 
position G2583 (see below). Because chloramphenicol and lincomycin are 
shown to affect primarily the acceptor substrate binding, correlation between 
hypersensitivity to these antibiotics and altered translational accuracy of G2583 
mutants could be described in terms of the improperly positioned aa-tRNA to 
the ribosomal A-site.
Transiocation Peptidyl
transfer
puromycin
E P A \  / E P A ' t
pep-tRNA puromycin
Figure 5. Schematic representation o f the “selective transpeptidation strategy”. Ribo­
somes and tRNA binding sites are as in Figure 2. A 1067 ribosomes are with 
wild type 23S rRNA, whereas U1067 ribosomes are carrying mutation 
(A1067U) in the same molecule. Base change at position A 1067 to U renders 
ribosomes resistant to antibiotic thiostrepton. By using thiostrepton under in 
vitro conditions, puromycin reaction kinetics can be measured exclusively on 
plasmid borne ribosomes that carry U1067 mutation in 23 S rRNA (Paper I 
and Spahn et al., 1996b).
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In the next series of experiments a more advanced experimental system was 
used (heteropolymeric mRNA instead of poly(U) and codon specific tRNAs). 
The mutations mentioned above and additional mutations G2582A and G2582U 
were found to be severely deficient in peptide bond formation. These results are 
in accordance with the observation that all these mutations were deleterious to 
bacterial growth (Paper I). At the same time, the mutations were shown to have 
no effect on ribosome assembly. The mutant 23 S rRNAs distributed equally in 
the polysomal fraction, in the 70S ribosomes and in 50S subunits (Paper IV).
Furthermore, the role of 23 S rRNA nucleotides in helix 90 region for pep­
tidyl transferase substrate (pep-tRNA) binding was assessed by CMP stimu­
lation assay. In this experiment pA-fMet is the minimal donor substrate for the 
ribosomal peptidyltransferase reaction but its donor activity is significantly 
lower than that of pCA-fMet. Phe-tRNAphe has been used as an acceptor 
substrate. CMP is known to stimulate the PTase reaction between pA-fMet and 
acceptor substrate by a factor of four, but has no stimulatory effect with the 
pCA-fMet (Cerna et al., 1973b). This result suggested that the universal C75 of 
tRNA 35 end is essential for the correct docking of the donor substrate at the 
PTC and that CMP stimulates the donor activity of pA-fMet by taking the place 
of C75 (Cerna, 1975). In a recent paper, Spahn and coworkers have shown that 
the pA-fMet reaction of ribosomes carrying mutations ¥25800 and G2581A 
cannot be stimulated by CMP (Spahn et al., 1996b). The same assay was 
performed with the ribosomes containing mutations at positions G2505, G2582 
and G2583. The mutations at G2582A and G2582C were demonstrated to have 
lost the CMP stimulation, while the adjacent G2583C and G2505C mutations 
responded fully to CMP (Paper IV). Thus, the loss of CMP stimulation seems to 
be restricted to mutations within the ¥GG2582 sequence, indicating that 
¥GG2582 could form a binding pocket for C75 of tRNA. C74 of pep-tRNA has 
already been shown to base-pair with G2252 from the helix 80 region of 23 S 
rRNA (Porse et al., 1996; Samaha et al., 1995). Using the “damage selection” 
approach, nucleotides at positions U2506 and U2585 were identified to be im­
portant in interaction with 3’ A76 of pep-tRNA (A. Mankin, personal communi­
cation). Additionally, a functional coupling between nucleotides of helixes 80 
and 90 has been shown (Green et al., 1997; Samaha et al., 1995), making these 
helices the most likely candidates for the interaction with the 3’ end of pep- 
tRNA.
2.1.2. Translational Accuracy
The very first 23 S rRNA mutants that affect translational accuracy were 
discovered in our laboratory and the finding was rather fortuitous. Occasioned 
by a few experimental hints and by a theoretical proposition that peptidyl 
transferase could be a limiting and irreversible step for aa-tRNA selection
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(Remme, 1993; Remme & Villems, 1985), we checked the misreading proper­
ties of mutant ribosomes and found that mutations G2583C and G2583U lead to 
increased translational accuracy in vitro. Accuracy increased in the order 
G<A<U<C (Paper I). The same mutations attributed error restrictive character 
to the ribosomes also in vivo (Nigul et al., unpublished; Paper II). Cells with 
such hyperaccurate ribosomes were not viable. There are examples available 
were the viability of cells was restored by introducing an extra mutation or 
agent (like antibiotic) that could change the accuracy level back to normal 
(Bilgin & Ehrenberg, 1994). Attempts to restore the growth of G2583C mutant 
with variety of ram mutants (mutations in r-protein and EF-Tu) was not 
successful (Fisher, M., unpublished). G2583C, G2582U and G2582A ribosomes 
have considerably lower processivity both in vitro and in vivo and exhibit 
enhanced pep-tRNA drop-off rate (Paper I; Maiväli et al., manuscript in 
preparation). These results are in accordance with theoretical considerations of 
Kurland and Ehrenberg who have proposed that high accuracy requires com­
paratively low affinity between tRNA and the ribosome, while high processivity 
requires a high affinity between ribosome and tRNA (Kurland & Ehrenberg, 
1987). What could be the reason why G2583C, G2583U and G2583A mutations 
are lethal? One possible explanation is an enhanced drop-off rate of pep-tRNA. 
Excessive accumulation of pep-tRNA is shown to be lethal (Menninger, 1976). 
Alternatively, the main reason to cause such a severe growth phenotype could 
lie in paralysed peptidyl transferase (Paper IV). Obviously, mutations at 
position 2583 affect the ribosomal PTC in the way that the CCA 3' end of the 
tRNA becomes improperly oriented in the PTC, leading to increased time for 
peptidyl transfer. This means longer period for tRNA selection and, since the 
binding of the CCA end is affected, pep-tRNA tends to fall off from the 
ribosome. Thus, peptidyl transfer and translational accuracy seem to be tightly 
dependent on each other and the severe growth inhibition could be induced by 
both factors. The finding that mutations at the 3’ end of tRNA]Val (bound to the 
P- or E-sites of the ribosome) increased frameshifting and readthrough of 
downstream stop codons, provides additional link between peptide bond 
formation and the fidelity of decoding (O'Connor et a l, 1993).
Base changes G2607C, G2608A, G2608C and G2608U had no effect on 
poly(U) translation. Neither they changed the sensitivity towards chlorampheni­
col and lincomycin nor affected translational accuracy (Paper II).
Taking together the results o f translational accuracy and transpeptidation 
experiments one can stress the importance o f nucleotides in helix 90 region on 
ribosomal peptidyl transferase and to the binding/selection o f its substrates. 
Although the experiments with 23S rRNA are strongly suggestive of rRNA 
involvement in the peptidyltransferase reaction, circumstancial evidence still 
exist for the possible involvement o f ribosomal protein(s).
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Table 1.
Mutant Second
mutation
Growth Peptidyl
transfer
Accuracy Publicatio
1. C1914A ok ok 9
2. C1914U m ram 9
3. delA1916 m ram 9
4. A1916+AA st ram 9
5. G1921C m ok 9
6. U1926C A2058G R, L st 15
7. U 1940A A2058G R,L st 15
8. U1946C A2058G R, L st 15
9. U1951C A2058G R, L ok 15
10. U1955G A2058G R, L st 15
11. U 1956A A2058G R, L ok 15
12. U1979C A2058G R, L st 15
13. U 1982A A2058G R, L st 15
14. G1984A A2058G R, L st 15
15. A2060C L 10
16. U2249C A1067U ok 1
17. G2250A A1067U ok ok 1,2
18. G2250A/C2254U A1067U ok 1
19. G2251A TAG R, L st 3
20. G2251U TAG R, L st 3
21. G2252A TAG D, L st 4
22. G2252A L 6
23. G2252C A2058G R, L st 5
24. G2252C L 6
25. G2252U TAG D, L st 4
26. G2252U A2058G R, L st 5
27. G2252U L ram 6
28. G2252C/G2253C m m 7
29. G2253A A2058G ok m 5
30. G2253A TAG R, m 4
31. G2253A ok ok 6
32. G2253C A2058G R, m st 5
33. G2253C m ram 6
34. G2253U A2058G ok m 5
35. G2253U TAG R, m 4
36. G2253U ok ram 6
37. C2254U A1067U ok 1
38. A2450C L 10
39. U2457+G m ram 9
40. U2457+A m ok 9
41. U2457+C m ok 9
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Continue (table 1)
Mutant Second
mutation
Growth Peptidyl
transfer
Accuracy Publicatioi
42. U2457+U m ok 9
43. G2458A ok ok 9
44. G2458A/U2493C m ram 9
45. G2458C/U2493C m ram 9
46. U2460A m ram 9
47. U2460C m ram 9
48. U2460G m ram 9
49. U2460C/G2490C ok ram 9
50. U2460G/G2490A m ram 9
51. U2460G/G2490U m ram 9
52. U2460G/G2490C m ram 9
53. U2477A ok ok 9
54. U2477C ok ok 9
55. G2490A m ram 9
56. G2490C ok ok 9
57. G2490U ok ram 9
58. U2492A m ram 9
59. U2492C m ram 9
60. U2492G m ram 9
61. U2493A A2058G R, L m 8
62. U2493A m ram 9
63. U2493C A2058G R,L m 8
64. U2493C m ram 9
65. delU2493 m ram 9
66. A2497G A2058G m m 8
67. G2502A m 10
68. A2503C m 10
69. A2503G A2058G R, m St 8
70. G2505A A2058G R, m m 5
71. G2505C A2058G R, m m 5
72. G2505C A1067U L m, st ok 12, 13
73. G2505U A2058G R, L St 5
74. U2506A A2058G D, L st 5
75. U2506C A2058G D, L m 5
76. U2506G A2058G D ,L st 5
77. C2507U/G2581A A1067U L 1
78. C2507del/G2581A A1067U L 1
79. G2508U A2058G ok ok 5
80. U2514C A2058G ok ok 8
81. A2516U A2058G ok ok 8
82. U2528A A2058G m ok 8
83. U2528C A2058G ok ok 8
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Continue (table 1)
Mutant Second
mutation
Growth Peptidyl
transfer
Accuracy Publicatio
84. A2530G A2058G ok m 8
85. U2546C A2058G ok ok 8
86. G2550A A2058G R, m m 8
87. U2552A A2058G R, m m 8
88. U2552C A2058G R, m m 8
89. U2555A m ram 11
90. U2555C ok ok 11
91. U2555C A2058G ok ok 8
92. U2555G m ram 11
93. G2557A A2058G m m 8
94. U2561C A2058G ok ok 8
95. A2565U A2058G R, m m 8
96. ¥2580A A2058G R, L St 5
97. ¥25800 A1067U m St 1,2
98. ¥25800 A2058G D ,L m 5
99. ¥2580C A2058G R, L St 8
100. ¥2580G A2058G R, L St 5
101. G2581A A2058G R, m m 5
102. G2581A A1067U L St 1,2
103. G2581C A2058G R, L m 5
104. G2581U A2058G R, L m 5
105. G2582A A2058G R ,L St 5
106. G2582A A1067U L 16
107. G2582C A2058G R, L St 5
108. G2582U A2058G R, L St 5
109. G2582U A1067U m 16
110. G2583A A2058G R, m St 5
111. G2583A A1067U L m, st 12, 13
112. G2583C A2058G R, L st 5
113. G2583C A1067U L m, st ER 12, 13
114. G2583U A2058G D, L st 5
115. G2583U A1067U L m ER 12
116. U2584A A2058G R, L m 5
117. U2584C A2058G R, m m 5
118. U2584C A1067U ok 16
119. U2584G A2058G D, L m 5
120. U2584G A2058G D, L st 8
121. U2585A A2058G D, L st 5
122. U2585A TAG D, L st 3
123. U2585C A2058G D, L st 5
124. U2585C TAG D, L m 3
125. U2585G A2058G D, L m 5
Continue (table 1)
Mutant Second Growth Peptidyl Accuracy Publication
mutation transfer
126. U2585G TAG D, L m 3
127. A2589G A2058G R, m m 8
128. A2600U A2058G ok ok 8
129. G2607C A1067U ok ok 14
130. G2608A A1067U ok ok 14
131. G2608C A1067U ok ok 14
132. G2608U A1067U ok ok 14
1. Spahn et al., 1996a TAG — sequence tag
2. Spahn et al., 1996b ok —- no inhibition
3. Green et al., 1997 m — moderate inhibition
4. Samahae/a/., 1995 st — strong inhibition
5. Porse etal., 1996 R — resessive phenotype
6. Gregory et al., 1994 D — dominant phenotype
7. Lieberman & Dahlberg, 1994 L — lethal
8. Porse & Garrett, 1995 ram-— error prone
9. O'Connor & Dahlberg, 1995 E R --  error restrictive
10. Vester & Garrett, 1988
11. O'Connor & Dahlberg, 1993
12. Paper I
13. Paper II
14. Paper IV
15. Leviev et al., 1995
16. Maiväli et al., manuscr. in preparation
2.1.3. Ribosomal elongation factor cycles
The aim of this study was to specify the involvement of the TBS (nucleotides 
1051-1108) in translational elongation cycle. For this purpose, we have ana­
lyzed kinetic properties of ribosomes with A to U transversion at position 1067 
in E. coli 23 S rRNA.
To date, the TBS has been considered mainly as an important structure for 
EF-G binding and for EF-G dependent GTPase activity. The consideration is 
based on the observations that this 23 S rRNA region is a binding site for ribo­
somal protein complex L10-L7/L12, LI 1, antibiotics thiostrepton and micrococ- 
cin which are all known either to promote or inhibit EF-G dependent GTPase 
reaction (Cundliffe, 1990; Thompson, 1996). A supposition, that the TBS might 
be involved in EF-G dependent GTPase (the TBS has been often called as 
ribosomal GTPase centre) has remained so far without direct experimental
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verification. Among other sites EF-G crosslinks to A 1067 (Sköld, 1983) and 
protects nucleotides at position A 1067 and A 1069 from chemical modification 
(Moazed et a l, 1988). Data presented here confirm the interaction between EF- 
G and the TBS (Paper III). As seen from EF-G cycle time experiment (Paper 
III), a decrease in kcat/KM value for U1067 ribosomes refers to a reduced binding 
efficiency between EF-G and mutant ribosomes. At the same time, there is no 
change in k^t limit, indicating to an unaltered trans location rate for mutant ribo­
somes. As shown earlier, an uncoupled EF-G dependent GTP hydrolysis pro­
ceeds normally for U1067 ribosomes (Thompson et a l, 1988). This notion 
leaves the question of whether the TBS is EF-G dependent GTPase centre still 
open for discussions. Thus, only modest deviations in elongation factor G cycle 
appeared for the mutant ribosomes, which is attributable to weaker interaction 
between EF-G and mutant ribosomes.
There is no evidence that demonstrates a direct interaction between EF-Tu 
and the TBS. Results in paper III are referring to functional interaction between 
EF-Tu and the TBS. Reduced k^/KM value for U1067 ribosomes in EF-Tu 
cycle time experiment reflects an inefficient ternary complex binding to the 
mutant ribosomes. A decreased kcat value implies that the maximal cycling rate 
for EF-Tu is inhibited due to the U1067 mutation. That is to say, EF-Tu stays 
longer in contact with the mutant ribosomes during elongation cycle. This 
phenomenon could be explained by another finding — the rate of GTP 
hydrolysis on EF-Tu is inhibited on U1067 ribosomes (Paper III). Once bound 
to the ribosome, EF-Tu cannot be released before GTP hydrolysis is completed. 
Thus, for the mutant ribosomes, GTP hydrolysis has become rate limiting for 
EF-Tu cycle.
Hence, the mutant 23 S rRNA has an effect on elongation factors Tu and G 
binding to the ribosome and on EF-Tu dependent GTPase. We infer, that 
integrity of the TBS is crucial for EF-Tu to carry out its functions during ribo­
some cycle. Thompson et a l, (1988) have found that U1067 mutation in 23S 
rRNA increases the doubling time of bacteria 1.5 fold. The growth impairment 
could be attributed to the perturbed EF-Tu cycle of U1067 ribosomes. This 
postulation receives a support from in vivo experiments, were it was demon­
strated that the rate of filling the ribosomal A-site is correlating with the speed 
of elongating ribosomes, which in turn determines the growth rate of bacteria 
(Pedersen, 1984). The alterations in kinetic efficiencies for U1067 ribosomes in 
EF-Tu cycle demonstrate the importance of A 1067 in constituting proper 
functional conformation for ternary complex binding to the ribosomal A-site. 
The assumption that the TBS might constitute a part of the ribosomal A-site 
receives support from earlier findings, where modest protections against 
chemical modifications at positions G1068 and G1071 appeared after the tRNA 
has been bound to the ribosomal A-site in an EF-Tu*GTP dependent manner 
(Moazed & Noller, 1989) and from the pattern of binding and action for 
antibiotics thiostrepton and micrococcin, both known to inhibit ribosomal A-site 
related processes. Thiostrepton and micrococcin can bind to the TBS, primarily
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to nucleotides A 1067 and A 1095 of E. coli 23 S rRNA and base changes at these 
positions are rendering ribosomes resistant or less sensitive to thiostrepton or 
micrococcin (Rosendahl & Douthwaite, 1995; Thompson et a l, 1988). The 
structure for thiostrepton binding is complex, depending, beside few direct 
interactions, on integrity of the tertiary structure of the TBS and the presence of 
ribosomal protein L l l  (Ryan & Draper, 1991). Xing and Draper have sug­
gested, that thiostrepton mimics some ribosomal component or factor which 
normally interacts with the L ll  N-terminal domain (Xing & Draper, 1996). 
Thiostrepton inhibits (p)ppGpp formation, peptide chain termination and 
binding of ribosomal factors IF-2, EF-Tu and EF-G to the ribosome (Gale et a l,
1981). Interestingly, depending on experimental conditions, thiostrepton can 
stimulate ribosomal peptidyltrasferase (Kutay et a l, 1990). All these events are 
ribosomal A-site dependent. Therefore, based on current data together with 
earlier findings, we conclude, that TBS forms a structure within the ribosome, 
which determines a part of the ribosomal A-site.
Are the deviations in ribosome cycle of the mutant ribosomes dependent 
only on the base change of A to U at position 1067? Or does the mutation alter 
the high-order structure of the TBS? Alternatively, the binding of ribosomal 
protein L l l  could be affected by the mutation. When the structure of domain II 
of 23S U1067 RNA was probed, no structural alterations were detected in com­
parison to wild-type 23S rRNA. In addition, LI 1 has retained its binding ability 
to U1067 ribosomes (Rosendahl & Douthwaite, 1995), as well as to 23S rRNA 
fragment (1051-1108) containing this mutation (Ryan & Draper, 1991). Thus, 
U1067 mutation in 23 S rRNA seems to have no influence neither to the struc­
ture of 23S rRNA nor to the binding of LI 1 and at a glance, all the changes in 
the EF-Tu cycle can be attributed simply to the base change. However, the data 
derived from the structure probing experiments describe only static state of the 
ribosome. Taking into account dynamic nature of the ribosome and the fact, that 
we have observed several perturbations in the EF-Tu cycle we infer, that the 
U1067 mutation could hinder to some extent the course of proper structural re­
arrangements within the ribosome during ribosomal elongation cycle. E. Cund- 
liffe has made already long ago a suggestion, that the role of LI 1 is to promote 
specific conformational changes in the TBS during translation and that 
thiostrepton inhibits protein synthesis by trapping ribosomal RNA, not allowing 
these changes to occur (Cundliffe, 1990). This idea receives a support from a 
very recent experiments, where structural changes were demonstrated to occur 
in 16S rRNA during translation (Lodmell & Dahlberg, 1997). Likewise, “in 
vitro evolution” experiments have pointed to the possibility of existence of two 
different NH4+ dependent conformations of the TBS (Lu & Draper, 1995). 
Additional information about structural movements of rRNA during translation 
comes from the statement, that ribosomes are oscillating between two con­
formations, known as pre- and posttranslocational stages, at the course of the 
ribosome cycle (Hausner et a l, 1988). Pretranslocational stage is recognized by 
EF-G and posttranslocational stage by EF-Tu. Both elongation factors promote
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the transition from one translocational stage to the other: EF-Tu induces tran­
sition from post- to pretranslocational and EF-G from pre- to posttranslational 
stage (Mesters et al., 1994). Recently, crystal structure of the ternary complex 
of Phe-tRMAPhe in its complex with EF-Tu • GDPNP (a GTP analog) has been 
published (Nissen et al., 1994), showing a striking similarity with the structure 
of EF-G ■ GDP (Czworkowski et al., 1994). These data are suggesting, that 
binding of one of the elongation factors causes a structural rearrangement, i.e. 
transition from one translocational state to another within the ribosome and 
determines binding site for another elongation factor. After the elongation factor 
has departured, the ribosome becomes fixed into a state, recognizeable by the 
other active elongation factor. Thus, structural changes within the ribosome are 
forcing ribosome cycle to go on and elongation factors promote this process. 
Therefore, it seems thoughtful to consider the impact of rRNA mutations on 
structural transitions during translation. Whilst no direct interactions between 
the TBS and EF-Tu has been found, and the binding of L ll  as well as local 
structure of 23 S rRNA have proved to remain unchanged at the time when EF- 
Tu and EF-G cycles are perturbed, we suggest, that the A to U transversion at 
position 1067 of E. coli 23 S rRNA interferes with the functional structure of the 
ribosome. Most plausible explanation to the U1067 phenotype is that the 
mutation affects performance of elongation factor Tu by inhibiting the mutant 
ribosomes to switch from post- to pretranslocational state during ribosomal 
elongation cycle, resembling in some extent to the mode of inhibition of 
thiostrepton. Alternatively, the base change at position 1067 interferes directly 
with EF-Tu and ribosome interaction.
We have not found any kinetic deviations for U 1067 ribosomes in the 
“puromycin reaction” (data not shown). Therefore, the increase in time to 
synthesize dipeptide might be explained by slower release of EF-Tu • GDP from 
U1067 ribosomes. An increased processing time of EF-Tu on mutant ribosomes 
(Paper III) also favours the latter explanation. However, it has to be mentioned 
that functional interactions (based on studies with antibiotics) occur between 
23S rRNA domains II and V (Mankin et a l, 1994).
As a summary o f this work, we have presented the results (Paper III) that 
affirm the involvement o f the TBS in translational elongation factors Tu and G 
dependent reactions. We conclude that integrity o f the TBS in domain II o f  
Escherichia coli 23S rRNA is vital fo r fluent action o f translational elongation 
factors Tu and G during ribosome cycle and that nucleotide at position 1067 
within the TBS seems to be a significant determinant in this process.
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CONCLUSIONS
The present study can be summarized as follows:
1. Development o f experimental strategy:
A common denominator for all known experimental strategies to analyse 23 S 
rRNA mutations has been the insufficiency to discriminate between wild type 
(chromosome derived) and mutant (plasmid borne) ribosomes. Bacteria with 
single rRNA operon cannot be utilized due to a simple reason — mutations at 
crucial positions af 23S rRNA gene are often deleterious for cell growth. We 
have developed an experimental strategy by taking advantage of the mutation 
A1067U of 23 S rRNA that renders ribosomes resistant to antibiotic thiostrep­
ton — an efficient inhibitor of ribosomal translocation reaction. Adjoining the 
thiostrepton resistance mutation to the mutation of interest in the same 23 S 
rRNA gene makes all the plasmid borne ribosomes resistant to the antibiotic. 
Subsequently, the presence of thiostrepton in a suitable in vitro assay enables to 
measure the activities of the mutant ribosomes, exclusively (Fig. 5).
2. Analysis of E. coli 23S rRNA mutations:
a) mutations in domain V:
To evaluate the importance of evolutionally highly conserved nucleotides in 
domain V of 23 S rRNA for ribosomal functions, we have introduced several 
base substitutions into the 23S rRNA gene: G2505C, G2582A, G2582U, 
G2583A, G2583C, G2583U, G2607C, G2608A, G2608C and G2608U (Fig. 3B 
and 4). Our study has shown that base changes within the domain V are often 
perilous to bacteria, leading to retarded growth or even cell death (mutations 
G2505C, G2582A, G2582U, G2583A, G2583C and G2583U). In vitro experi­
ments have revealed correlation between growth phenotype and peptide bond 
formation —  23 S rRNA mutants with growth deflections have been found to 
suffer from deficient peptidyl transferase, as judged in ‘puromycin reaction’. 
Mutations in domain V have demonstrated to be hypersensitive to antibiotics 
known to block ribosomal peptide bond formation, providing an additional link 
between domain V and ribosomal peptidyl transferase function. Furthermore, 
CMP stimulation experiments with pA-fMet as minimal donor of the PTase 
suggest that G2582 in addition to ^2580 and G2581 might interact with nucleo­
tide C75 of P-site located tRNA.
Translational accuracy and ribosomal peptidyl transferase have supposed to 
be bound. We have proven it experimentally by showing that decresed missense 
error rate could be attributed to ‘peptidyl transferase’ mutants G2583C and 
G2583U.
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b) mutation in domain II:
An A to U transversion at position 1067 of 23 S rRNA has been previously 
characterized as to confer resistance against antibiotic thiostrepton, a powerful 
inhibitor of ribosomal translocation reaction. This region of 23 S rRNA (Fig. 
3 A) has also been connected to elongation factor EF-G dependent functions. By 
using an advanced fast kinetic methodology we have evaluated kinetic cha­
racteristics of U 1067 ribosomes. We could show that the mutant ribosomes are 
impaired in their effective association rate constants for both EF-G and EF-Tu 
binding. In addition, the times that EF-G and EF-Tu spend on the ribosome 
during elongation are significantly increased by the A to U transversion. On a 
contrary to earlier assessments, we claim that the U1067 mutation affects EF-Tu 
function more than EF-G function. The rates of EF-Tu dependent GTP hydro­
lysis and subsequent release of EF-Tu-GDP are severely inhibited, while the 
EF-G dependent translocation rate was not impaired. We infer that nucleotide 
U1067 of 23 S rRNA domain II is important determinant for both elongation 
factors during the elongation cycle.
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MUUTUSED RIBOSOOMI ELONGATSIOONITSÜKLIS 
MUTATSIOONIDE TÕTTU 23S rRNAs
KOKKUVÕTE
Rakuline valgusüntees on elutähtis protsess kõigis tuntud elusorganismides. 
Valkude süntees toimub ribosoomidel (eestikeelse vastena võib leida ka terminit 
pihukeha). Mudelorganismina kasutatava Escherichia coli ribosoomid moodus­
tuvad kahest allühikust, sedimentatsioonikoefitsientidega 30S ja 50S. 50S all- 
ühik (jn. 1), mis omakorda koosneb 34 ribosoomivalgust ja  kahest ribosomaal- 
sest RNAst, 5S ja  23S rRNA, vastutab keskse ribosoomi poolt läbiviidava 
reaktsiooni, peptidüüljäägi ülekande ehk peptidüüli transferaasi, eest. Seni ei ole 
leitud ühtegi ribosoomivalku, mis suudaks katalüüsida peptiidliite moodustu­
mist. Üksnes kaudsed eksperimentaalsed andmed on viidanud 23 S rRNA V 
domääni (jn. 3B ja 4) võimalikule osalusele ribosoomi peptidüülitransferaasses 
reaktsioonis. Ka hiljutine katalüütiliste RNAde avastamine viitab võimalusele, 
et hoopis rRNA võib olla peamiseks komponendiks peptiidsideme sünteesil.
Käesolev doktoritöö ongi ajendatud huvist teada saada, milline on 23S rRNA 
osa peptiidsideme sünteesi katalüüsil ja  milline 23S rRNA piirkond võiks selle 
protsessi eest vastutada. Eksperimentaalse strateegiana valisime 23S rRNA 
suunatud mutageneesi ja  saadud mutantsete ribosoomide kineetilise analüüsi in 
vitro.
On tuntud tõde, et teaduslike uuringute kvaliteet sõltub otsese kasutatavast 
eksperimentaalsest süsteemist. Senini ei olnud võimalik määrata mutantsete 
ribosoomide kineetilisi parameetreid, nende hulgas peptiidsideme moodustu­
mise kiirust. Põhjus on lihtne, mutantsete 23S rRNA geenide ekspressiooniga 
plasmiidilt kaasneb alati ka kromosomaalsete 23 S rRNA geenide (E. colfs  on 
seitse rRNA operoni) süntees, mis tähendab, et eraldades rakust ribosoome, saa­
me alati mutantsete ja  metsikuttüüpi ribosoomide segapopulatsiooni. Selline 
olukord ei võimalda aga adekvaatselt hinnata mutantsete ribosoomide mõju 
uuritavale ribosoomi funktsioonile. Esmaseks ülesandeks oligi välja töötada 
meetod, mis võimaldaks in vitro tingimustes alla suruda metsikuttüüpi ribosoo­
mide valgusünteesi võime. Oli teada, et A1067U transversioon muudab ribo­
soomid resistentseks antibiootikumi tiostreptooni suhtes. Tiostreptoon on tuntud 
kui efektiivne ribosoomi translokatsioonireaktsiooni blokaator. Viies samasse 
23S rRNA geeni nii A1067U mutatsiooni kui ka meid huvitava mutatsiooni, 
saame ekspressiooni tulemusena ribosoomid, mis suudavad in vitro tingimustes 
transleerida tiostreptooni juuresolekul. Samal ajal surub antibiootikum alla 
metsikuttüüpi ribosoomide aktiivsuse (põhimõtteline skeem on kujutatud joo­
nisel 5).
Muteerisime mitmed evolutsiooniliselt kõrgeltkonserveerunud nukleotiidid 
23S rRNA domäänis V: G2505C, G2582A, G2582U, G2583A, G2583C,
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G2583U, G2607C, G2608A, G2608C ja  G2608U. Leidsime, et enamiku mutan­
tide kasv on kas tugevalt alla surutud või ei suuda mutantse 23 S rRNAga bakter 
üldse kasvada (välja arvatud mutandid G2607C, G2608A, G2608C ja G2608U). 
Bakteri kasvufenotüüp korreleerus ribosoomide võimega sünteesida peptiidsi- 
det: tugevalt allasurutud kasvufenotüübiga mutantide ribosoomid ei olnud või­
melised sünteesima peptiidsidet. 23S rRNA mutandid G2505C, G2583C ja 
G2583U osutusid võrreldes metsikuttüüpi ribosoomidega tundlikumaks pepti- 
düüli transferaasi inhibeerivate antibiootikumide klooramfenikooli ja  linko- 
mütsiini suhtes, mis viitab veel kord 23 S rRNA V domääni seotusele peptiid- 
sideme moodustumisega (Publikatsioonid I, I lja  IV).
Katsed ribosoomi minimaalse doonorsubstraadiga pA-fMet osutavad või­
malusele, et 23 S rRNA V domääni nukleotiidid ¥2580, G2581 ja G2582 moo­
dustavad ribosoomi peptidüültransferaasses tsentris seondumiskoha tRNA nuk- 
leotiidile C75 (Publikatsioon IV).
Teatav valgusünteesi täpsuse tase on rakule samavõrra elutähtis kui peptiid- 
sideme sünteesi võime. Mõõtes 23 S rRNA mutantide valgusünteesi täpsust, 
leidsime, et mutatsioonid G2583C ja  G2583U muudavad ribosoomid võrreldes 
metsikuttüüpi ribosoomidega täpsemaks, st. nad lülitavad valesid aminohappeid 
sünteesitava peptiidi koosseisu oluliselt harvem. Kirjandusest võib leida hüpo­
teese peptidüüli transferaasi seotusest translatsiooni täpsusega. Meie eksperi­
mentaalsed andmed kinnitavad toodud seose olemasolu — mutatsioonid 
G2583C ja  G2583U 23S rRNAs suurendavad nii valgusünteesi täpsust kui ka 
inhibeerivad peptiidsideme sünteesi (Publikatsioonid I ja  IV). Saadud andmed 
on originaalsed. Kasutades analoogilist eksperimentaalset lähenemist riboso- 
maalse 23S RNA mutantide uurimisel on mitmed laborid hiljem leidnud sarna­
seid ribosoomianomaaliaid.
23S rRNA domääni II (jn. 3A) on seni peetud oluliseks elongatsioonifakto- 
rist G (EF-G) sõltuvates reaktsioonides. Uurisime 23S rRNA II domääni mutat­
siooni A1067U transversiooni mõju ribosoomi elongatsioonitsüklile. Kasuta­
sime metoodikat, mis võimaldab ribosoomist sõltuvate reaktsioonide kineetikat 
mõõta väga lühikeste ajavahemike jooksul (nn. quench-flow-meetod). Tuvas- 
tasime, et antud mutatsioon mõjutab elongatsioonifaktorist Tu (EF-Tu) sõltu­
vaid protsesse hoopis suuremal määral kui EF-G-st sõltuvaid. Mutatsioon 
A1067U inhibeeris mõlema elongatsioonifaktori ribosoomile sidumise kineeti­
kat, samas näitasime, et EF-Tu-st sõltuva GTP hüdrolüüsi kiirus ning EF- 
Tu-GDP vabanemine ribosoomilt on olulisel määral aeglustunud. EF-G-st 
suunatav translokatsioon toimis aga samaväärselt kui metsikuttüüpi ribosoo­
midel. Publikatsioonis III näitasime esmakordselt, et lisaks EF-G sidumisele on 
23S rRNA domään II seotud ka EF-Tu sidumise ja  tema poolt läbiviidavate 
reaktsioonidega.
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ABSTRACT
Single point mutations corresponding to the positions 
G2505 and G2533 have been constructed in the gene 
encoding E.coli 23S rRNA. These mutations were linked 
to the second mutation A1067 to T, known to confer 
resistance to thiostrepton (1). Mutant ribosomes were 
analyzed in vitro for their ability to direct poly(U) 
dependent translation, their missence error frequency 
and in addition their sensitivity to peptidyltransferase 
inhibitors. It was evident that the mutated ribosomes 
had an altered dependence on [Mg2 + ] and an 
increased sensitivity to chloramphenicol during poly(U) 
directed poly(Phe) synthesis. In a transpeptidation 
assay mutated ribosomes were as sensitive to 
chloramphenicol as wild-type ribosomes. However, the 
mutant ribosomes exhibited an increased sensitivity to 
lincomycin. An increase in translational accuracy was 
attributed to the mutations at the position 2583: 
accuracy increased in the order G < A < U < C.
INTRODUCTION
A solid body of evidence has been published on the role of 23S 
RNA in the peptidyltransferase reaction, including crosslinking 
of photoreactive analogs of aa-tRNA, peptidyl-tRNA and 
puromycin (2,3), protection of rRNA against chemical 
modification by various ribosome ligands (4 -6 ) , inhibition of 
substrate binding by complementary oligodeoxynucleotides (7) 
and analysis of antibiotic resistant mutations in rRNA (for review 
8). Based on these data, the central ring of domain V in the 23S 
RNA was defined as being part of peptidyltransferase centre. The 
importance of nucleotides within this region for cell viability and 
antibiotic resistance has been shown by site-directed mutagenesis 
(9—10). Protection of A2438, A2451 and A2602 are shown to 
be dependent on acyl moiety, U2506, U2584, U2585 on the 3' 
terminal A and G2505 is protected by tRNA. lacking 3' terminal 
CA (4, see fig.4).
In this paper the effects of mutations at the peptidyltransferase 
region of 23S RNA on the ribosomal functions, observed in vitro. 
are described. The mutant species of the gene for 23S RNA were 
expressed in vivo. In order to discriminate between the activities 
of plasmid encoded mutant ribosomes and wild-type ribosomes
a second mutation in the gene of 23S RNA, corresponding to 
the position A1067 of 23S RNA, was used. Transversion A to 
T confers a high level resistance of in vitro translation to 
thiostrepton (1). In the presence of the drug it is possible to 
selectively inhibit wild-type ribosomes. By comparing the 
activities of the mixed ribosomal populations in the presence and 
absence of thiostrepton, it was possible to detect alterations caused 
by mutations in 23S RNA.
MATERIALS AND METHODS
Plasmids and strains
Plasmid pLST1067T, containing the rmB operon with single point 
mutation A to T at the position 1067 was a kind gift from Dr 
J. Thompson (1). Plasmid pN02680 contains the E.coli rmB 
operon under control of the lambda leftward promoter (11) and 
plasmid ptBsB contains the E.coli 23S RNA structural gene under 
control of the tac promoter (12). E.coli CJ236 (dut ung thi relA) 
was used for the preparation of single-stranded DNA template 
for site-directed mutagenesis. JM109 containing the laclq gene 
was the host for ptBsB based plasmids and pop2136, which 
contains the chromosomally located gene encoding for the 
temperature-sensitive lambda repressor clfs857, was used for 
expression of mutant rRNAs from the pN02680 based plasmids. 
Plasmid pSP-65 (Pharmacia) containing the /3-lactamase gene was 
used as a control during the cotransformation assays.
Construction of mutants
The single point mutations at the position 2505 (G to C) and at 
the position 2583 (G to A, U and C) of the 23S rRNA gene were 
constructed by oligonucleotide directed mutagenesis (13) using 
the Sall-BamHI fragment from rmB cloned into m l3 mpl9. 
Following mutagenesis the Eco52I-BamHI fragments were cloned 
into expression vector ptBsB (12). Xbal-BamHI fragments from 
each ptBsB mutant were subcloned into pN02680, carrying 
A 1067 T transversion. The mutations were confirmed by DNA 
sequencing of the final expression vectors, as well as by 
sequencing the cellular 23S rRNA moiety, using the primer 
directed reverse transcriptase reaction (12). Manipulations with 
DNA were accordingly to (14). The resulting plasmids were 
designated as follows: single mutants A1067 to T—ptBsB1067T,
* To whom correspondence should be addressed
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pN01067T; in the case of the double mutants, all of which 
contained the 1067T mutation and the mutation at either position 
2505 or 2583, these were indicated only by the latter mutation.
Preparation of ribosomes
Transformants of E.coli JM109 carrying the plasmid ptBsB, were 
induced by 1 mM IPTG at AfÄ)=0.5 and cells were harvested 
after 1 hour. E.coli pop2136 harboring pNO was grown at 30°C 
up until A6OO=0.2 and subsequently induced for 2 hours at 
42°C. The cells were lysed by lysozyme (0.5 mg/ml) in buffer 
A (60 mM NH4CI; 60 mM KC1; 12 mM MgCl2; 20 mM Tris- 
HC1 pH —8; 6 mM /3-mercatoethanol) containing 16% (w/v) 
sucrose, by three freeze-thaw cycles. Cell debris was removed 
by centrifugation 16000 rpm, 15 min. Sorvall SS-34 rotor. 
Lysates were diluted three times with buffer A and loaded onto 
1 ml sucrose cushion (20% sucrose in 0.5 M NH4C1; 12 mM 
MgCl2; 20 mM Tris-HCl pH —7,6; 6 mM /3-mercaptoethanol) 
in a Sw-60 (Beckman) rotor and the ribosomes were pelleted by 
centrifugation 33000 rpm, 12 hours. Ribosomes were redissolved 
in buffer A and stored in aliquots at — 70°C. 70S ribosomes were 
prepared from the total ribosome fraction by sucrose gradient 
centrifugation (10-30% sucrose in buffer A) 20000 rpm 16 hours 
in a Beckman Sw-28 rotor. RNA was extracted from 70S fraction 
by phenol extraction and mutated regions were sequenced by 
dideoxy sequencing, using end-labeled primer (complementary 
to bases 2598-2617 in 23S RNA) (12).
Cell-free translation
Poly(U) translation was performed essentially as described in 
(15). 0.1 ml assay contained in buffer A 0.5 A25q units 
ribosomes, 0.01 mg bulk tRNA, 0.02 mg poly(U) (Reanal, 
H ungary), 2 mM ATP, 0.5 mM GTP, 8 mM 
phosphoenolpyruvate (PEP), 2 fig pyruvate kinase, 0.05 mM 
[3H]Phe (40 cpm/pmol) (Amersham), 0.02 mM [l4C]Leu (700 
cpm/pmol) (UVVVR, Czechoslovakia) and 0.2 mg S-100 
enzyme. After 30 min. incubation at 30°C, reactions were 
stopped by addition 1 ml 5% trichloracetic acid (TCA), heated 
for 15 min. at 95°C. Precipitates were collected onto GF/A filters 
(Whatman) and counted for radioactivity in a Rackbeta 1219 
(LKB) scincillation spectrometer. Thiostrepton (Calbiochem) was 
dissolved in 10% dimethylsulfoxide (DMSO) at concentration 
0.05 mM. Therefore all assays in the presence of thiostrepton 
contained also 0.02—0.1% DMSO. Minus drug controls were 
made in the presence of DMSO.
Missence error frequency
The missence error frequency was determined by measuring the 
misreading of UUU codons by near-cognate tRNA4Leu 
competing with tRNAphe. The experiments were done in buffer 
A essentially as described by Ehrenberg etal (16). Source for 
elongation factors and synthetases was DEAE-fractionated S-100 
supernatant (20 mg/ml protein). Two mixes were prepared: 
ribosome mix contained in 50 /^ 1 0.5 A u n i t s  of ribosomes, 
0.2 mg/ml polyuridylic acid, 20pmoles tRNAphe (1100 
pmoles/Anftounit, Sigma) and 15 pmoles of thiostrepton if 
indicated; factor mix containing 60 pmoles tRNAphe, 4 mM 
ATP, 1 mM GTP, 16 mM phosphenolpyruvate. 7 fig pyruvate 
kinase, 0.12 mM [JH]Phe (5.2 cpm/pmole), 0,06 mM [l'*C] Leu 
(700 cpm/pmole), saturating amount of S-100 enzyme and 
between 0 -1 5 0  pmoles tRNA4Leu (1520 pmoles/A260 unit. 
Subraiden). Ribosome mix was preincubated for 10 min. at 37°C, 
factor mix was preincubated for 5 min. at the same temperature.
Reaction was started by mixing 50 fj.1 of ribosome mix by the 
same amount of factor mix. Incubation was at 37°C for 1 min. 
Reaction was stopped by addition 1 ml of 5% TCA, heated at 
95°C for 15 min. and filtrated through GF/A filter (Whatman). 
Filters were processed as described in previous section.
Puromycin assay
Dipeptide synthesis was studied essentially as described (15). 
Ribosomes (0.5 A260 units per 50 /d assay) were preincubated 
with poly(U) (0.01 mg) and bulk tRNA (0.017 mg) in buffer 
A for 10 min. at 37°C in the presence of thiostrepton (0.37 jiM). 
After addition 3 pmoles of N-ac[3H]Phe-tRNAphe (1.5X105 
cpm/pmol, charging efficiency 1000 pmol/A26o unit) incubation 
was continued for 20 min. at 37°C. Trasnslocation was carried 
out at 0°C for 30 min. by adding EF-G (3 fig) and GTP (0.2 
mM) followed by puromycin reaction (0.5 mM puromycin) 30 
min. at 0°C. Reactions were stopped by 200 /d 1 M potassium 
phosphate (pH-7 .0 ); lOmM EDTA. N-Ac[3H]Phe-puromycin 
was extracted by 1 ml ethylacetate, 0.5 ml of organic layer was 
counted in 10 ml of scincillation cocktail (High-Safe, LKB). 
Background values were obtained from minus puromycin 
experiments.
RESULTS
The effect of mutations on the cell growth
The mutation A 1067 to T in the 23S RNA is known to reduce 
bacterial growth rate 1,5 fold (1). The effect of double mutations 
on the cell viability was studied using derivatives of the pNO 
vector transformed into the E.coli strain pop2136. At 30°C the 
lambda promoter is repressed and mutant RNAs are not 
significantly expressed. At 42°C the temperature-sensitive 
repressor cIM7 is inactive and rRNA genes are transcribed from 
the plasmid. The plasmid pSP-65 was used as a control in the 
cotransformation assay. The number of colonies were the same 
at 30°C and 42 °C for both pSP-65 alone and in combination with 
pNO 1067T, indicating that transformed bacteria could grow 
equally well at both temperatures. When derivatives of the pNO 
containing the double mutant 23S RNA gene were used for 
transformation, no colonies were found at 42°C. In a 
cotransformation assay at 30°C there were 10—20 times more 
colonies than at 42°C. Four colonies from each temperature 
group were analyzed for plasmid content and it was found that 
at 42°C the transformants exclusively contained plasmids pSP-65. 
From these data we concluded that mutations C2505 and all base 
substitutions at position 2583 were lethal at 42°C.
Cell-free translation by mutant ribosomes
For in vitro assays the ribosomes were isolated from E.coli JM109 
carrying one of ptBsB plasmids and pop2136 transformed with 
one of pNO plasmids. RNA from 70S fraction was sequenced 
using end-labeled primers directed towards the 2500 — 2600 
region and showed that ribosomes encoded bv the pNO plasmids 
constituted 40—50% of the total 70S population, following 2 
hours induction. By contrast, ribosomes encoded by ptBsB 
plasmids represented approximately 30% following 1 hour 
induction (see also 12). Further induction did not yield a higher 
percentage of mutant ribosomes.
In the presence of 5-fold molar excess of thiostrepton poly(U) 
translation on the ribosomes from uninduced cells (wild-type) 
were inhibited 9 7 -9 9 % . The ribosomes derived from 
pN01067U were inhibited 50%, while the ribosomes from
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Table I. Poly(U) dependent protein synthesis in the presence and absence of 
thiostrepton. Phe incorporation into peptides is in pmoles. Ratio of protein synthesis 
in the presence and absence of the drug is given as resistance. A-ribosomes were 
derived from ptBsB plasmids in E.coli JM lff). B-ribosomes encoded by pNO 
plasmids in pop2136.
Ribosomes
10 mM MgCIi 
- th io  + thio resistance
25 mM MgCU 
- th io  — thio resistance
A
wild-type 54 1.62 0.03 26 0.26 0.01
U1067 52 9.36 0.18 27 4.86 0.18
C2505 33 4.29 0.12 38 «.36 0.23
C2583 29 3.48 0.12 39 9.36 0.24
B
wild-type 52 0.78 0.015 32 0.32 0.01
U 1067 49 20.6 0.42 31 13.7 0.44
C2505 41 13.5 0.33 32 16.9 0.51
C2583 36 10.4 0.29 35 18.9 0.54
Table II. Poly(U) dependent incorporation of Phe and Leu into peptides in the 
presence of thiostrepton. Ribosomes were isolated from E.aili pop2136 carrying 
one of the pNO plasmids.
Ribosomes
10 mM MgCK 
pm Phe pm Leu Leu/ Phe + Leu
!5 mM MgCU 
pm Phe pm Leu Leu. Phe +  Leu
U 1067 17.7 0.24 0.013 20.9 3.03 0.127
A2583 16.9 0.16 0.0094 23 2.52 0.099
C2583 11.5 0.056 0.0048 15.4 0.73 0.045
U2583 10.4 0.096 0.(X)9I 12.2 0.99 0.075
ptBsB1067U were inhibited 82% (Table I). Drug resistance on 
double mutant ribosomes U1067/C2505 and U1067/C2583 was 
in both strains dependent on Mg2* concentration: at 25 mM the 
resistance was nearly 2 times higher than at 10 mM (Table 1). 
It is clear from table I that in all cases the resistance to thiostrepton 
was higher on the ribosomes derived from E.coli pop2136 strain. 
Thus, the data from poly(U) translation in the presence and 
absence of thiostrepton are in good correlation with the RNA 
sequencing data. It should be noted that the ribosomes containing 
the U1067 mutation are also inhibited in the presence of excess 
of thiostrepton 10-20% .
The effect of magnesium ions concentration on the translational 
activity was tested during poly(U) dependent poly(Phe) synthesis 
on the ribosomes derived from pNO plasmids in the presence 
of thiostrepton. The data are presented on the fig. 1. It was 
evident that the ribosomes containing the single mutation U1067 
had an optimum at 12 mM MgCh and at higher concentration 
of Mg2 + , processivity of poly(Phe) synthesis decreased. 
Ribosomes containing the double mutation clearly had a different 
dependence on [Mg2^]. At 10-12 mM MgCl2 the processivity 
was lower for the double mutants as compared with the ribosomes 
containing the U1067 mutation alone. In contrast, at 25 mM 
MgCli all the double mutants exhibited higher activity during 
poly(U) translation than single mutant ribosomes. It is interesting 
to note that the double mutants C2505 and C2583 had virtually 
the same dependence on (Mg2*). The double mutant with 
U2583 showed the best processivity at high magnesium 
concentration and the U1067/A2583 mutation reflected the 
smallest difference on the M g-'  concentration a.s compared with 
ribosomes containing the single mutation U1067.
Fig. 1. Poly(U) directed translation by mutant ribosomes. Dependence on Mg: * 
concentration. 0.5 A:w) units of ribosomes were tested for activity in poly(Phe) 
synthesis in the presence of thiostrepton (I //M) at different magnesium 
concentrations: A-single mutant UI067: B - E  double mutants: C2505 (B): A2583 
ICV. C2583 (D>; U2583(E).
The effect of mutations on the translational accuracy
The effect of mutations in 23S rRNA on the fidelity of translation 
was analyzed in conventional poly(U) translation assay and 
accordingly to the method of Ehrenberg (16). Table II shows 
the incorporation of Phe (correct) and Leu (incorrect) by mutant 
ribosomes at two magnesium ion concentrations in a conventional 
poly(U) translation system, in order to reduce the activity of wild- 
type ribosomes, the assays were carried out in the presence of 
thiostrepton. Incorporation of both amino acids into peptides was 
affected by increasing Mg2+ concentration, the effect on Leu 
incorporation was more dramatic. As it can be seen on table II 
the incorporation of Leu is lower on double mutant ribosomes 
as compared to single mutant ones at both concentrations of 
MgCl2.
In order to determine whether or not the effect on Leu 
incorporation on mutant ribosomes is due to reduced 
mistranslation, we have used the method of Ehrenberg (16) for 
determination of missence error frequencies. This method is based 
on titration of ribosomes by miscognate tR N A ^ u  in the 
presence of a constant amount of tRNAphe. The missence error 
frequencies were detected on mutant ribosomes in the presence 
and absence of thiostrepton; wild-type ribosomes were analyzed 
in the absence of drug. In this assay, equimolar concentrations 
of the drug were sufficient to almost completely inhibit wild-type 
ribosomes. The active fraction of ribosomes in the presence of 
thiostrepton was 1 —5 pmoles per one A:fi0 unit, as determined 
by Nac-Phe incorporation into poly(Phe) during 20 seconds (data 
not shown). This value did not differ significantly for the different 
mutants at optimal magnesium ion concentrations, but activity 
was preparation dependent. The missence error frequencies are 
presented on table ID. Leucine misincorporation by single mutant 
U1067 ribosomes was nearly the same as that observed in the 
presence or absence of the drug. The same value was obtained 
on the wild-type ribosomes in the absence of the drug, indicating 
that under conditions used the A 1067 to T transversion had no 
effect on the accuracy of translation. The same was true for the 
G2505 to C transversion (table III). On the other hand it implied 
that the presence of thiostrepton did not altect the selection aa- 
tRNA by the resistant ribosomes. By contrast it was evident that
22
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T able III. Missence error frequencies of poly(U) translation in the presence a r j  
absence of thiostrepton. The wild-type ribosomes were isolated from E.coli 
pop2136 without plasmid, mutant ribosomes were isolated from the same strain 
canying the pNO plasmid with mutated 23S RNA gene.
Ribosomes -thiostrepton
wild-type
U1067
C2505
A2583
C2583
U2583
0.0119
0.0121
0.0120
0.0109
0.0082
0.0098
+ thiostrepton
0.0122
0.0122
0.0118
0.0101
0.0039
0.0057
Table IV. The effect o f lincomycin on transpeptidation with mutant ribosomes 
in the presence of thiostrepton. Backgrounds were delected in the absence of 
puromycin and subtracted.
Ribosomes: 
Lincomycin (mM)
I'HlNacPhe-puromvcin (cpm). 
U 1067 C2505 ’ A2583 U2583 C2583
0 10121 6578 7459 8387 6121
0.05 8418 3649 4885 5187 3830
0.1 7637 3032 4319 4212 3162
0.3 6297 2305 3243 3335 2263
0.5 4887 1735 2366 2408 1756
1 3099 1068 1620 1603 1101
5 446 239 301 287
both in the presence and absence of thiostrepton, the 
misincorporation of Leu was lower on ribosomes mutated at the 
position 2583 (table III). In the absence of the drug both, wild- 
type and mutant ribosomes participated in the polymerization 
reaction. In the presence of thiostrepton, wild-type ribosomes 
contributed less than 5 % and nearly all amino acids incorporated 
into hot TCA insoluble material were due to the mutant ribosomes 
(see table I). As compared the missence error frequencies in the 
presence and absence of the drug, the single mutant U1067 and 
the double mutant U1067/C2505 ribosomes exhibited the same 
translational accuracy, while the ribosomes mutated at the position 
G2583 were more accurate in the presence of the drug. Taking 
into account that in the absence of thiostrepton mutated ribosomes 
contributed 40 — 50% in translation (percentage of mutant 23S 
RNA in the 70S fraction) it is evident from table III that mutant 
ribosomes translated poly(U) with the same accuracy both, in 
the presence and absence of the drug. The effect on the 
translational accuracy was biggest on C. intermediate on U and 
smallest on A at the position 2583.
The effect of mutations on antibiotic sensitivity
The sensitivity of mutant ribosomes to antibiotics which inhibit 
the peptidyltransferase reaction, were analyzed during poly(U) 
translation and during a 'puromycin assay’. No differences were 
detected between wild-type, single mutant U1067 and double 
mutant ribosomes with respect to their sensitivity to erythromycin 
(data not shown). Interestingly, notable differences were found 
with chloramphenicol. Data is presented on poly(U) translation 
as a function of chloramphenicol concentration, in the presence 
of thiostrepton (fig.2). The single mutant U1067 and double 
mutant U1067/A2583 were only slightly inhibited by 
chloramphenicol, using concentrations up to 3 mM. By contrast, 
the double mutants containing C2505. U2583 and C2583 were 
more sensitive than the wild-type ribosomes.
Cm (mM)
Fig. 2. Poly(U) directed translation by mutant ribosomes. Dependence on 
chloramphenicol (Cm) concentration in the presence of thiostrepton (I jiMl. 
Activities of mutant ribosomes are expressed as ratio to 0 concentration of 
chloramphenicol. A-single mutant U1067: B -K  double mutants: C250.S (B); 
A2583 (C); C2583 (D): U2583(E>.
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Fig. 3 . Central ring of domain V of E.coli 23S RNA. Mutations described in 
this study are indicated by arrows. Protection of encircled bases are dependent 
upon the presence of the 3 ’ terminal A (4). Nucleotides whose alteration can 
confer resistance to chloramphenicol (o) and to macrolides or lincomycin u i  (8|.
In order to study the effects of antibiotics that interfere with 
peptidyltransferase on the mutant ribosomes, the ability of 
thiostrepton to block translocation on wild-type ribosomes was 
employed. NacPhe-tRNA was bound to the ribosomal A-site 
following occupation of the P-site by deacylated tRNA. Alter 
EF-G promoted translocation. peptidyl-tRNA becomes competent 
to puromycin. When this reaction is carried out in the presence 
of thiostrepton translocation occurs only on the U1067 containing 
ribosomes. For the peptide bond synthesis assay, 4 /*M 
chloramphenicol inhibited the transfer reaction by 50% with both 
wild-type and mutant ribosomes indicating that the mutations in 
2?S RNA had no effect during this particular assay. Small 
differences between mutant ribosomes were detected in the 
inhibition pattern by lincomycin (see table IV). 50% inhibition
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of the reaction on the mutant ribosomes was obtained with the 
following concentrations of lincomycin: single mutant U1067 
0,35 mM and double mutants: C2505 0,07 mM; A2583 0,15 
mM; U2583 and C2583 at 0,1 mM. Thus mutations C2505, 
U2583 and C2583 led to increased sensitivity to lincomycin 
during peptidyltransferase.
DISCUSSION
The effects of mutations at position G2505 (to C) and G2583, 
(all three substitutions) have been studied in vitro. These 
universally conserved nucleotides are located in the central ring 
of domain V (see fig. 3). Substitution of one of these nucleotides 
by C could lead to an extension of helix 90 (17) by one base 
pair. The mutant genes were expressed under the control of two 
different inducible promoters: lambda pL and tac. In these 
systems high levels of expression of plasmid encoded rR.NA is 
possible.
Mutations at the positions 2505 and 2583 did not prevent 
processing and assembly of the 23S RNA into 50S particles. The 
resulting subunits were able to associate with 30S subunits in 
amount comparable to the wild-type 50S subunits. The mutated 
ribosomes were able to translate poly(U) in vitro. However, in 
vivo expression of these mutations were shown to be lethal at 
42°C.
The mutated regions were linked to the mutation U1067, which 
is known to confer resistance to thiostrepton in vitro (1). By 
comparing the results plus and minus thiostrepton, no differences 
were detected with single mutant U1067 ribosomes during 
poly(U) translation, in the ribosomal accuracy and in the 
sensitivity to peptidyltransferase inhibitors.
The magnesium ion concentration has multiple effects on 
ribosomal structure and function. It is known to stimulate tRNA 
binding (18) and inhibit translocation (over 15 mM) (19). At 
higher magnesium concentrations translational accuracy is 
decreased (16). The mutations C2505 and C2583, which favor 
base-pairing with juxtaposed G reduces significantly reduced the 
processivity of poly(U) translation at low Mg2+ concentration. 
In contrast at higher concentration of magnesium ions, all double 
mutants exhibited higher processivity as compared to the single 
mutant U1067 ribosomes. Both the reduced processivity at low 
Mg2+ concentration and the resistance to the inhibitory effect 
of high Mg2+ concentrations indicated that tRNA binding was 
affected on the ribosomes containing double mutations.
The sensitivity of mutant ribosomes to chloramphenicol and 
lincomycin was increased, the response to erythromycin was not 
affected as compared with wild-type ribosomes. Lincomycin does 
not inhibit poly(U) dependent poly(Phe) synthesis and 
erythromycin is inactive in the NacPhe-tRNA puromycin system, 
whereas chloramphenicol can block both steps (20). 
Chloramphenicol and lincomycin are known to inhibit acceptor 
substrate binding, erythromycin destabilizes the peptidyl-tRNA 
complex with ribosomes (20). In addition, erythromycin and 
chloramphenicol have been shown to induce oligopeptidyl-tRNA 
release during poly(U) translation in vitro (20, 15). 
Hypersensitivity of mutated ribosomes to chloramphenicol and 
lincomycin can be caused by a reduced binding affinity of tRNA 
3' end to the ribosomal peptidyltransferase centre. Several 
mutations in the central ring of domain V of 23S RNA are known 
to confer resistance to chloramphenicol, among them are 2503 
in E.coli (10) and 2504 in mammalian mitochondria (8). G2505 
is protected against chemical modification by the drug (5). In
this context it is interesting to note that the G2505 to C 
transversion led to increased sensitivity of in vitro translation to 
chloramphenicol. Observation, that mutations at positions 2505 
and 2583 conferred hypersensitivity to chloramphenicol during 
poly(U) directed translation but not in the puromycin reaction 
indicated that tRNA binding to the ribosomal A site was the likely 
step to be affected by these mutations. Mutant ribosomes were 
slightly more sensitive to lincomycin during peptidyltransferase 
assay, as compared to wild-type ribosomes. Obviously, 
chloramphenicol and lincomycin both inhibit acceptor substrate 
binding but each in a different manner.
It is known that mutations in both small and large ribosomal 
subunit proteins can affect translational accuracy (21, 22). The 
mutations at the position 2583 are the first examples for fidelity 
mutations in 23S ribosomal RNA. One possible way to explain 
this phenomenon is the assumption that binding of the aa-tRNA 
to the peptidyltransferase centre is weaker (or alternatively 
transfer reaction is slower) by the 2583 mutant. In this way, 
ribosomes would have a longer time for aa-tRNA dissociation 
during proofreading. Accordingly, the peptidyltransferase 
reaction must be limiting and an irreversible step for aa-tRNA 
selection, as has been suggested earlier (23). This model predicts 
that mutant ribosomes need more GTP’s to hydrolyze to aa-tRNA 
binding. Moazed and Noller have demonstrated that protection 
against chemical modification of bases A2439, A2451 and A2602 
in 23S RNA are dependent upon the acyl moiety on tRNA, 
protection of bases U2506, U2584 and U2585 depend on the 
presence of 3' terminal A (4, see also fig.3). U2584 and U2585 
were shown to cross-link with photo-reactive Phe-tRNA at the 
ribosomal A site. All these data are in agreement with our 
conclusion that the region around helix 90 in 23S RNA is involved 
in aa-tRNA binding to the ribosomal A site.
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INTRODUCTION
Several experimental approaches have been employed to study the structure and 
function o f ribosomes (reviewed in Dahlberg, 1989, and Leclerc and Brakier-Gingras, 1990). 
One such approach is that o f site-directed mutagenesis o f  the rRNA, most commonly in the 
rRNA o f the bacterium Escherichia coli. This organism has seven rRNA operons and thus 
separation o f the host encoded rRNA from that o f the mutated plasmid-encoded rRNA is 
necessary for further biochemical studies. The problem can be overcome by using in vitro 
synthesized rRNA for reconstitution o f  the subunit. This has been sucessfully achieved for 
total reconstitution o f functional 30S particles. In contrast, transcribed and unmodified 23S 
rRNA cannot form active particles in reconstitution assays. Therefore, 23S rRNA should be 
expressed in vivo followed by isolation o f the ribosomes. It is possible to discriminate 
between activities o f mutant and wild-type ribsomes by using a second mutation in the gene 
of 23S rRNA. One such mutation is the A to T transversion corresponding to the position 
1067 o f 23 S rRNA which confers resistance to thiostrepton during cell-free translation 
(Thompson et al., 1988). Thiostrepton has a high affinity to wild-type ribosomes. U1067 
ribosomes bind the drug with a reduced affinity (Thompson and Cundliffe, 1991). Therefore, 
A to U substitution at position 1067 can be used for selective inactivation o f wild-type 
ribosomes and for physical separation o f  mutant ribosomes. This experimental approach has 
been used to analyze functional properties o f mutations corresponding to positions G2505 
and G2583 o f 23S rRNA (Saarma and Remme, 1992). The most interesting finding was that 
mutations at position 2583 increased the translational accuracy. These results, together with 
those o f mutations at positions G2505, G2583, G2607, and G2608 in vitro and G2505 and 
G2583 in vivo will be summarized here.
Furthermore, data concerning the formation o f 50S subunits are presented. The 
assembly o f ribosomes in vivo is strongly coupled with the transcription o f the ribosomal 
RNA and includes the rRNA processing and rRNA modification. All attempts to show this 
process in vivo and to mimic it in vitro have to date failed. As a first approach the properties
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o f ribosomes whose rRNA was derived either by T7 RNA polymerase or E. coli RNA 
polymerase were compared with regard to both the in vivo transcription o f the plasmid- 
encoded rrnB operon and ribosomal assembly. To distinguish between plasmid- and 
chromosomal-derived rRNA the above described A to T transversion at the position 1067 in 
the plasmid-encoded 23 S rRNA gene was used. The relative amount o f  the plasmid-derived 
ribosome fraction in the mixed population was determined by sequencing the 1067 region of 
the 23 S rRNA by means o f  reverse transcriptase, whereas the activity o f the mutant particles 
could be measured in a poly(U) dependent poly(Phe) synthesis system in the presence o f 
thiostrepton. It was found that the 50S particles containing rRNA transcribed by the viral T7 
RNA polymerase were practically inactive in contrast to ribosomes synthesized by the host 
transcriptase. The significance o f these results is discussed.
ANALYSIS OF 50S ASSEMBLY
To study the influence o f the RNA polymerase species on the in vivo transcription of 
the rrnB operon and the ribosomal assembly, two series o f plasmids were constructed. All of 
them carry the A to T transversion at the 1067 position in the 23 S rRNA gene. In the first 
set the ribosomal RNA genes are under the control o f  a T7 late promoter instead o f  the 
natural PlP2-tandem  promoters. These constructs are designated pT7... and were 
transformed into E. coli BL21(DE3). This strain contains a chromosomal copy o f  the gene 
for the T7 RNA polymerase under control o f the IPTG-inducible /acUV5 promoter. The 
rrnB operon on pT7-l is complete, whereas on pT7-2 the spacer following the P2 promoter 
and the 16S rRNA gene was excised, except for 39 bases at the 3' end. The construct pT7-3 
furthermore lacks in addition the 5' half o f  the spacer between the 16S and 23 S rRNA genes 
including the 5' half o f  the spacer tRNAülu2. The second series is called p tac-1, ptac-2 and 
ptac-3 and contains the identical gene arrangement than the first series but here the rRNA 
genes are under the control o f the tac promoter instead o f  the T7 promoter. The second 
series o f constructs were transformed into E. coli JM 109 where the transcription from the 
tac promoter by the E. coli RNA polymerase is induced by the addition o f 1PTG.
An effect on the cell growth could be observed only in the presence o f  IPTG with E. 
coli cells carrying the pT7 constructs. Here the cell growth stopped about 45 min after 
induction whereas the growth was not disturbed upon induction o f  the T7 RNA polymerase 
encoded in the chromosome in the absence o f any plasmid. In contrast, the growth o f  the 
host with the ptac plasmid was hardly affected by induction (Lewicki et al., 1993) . These 
results were not surprising since the T7 late promoter is very strong and highly specific for 
its own RNA polymerase resulting in a large overproduction o f rRNA. It is known that a 
large excess o f  rRNA over ribosomal proteins increases the formation o f inactive particles 
which could be one o f  the reasons for the premature inhibition o f growth o f the cells 
containing the pT7 constructs. This overproduction o f  rRNA in the presence o f  T7 RNA 
polymerase was confirmed when the cells containing pT7-3 grew with 32pc>4 either under 
steady state conditions (the radiolabled orthophosphate was present for at least 4 
generations) or pulse labelling conditions (the label was added 15 min prior to the 
corresponding harvesting point). Evidently 85 % of the rRNA overproduced by the T7 RNA 
polymerase was degraded whereas only about 15 % o f the excess 23 S rRNA was stably 
incorporated into ribosomal particles.
To determine the functional activity o f the mutant ribosomes, the distribution o f 
ribosomal particles and their content o f plasmid-born rRNA was determined by analysis o f 
sucrose gradients (Figure 1). The particles corresponding to the 70S and 50S fraction were 
isolated, and the 23 S rRNA sequenced around nucleotide 1067. The amounts of 
chromosomal and plasmid-derived rRNA were determined and the relative amounts o f 
plasmid-born 23S rRNA calculated, as percentages o f the total 23S rRNA below the 70S 
and 50S peaks, respectively.
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As it is shown in Figure 1 (left side) all three pT7 containing cell lysates have a normal 
70S peak but show overproduction o f  50S subunits and the presence o f  precursor particles. 
The plasmid-coded rRNA is unequally distributed between the 70S and 50S fraction
Figure 1. Sucrosc gradient analysis of ccll lysates with various plasmid constructs. The 23S rRNA derived 
from 5()S arid 70S fractions, respectively, were sequenced around the 1067 region and the relative amount of 
plasmid-born rRNA was determined as described elsewhere (Lewicki et at.. 1993). The percentage values 
below the peaks give the relative amounts of mutant (plasmid-born) 23S rRNA as compared to total 23S 
rRNA derived from plasmids plus chromosome.
containing 1 0 - 2 0  % and 70 ± 10 % rRNA synthesized by the viral transcriptase, 
respectively. Obviously, no free exchange exists between the free pool o f  50S subunits 
carrying plasmid-encoded rRNA and the 50S subunits in the 70S ribosomes which 
represents the fraction active in protein synthesis. These results leads to the conclusion that
24
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most o f  the particles which contain rRNA transcribed by T7 RNA polymerase seem to be 
inactive. A different picture was evident when the plasmid-encoded rRNA was transcribed 
by the E. coli RNA polymerase. At least the presence o f pT7-l containing the entire rrnB 
operon resulted in an indistinguishable sucrose gradient pattern in the presence and absence 
o f  the inducer and a much more equal distribution o f  plasmid-derived rRNA between the 
50S and 70S fraction (Figure 1, right side). These findings agreed with the relative degrees o f 
thiostrepton resistance observed with the lysates in poly(Phe) synthesizing systems. The 
lysates with the pT7 plasmids showed low activity in the presence o f  thiostrepton (Table 1), 
whereas about 3-fold higher activity was found with all ptac constructs.
Table 1. Poly(Phe)-synthesis activity o f  70S ribosomes in the presence o f thiostrepton (3
m r
plasmid
induction
poly(Phe) synthesis
- thio + thio 
[cpm]
relative activity 
in the presence 
o f thiostrepton
m
no - 4100 45 i
pT7-l no 1800 25 1.4
yes1 6700 500 7
pT7-2 no 2350 33 1
yes 4700 300 6
pT7-3 no 2100 40 2
yes 3200 180 5.6
ptac-1 no 5451 113 2
yes 7450 1363 18
ptac-2 no 9617 586 6
yes 8550 1577 18
ptac-3 no 8207 254 3
yes 7496 1349 18
1 In the case of induction IPTG was added 60 min before the harvesting point.
It was considered whether the inactivity o f  the large excess o f  50S particles produced 
in the presence o f  pT7-3 was caused by functionally inactive 23 S rRNA or, alternatively, by 
an accumulation o f assembly-defective particles containing normal 23 S rRNA. To test these 
alternatives the rRNA from the corresponding inactive 50S particles was isolated and a total 
reconstitution in the presence o f  wild-type TP50 was performed. A relative activity in the 
presence o f  thiostrepton was found which was the same as that o f reconstituted particles 
containing ptac derived 23 S rRNA. It follows that the pT7-3 derived rRNA in native 
particles is functional, and that the inactivity o f  the corresponding particles is caused by a 
defective assembly process. It cannot be excluded that one or more o f  the rRNA 
modifications are lacking since it was shown that modified nucleotides are important for a 
correct assembly process in the case o f 16S rRNA (Cunningham et al., 1991). A second 
reason could be the T7 RNA polymerase itself whose transcription elongation rate is about 
five times faster compared to that o f  the host polymerase (Chamberlin & Ring, 1973) This 
higher velocity o f  the transcriptase might cause premature folding o f  the nascent rRNA chain 
and/or premature association o f  ribosomal proteins.
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To analyze the question whether the assembly defect is a cause o f the high expression 
level o f the rRNA or is due to the T7 P.NA polymerase itself, the transcription initiation rate 
o f the viral enzyme was decreased by using very low amounts o f  IPTG (0.03 mM). This 
condition reduces the overproduction o f  rRNA and should lead to an increased production
Figure 2. Sucrose gradient analysis of lysates prepared from cells grown in the presence of different IPTG 
concentrations and temperatures, and the relative amounts of piasmid-bom 23S rRNA within the 70S and 
50S fractions. For further details see legend of Fig. 1.
of active particles. Interestingly, the same unequal distribution o f  plasmid-encoded rRNA 
between the 70S and 50S fraction was observed (Figure 2, top) whereas the absolute 
amount o f rRNA produced bv T7 RNA polymerase was lowered. The exchange and 
therefore the activity o f 50S particles containing pT7-l derived rRNA between 50S and 70S 
pool is not increased indicating that the assembly defects are independent o f  the expression 
levels o f the rRNA genes on the pT7-l plasmid and therefore are caused by the T7 RNA 
polymerase itself. However, when the growth temperature was lowered to 25°C the rRNA 
analysis showed a distribution o f plasmid-derived rRNA in the 50S and 70S fraction similar 
to that from the ptac constructs (Figure 2, bottom) Note, that both experiments lead to very 
similar sucrose gradient patterns with only very little amount o f overproduced 50S and 30S
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partides. Under conditions in which the transcription initiation rate was lowered (0.03 mM 
IPTG) the distribution o f rRNA, synthesized by T7 RNA polymerase, between the 50S and 
70S pool was unequal, whereas by lowering the transcription elongation rate o f  the viral 
enzyme (at 25°C) this distribution was much more equal indicating the increased production 
o f active 50S particles.
EFFECT OF MUTATIONS ON THE FUNCTION OF RIBOSOMES
The mutant rRNA genes were cloned under control o f an inducible prom oter (lambda 
PL in pN 02680, Gourse et al., 1983). Conditional expression was necessary because the 
expression o f mutant 23 S rRNA had a deleterious effect on the bacterial growth. The 
mutations at positions G2505, G2583, G2607, and G2608 did not prevent 23S rRNA from 
beeing processed and assembled into 50S subunits, although the expression o f  23S rRNA 
containing C2583 and U 2583 was accompanied by the appearence o f incomplete particles 
(25S). Mutant rRNA formed 40 - 50 % o f the total 70S ribosome population indicating that 
mutant 50S subunits were able to associate with 30S subunits.
The ability o f mutant ribosomes to participate in cell-free translation was tested during 
poly(U) directed poly(Phe) synthesis. In the presence o f  5-fold molar excess o f thiostrepton 
over ribosomes, poly(U) translation on the wild-type ribosomes was inhibited 97 - 99 %. 
The ribosomes derived from pN 01067U  (a mixed population containing 50% mutant 
ribosomes) were inhibited by 50 %, whereas the ribosomes encoded by the double mutant 
plasmid were inhibited by 54 - 71 %. This indicates that the double mutant ribosomes were 
able to translate poiy(U). Thereby, in the presence o f  the drug only mutant ribosomes were 
active. Thiostrepton resistance o f  the double mutant ribosomes depended on the Mg2' 
concentration. The effect o f the magnesium ion concentration on the translational acitivity of 
mutant ribosomes was analyzed during poly(U) directed cell-free protein synthesis in the 
presence o f thiostrepton. Neither thiostrepton nor the U1067 mutation had an effect on the 
magnesium dependence o f  in vitro translation as compared to the wild-type ribosomes. The 
results indicated that the nucleotide substitutions at different positions led to similar 
alterations o f the response by the mutant ribosomes to the Mg2' concentration. All mutants 
exhibited a lower acitivity at 10 mM MgCl2 and a higher acitivity at 25 mM MgCI2 as 
compared to the single mutant U1067 or wild-type ribosomes. G to A transitions 
corresponding to positions G2583 and G2608 had the smallest effect, as expected. Mutant 
ribosomes containing G to C transversions at positions G2505, G2583, G2607, and G2608 
exhibited lower acitivity at low Mg2' concentration as compared to the corresponding G to 
U transversions. Taking into account the known influence o f magnesium concentration on 
the ribosome, the results suggested that mutations affected tRNA binding to the ribosome.
The sensitivity o f mutant ribosomes to antibiotics, which are known to interfere 
ribosomal peptidyltransferase activity, was tested in two different systems. The first system 
was poly(U) directed translation according to Rheinberger and Nierhaus, 1990. The poly(U) 
translation is less sensitive to inhibitors as compared to the natural mRNA translation 
(Pestka, 1977). Wild-type ribosomes were inactivated by thiostrepton as previously 
described. By comparing the results o f poly(U) translation on wild-type and U1067 
ribosomes with respect to the sensitivity to chloramphenicol and erythromycin, it was 
evident that the U1067 mutation had no influence on the sensitivity to peptidyltransferase 
inhibitors. On the other hand, the sensitivity o f the mixed U1067 ribosome population 
exhibited no difference in the presence or absence o f thiostrepton. Thus, the translocation 
inhibitor thiostrepton does not effect the sensitivity o f ribosomes to the peptidyltransferase 
inhibitors (chloramphenicol and erythromycin). Inhibition o f poly(U) directed translation on 
the mutant ribosomes was tested in the presence o f thiostrepton. The concentrations o f the 
antibiotics corresponding to the 50 % inhibition level are indicated in Table 1. The results
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obtained with erythromycin were similar for all the mutants within the experimental error. 
By contrast, inhibition o f  cell-free translation by chloramphenicol was effected on the U2583 
and C2583 double mutant ribosomes in the reprocucible manner indicating that mutations at 
this position conferred hypersensitivity o f  poly(U) translation to chloramphenicol.
The second system to assay the sensitivity o f  the mutant ribosomes to antibiotics was 
based on the ability o f thiostrepton to block translocation on the wild-type ribosomes. 
NacPhe-tFlNAPhc was bound to the ribosomal A site following preoccupation o f  the P site by 
deacylated tRNA. After EF-G promoted translocation, peptidyl-tRNA becomes competent 
to puromycin. When this reaction is carried out in the presence o f thiostrepton, translocation 
occurs only on the ribosomes containing U1067. Consequently, this route allows analysis o f 
the peptidyltransferase reaction catalyzed by mutant ribosomes using a mixed ribosome 
population. Chloramphenicol and lincomycin inhibited the transfer o f  Nac-Phe to puromycin, 
whereas erythromycin had no effect on the peptide bond formation, which has also been 
shown in earlier reports (Pestka, 1977). The concentration o f drugs corresponding to 50 % 
inhibition o f peptidyltransferase reaction on the wild-type and mutant ribosomes is indicated 
in Table 1. The inhibition pattern o f  chloramphenicol was similar indicating that mutations in 
23S rRNA had no effect during this particular assay. By contrast, mutations C2505, U2583, 
and C2583 led to an increased sensitivity o f peptide bond formation by lincomycin. It is 
known that both, chloramphenicol and lincomycin, inhibit the acceptor substrate binding 
(Pestka, 1977) but different effects o f  mutations on the sensitivity o f these two drugs show 
that inhibition is caused by a different way o f action. In addition, both, erythromycin and 
chloramphenicol, have been shown to indure the release o f  oligopeptidyl-tRNA during cell- 
free translation (Pestka, 1977; Rheinberger and Nierhaus, 1990). Hypersensitity o f mutants 
U2583 and C2583 to chloramphenicol during poly(U) translation and to lincomycin during 
puromycin reaction can be caused by a reduced binding affinity o f the 3' end o f tRNA to the 
ribosomal peptidyltransferase centre.
The influence o f mutations in 23 S rRNA on the fidelity o f translation was analyzed 
during poly(U) directed translation system in the presence and absence o f thiostrepton. 
Single mutant U1067 ribosomes exhibited the same Leu misincorporation level as wild-type 
ribosomes both in the presence and absence o f thiostrepton. Consequently, A 1067 to U 
transversion and the presence o f thiostrepton had no effect on the translational accuracy. 
The comparison o f the missense error frequencies in the presence and absence o f the drug 
showed that only the double mutants at position G2583 exhibited significant difference. Data 
on the Leu misincorporation in the presence o f thiostrepton is presented in Table 2. It is 
interesting to note that the effect on the translational accuracy correlates with the sensitivity 
to chloramphenicol during cell-free translation. One possible way to explain this 
phenomenon is to assume that binding o f the aa-tRNA is weaker (or alternatively the 
transfer reaction is slower) on the C or U2583 mutant. In this way, ribosomes would have 
more time for aa-tRNA dissociation during proofreading. Accordingly, the 
peptidyltransferase reaction must be limiting and an irreversible step for aa-tRNA selection. 
This model predicts that mutant ribosomes need more GTP's to hydrolyze for aa-tRNA 
binding.
The effect o f mutations in 23 S rRNA on the translational accuracy was tested in vivo. 
Plasmids containing mutant rRNA genes were introduced into cells with nonsense mutants in 
B-galactosidase. In this system the ribosomes must translate through a stop codon in order 
to synthesize functional B-galactosidase. Changes in the level o f enzyme synthesis, which are 
due to the presence o f mutant ribosomes, were detected as described in Prescott and 
Komau, 1992. The strains used were suppressor-free and therefore the level o f enzyme 
synthesis reflected the mistranslation at nonsense codons (Petrullo et al., 1983). The activity 
of B-galactosidase was normalized to the level o f B-lactamase activity synthesized at the 
same point in time. The B-lactamase gene contains no internal in-frame stop codon. 
Therefore, the amount o f this enzyme synthesized is a reflection o f overall in vivo translation
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activity. The ratio o f  8-galactosidase activity relative to that o f 13-lactamase represents the 
level o f mistranslation to translational acitvity.
The relative level of mistranslation at UAA nonsense condon was ap­
parently unaffected by the presence of mutation U 1067a. The double mutants 
caused the efficiency of mistranslation to be decreased in the following order: 
U1067>C2505>A2583>U2583>C2583. Thus these results are in good agreement with the 
results obtained in vitro. On the other hand an increased level o f  translational readthrough
Table 2. Functional effects o f  mutations in 23 S rRNA during poly(U) directed cell-free 
translation and peptidyltransferase reaction (PTR). Assays were performed as described in 
Saarma and Remme, 1992.
__________________________ Poly(U) translation______________________PTR
Thio1 Inhibition2 Leu/Leu+Phe)3 Inhibition4
Ribosomes
resist Cm
(mM)
Ery
(mM)
Cm
(HM)
Lin
(mM)
wild-type 0.04 >3 4 0.0122 4 0.35
U1067 0.52 >3 4 0.0123 4 0.35
U1067/C2505 0.32 2.5 5 0.0188 4 0.07
U1067/A2583 0.43 >3 4 0.0101 4 0.15
U1067/U2583 0.35 1.0 5 0.0057 4 0.10
U1067/C2583 0.29 2.0 5 0.0039 4 0.10
U1067/C2607 0.39 >3 6 0.0120 ND ND
U1067/A2608 0.46 >3 4 0.0121 ND ND
U1067/U2608 0.41 >3 8 0.0122 ND ND
U1067/C2608 0.38 >3 8 0.0121 ND ND
'Thiostrepton resistance is suongly dependent upon Mg2+ concentration. The data correspond to 12 mM 
MgCl2 and represent the ratio of cpms ± thiostrepton (1 fiM).
2 Inhibition was detected in the presence of thiostrepton on the mutant ribosomes and in the absence of drug 
on the wild-type ribosomes. Poly(U) translation was inhibited by 50 % at the indicated concentrations; Cm 
= chloramphenicol. Ery = erythromycin.
3 Leu misincorporation was measured in the presence of thiostrepton on the mutant ribosomes and in the 
absence of drug on the wild-tvpe ribosomes.
4 PTR was inhibited by 50 % with either both wild-type and mutant ribosomes (Cm) or with mutant 
ribosomes (Lin) at the indicated concentrations; Lin = lincomycin.
ND - not determined.
was observed at UAG stop codon due to the presence o f U1067 ribosomes. This effect was 
suppressed by the second mutation at position G2583. The UAG specific readthrough on the 
U1067 ribosomes can be explained by affecting RF-1 and RF-2 binding in a different way 
Therefore, mutations at position G2583 reduce the level o f mistranslation at both UAA and 
UAG nonsense codons.
Taking into account that mutant ribosomes form about 40 - 60 % o f the total ribosome 
population (Saarma and Remme, 1992), the effects o f mutations in 23 S rRNA on the 
translational accuracy should be higher than those observed in these experiments. A 
comparison o f the results obtained in vivo and in vitro show that the effect o f mutations at 
position 2583 o f 23S rRNA on the translational accuracy are in agreement in both systems. 
Surprisingly, C2505 had a small effect in vivo but not in vitro
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The A 1067 to U transversion is known to reduce the affinity o f thiostrepton to 
ribosomes 100 times (Thompson and Cundliffe, 1991) allowing the physical separation o f 
mutant ribosomes as it was proposed (Thompson et al., 1988). Several solid supports were 
tested in respect to binding o f  ribosomes to the immobilized thiostrepton. It was found that 
the acid-hydrolyzed Sephadex can be used as a support for affinity purification o f  U1067 
ribosomes. Evidently polysaccharide chains are long enough spacers to avoid steric 
hindrances in ribosome-thiostrepton interaction. Physical separation o f  mutant ribosomes 
would be important for the analysis o f  effects o f mutations in 23 S rRNA concerning the 
structure and function o f the ribosome. Direct measurements o f the binding affinities of 
aminoacyl-oligonucleotides to the peptidyltransferase centre o f  the mutant ribosomes would 
answer to the question whether the mutations in the 23 S rRNA effect the binding o f 
substrates to the peptidyltransferase centre.
CONCLUSION
Thiostrepton is known to inhibit both elongation factor dependent allosteric transition 
and nonemzymatic translocation o f  the wild-type ribosomes (Hausner et al., 1988). The A to 
U transversion at position 1067 o f  23S rRNA has been shown to confer resistance to 
thiostrepton during cell-free translation on the E. coli ribosomes (Thompson et al., 1988). 
U1067 has proven to be a useful mutation to discriminate between the activities o f 
chromosomal and plasmid encoded ribosomes.
In this study the thiostrepton resistance was used first to study the 50S assembly 
process It was shown that 50S particles containing transcripts synthesized by the T7 RNA 
polymerase at 37°C are inactive. 1) The corresponding 50S particles accumulated in the 50S 
pool and could not enter the 70S pool in vivo indicative o f their inactivity. 2) In vitro the 
plasmid-derived ribosomes were not active in poly(Phe) synthesis. 3) The pT7-l derived 
transcripts accumulate in the 50S fraction even when the transcription initiation rate was 
lowered which caused low expression levels o f the plasmid rRNA genes. 4) The 50S 
subunits with pT7-l rRNA could partially enter the 70S fraction when the transcription 
elongation rate was decreased by incubation at 25°C. It follows that it is neither the 
transcription providing defective rRNA nor the overproduction o f  ribosomal RNA but rather 
the assembly o f defective 50S subunits which caused the inactivity o f  the 50S particles in 
vivo when the rRNA is synthesized with the T7 RNA polymerase. A likely explanation is 
that the coupling beween rRNA transcription and ribosomal assembly ("assembly gradient", 
for review see Nierhaus, 1991) is a prerequisite for the formation o f active particles and can 
be disturbed in the presence o f T7 RNA polymerase. The viral enzyme is five times faster 
than the host transcriptase and so the finely tuned interaction between rRNA folding and 
protein binding might be uncoupled.
Further, the thiostrepton resistance was used as a second mutation for the functional 
characterization o f single point mutations at the peptidyltransferase region o f  E. coli 23 S 
rRNA. It was found that mutations corresponding to positions G2505 and G2583 affected 
ribosomal sensitivity following exposure to the inhibitors o f peptide bond formation, 
whereas mutations at G2607 and G2608 had no effect. An increase in translational accuracy 
was attributed to the mutations at position 2583. The hyperaccurate phenotype o f these 
mutations was confirmed in vivo. In addition, it was found that the U1067 mutation had an 
influence on the UAA directed termination event. The nucleotide 1067 is situated at a region 
which might be related to  the factor dependent GTPase activity. Therefore, mutations at this 
position might affect factor directed reaction on the ribosomes and are possibly not suitable 
for the study o f  mutations which interfere with factor-dependent reactions. On the other 
hand, U1067 had no influence on the ribosomal peptidyltransferase centre and can indeed be 
used as a second mutation to study the role o f  23S rRNA in the peptide bond formation.
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Escherichia coli ribosomes with an A to U transversion at nucleotide 1067 
of their 23 S rRNA are impaired in their effective association rate con­
stants (kat/K M) for both EF-Tu and EF-G binding. In addition, the times 
that EF-G and EF-Tu spend on the ribosome during elongation are sig­
nificantly increased by the A to U transversion. The U1067 mutation 
impairs EF-Tu function more than EF-G function. The increase in the 
time that EF-Tu remains bound to ribosome is caused, both by a slower 
rate of GTP-hydrolysis in ternary complex and by a slower EF-Tu-GDP 
release from the mutated ribosomes. There is, at the same time, no 
change in ribosomal accuracy for aminoacyl-tRNA recognition. With sup­
port from these new data w e propose that nucleotide 1067 is part of the 
ribosomal A-site where it directly interacts with both EF-G and EF-Tu.
r 1997 Academic Press Limited
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Introduction
Two soluble protein elongation factors, EF-Tu 
and EF-G, use GTP as a co-factor to enhance speed 
and accuracy of mRNA translation in Escherichia 
coli (Kaziro, 1978; Kurland et al., 1996). Two well 
defined, local regions of E. coli 23 S rRNA appear 
to interact directly with elongation factor G (EF-G). 
The first is situated in domain II of 23 S rRNA. It is 
defined by bases 1051 to 1108 and is commonly 
referred to as the thiostrepton binding structure, 
TBS. The second is the a-sarcin stem-loop struc­
ture, SRL, in domain VI. The latter domain, but not 
the former, has been shown to interact directly also 
with elongation factor Tu (EF-Tu). These two 
domains are distal in sequence, but they may be 
proximal in the tertiary fold of 23 S rRNA (for 
reviews see Cundliffe, 1990; Thompson, 1996; 
Czworkowski & Moore, 1996).
A previous study demonstrated profound effects 
on the function of EF-Tu as well as EF-G by a base 
change at position 2661 in the SRL of E. coli ribo­
somes (Bilgin & Ehrenberg, 1994). The present 
work extends these investigations of functional
Present address: N. Bilgin, Department of 
Biochemistry, U ppsala University, Biomedical Center, 
Box 576, S-751 23 Uppsala, Sweden.
Abbreviations used: EF-Tu, EF-G, elongation factors 
Tu and G; TBS, thiostrepton binding structure; SRL, 
stem -loop structure; w .t., wild-type.
interactions between rRNA and elongation factors 
to the thiostrepton binding structure.
The TBS is conserved in all three kingdoms, as 
indicated by computer simulations of its secondary 
structure (De Rijk et al., 1996) and by the striking 
result that TBS regions in E. coli and yeast can be 
exchanged without loss of ribosome activity 
(Musters et al., 1991; Thompson et al., 1993).
Direct interaction between EF-G and TBS is indi­
cated by early experiments (Sköld, 1983), demon­
strating crosslinking between TBS and EF-G. Later 
it was shown that EF-G protects bases in TBS from 
chemical modification (Moazed et al., 1988).
Further evidence for an intimate interplay 
between EF-G and the TBS comes from obser­
vations that, first, thiostrepton and micrococcin 
bind to the TBS and that, second, these drugs 
strongly affect the function of EF-G. The binding 
sites for both drugs were early ascribed to the 
TBS (Cundliffe & Thompson, 1981; Egebjerg et al.,
1989) and subsequent experiments confirmed this 
conclusion. It was found that binding of both 
thiostrepton and micrococcin change the pattern 
of chemical modification of N1 position of base 
A1067 by DMS. Thiostrepton reduces, while 
micrococcin enhances the accessibility of the DMS 
(Egebjerg et al., 1989). Experiments also demon­
strated that mutations A 1067 to U or C give high 
resistance to both thiostrepton and micrococcin 
(Thompson et al., 1988; Rosendahl & Douthwaite,
1995). The binding of both drugs is modulated
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by ribosomal protein L ll, which has been shown 
to stabilize the tertiary structure of the TBS, thus 
being an important factor for the folding of this 
23 S rRNA region (Draper, 1996 and references 
therein). Furthermore, the thiostrepton producing 
organism Streptomyce s azureus protects itself 
against the drug by methylating A1067 in its 23 
S rRNA (£. coli numbering) (Thompson et al., 
1982).
Evidence for the existence of direct interactions 
between thiostrepton or micrococcin, bound in the 
TBS, and EF-G comes from how these drugs affect 
the ribosome-dependent GTPase activity of EF-G, 
which is stimulated by micrococcin and inhibited 
by thiostrepton (Cundliffe & Thompson, 1981). 
Earlier experiments also show that thiostrepton 
and micrococcin inhibit other ribosome functions 
involving EF-G (Vazquez, 1979).
While chemical protection studies suggest that 
EF-G, but not EF-Tu, interacts directly with the 
TBS (Moazed et al., 1988), the functional exper­
iments by Vazquez (1979) show that micrococcin 
and thiostrepton inhibit the action not only of 
EF-G, but also of EF-Tu. This suggests that the 
TBS may, in fact, interact directly also with EF- 
Tu. The reason whv chemical protection exper­
iments have failed to reveal such contacts 
(Moazed et al., 1988), may simply be experimen­
tal conditions where the ribosome was not in the 
right configuration to interact with EF-Tu. If so, 
base substitutions in the TBS may influence not 
only the kinetics of EF-G, but may also affect the 
function of EF-Tu.
The present work is an experimental study of 
how the above mentioned A to U transversion at 
position 1067 of 23 S rRNA in the TBS affects EF- 
Tu as well as EF-G function in translation.
The experiments were performed with an opti­
mized in vitro translation system with in vivo like 
properties (Ehrenberg et al., 1990). Both steady 
state and fast kinetic methods (quench-flow) were 
used to study how this mutation influences the 
cycling times of EF-G and EF-Tu, the rate of GTP- 
hydrolysis in a cognate ternary complex in the A- 
site and the rate of peptide bond formation.
The experiments reveal significant functional 
effects of the A1067U transversion on both 
elongation factors, and demonstrate that the 
mutation inhibits the EF-Tu much more than the 
EF-G function. The results suggest that not only 
the ot-sarcin stem-loop structure, but also the TBS 
may be a constitutive part of the ribosomal A- 
site.
Results
Content of U1067 23 S rRNA in the 
ribosome population
Ribosomes were isolated from an £. coli strain 
(POP2136), transformed by the pNO-U1067 plas­
mid, coding for 23 S rRNÄ containing a U at pos­
ition 1067 of its gene for 23 S rRNA (Spahn et al.,
1996). Sequencing of 23 S rRNA from ribosomes 
purified from the transformed cells revealed that 
about 51% of 23 S rRNA was of U1067 and the rest 
of wild-type (w.t.: Materials and Methods, data not 
shown). The fraction of U1067 in 23 S rRNA 
extracted from polysomes, 70 S and 50 S particles 
are the same (Spahn et al., 1996), indicating that 
ribosome activity is unchanged bv the A to U 
transversion. We confirmed this result by measur­
ing peptide bond formation kinetics for the w .t./ 
U1067 mixture in the presence and absence of 
thiostrepton and found that 50% of the ribosome 
population was drug resistant (data not shown, N. 
Bilgin, unpublished). This result showed that the 
fraction of U1067 ribosomes found bv sequencing 
(51%) also represents the fraction of U1067 in the 
translationallv active ribosomes.
EF-Tu cycle
We first studied the influence of an A to U trans­
version at position 1067 in 23 S rRNA on the full 
EF-Tu cycle. EF-Tu was kept at a small, constant 
concentration and the ribosome concentration was 
titrated from small to high values, with all other 
translation components in excess. The experiment 
measured the effective association rate constant 
(kcat/K M) for the binding of ternary complex to the 
ribosomal A-site and the average time (1 /k rM) that 
EF-Tu stays either on the ribosome or on the path 
from free EF-Tu GDP to ternary complex (see 
Ehrenberg et al., 1990 for details).
The Eadie-Hofstee plot in Figure 1 shows that 
kcat/K M is 28 x 101’ M-1 s "1 for wild-tvpe ribosomes 
and 17 x 10bM- 1 s-1 for the w .t./U 1067 mixture. 
The same plot gives kcM =  6.8 s -1 for wild-tvpe 
ribosomes and kcM =  5 A s~ l for the w.t./U1067  
mixture. Knowledge of the fraction of U1067 in 
23 S rRNA allows estimation of kcM/K M and kCM 
also for pure U1067 ribosomes (Bilgin & 
Ehrenberg, 1994, details in Materials and Methods) 
and estimates of 6.9 x 10h M“ ' s _l, respectively 
3.1 s~ l were obtained. These data show that the A 
to U transversion at position 1067 of 23 S rRNA 
significantly affects both the rate of binding of tern­
ary complex to the A-site (kcM/K M reduced about 
threefold) and the time EF-Tu stays on the 
ribosome (1 / Arcrit increased about twofold; Table 1).
The rate of GTP hydrolysis on EF-Tu and 
peptide bond formation
The effects of the A to U change at position 1067 
on the rate of hydrolysis of GTP, when a cognate 
ternary complex is in the A-site, as well as on the 
rate of peptide bond formation were studied next. 
The experiments were done with the quench flow 
technique (Bilgin et al., 1992), which allows rapid 
mixing and subsequent quenching of the reaction 
components for short incubation times. One 
quench-flow svringe was loaded with poly(U)-pro- 
grammed ribosomes and the other with (cognate) 
ternary complex containing EF-Tu, GTP and Phe-
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Poly(Phe)/s/EF-Tu/70S ((jM-1s-1)
Figure 1. EF-Tu cycle. Eadie-Hofstee plots from  
titrations w ith  w ild -type (□) or w ith  w .t./U 1067  ribo­
som e mixture ( ♦ )  at a fixed and rate limiting concen­
tration of EF-Tu. The rate of poly(Phe) synthesis 
norm alized to the am ount of EF-Tu (p oly(P h e)/s/E F -  
Tu) is plotted as a function of the rate of poly(Phe) syn­
thesis norm alized to the am ount of EF-Tu and to the 
concentration of active ribosom es (p o ly (P h e)/s/E F -T u / 
70 S). The intercept at the ordinate is the kcM for the EF- 
Tu cycle and the intercept at the abscissa is the /cCilt/X M 
for the EF-Tu-ribosome association.
tRNAphe in large excess so that the time to fill the 
ribosomal A-site could be neglected (Materials and 
Methods). Figure 2 shows the result of two such 
experiments, where the extent of GTP hydrolysis 
and dipeptide formation is measured as a function 
of time for wild-type ribosomes as well as for the 
w .t./U 1067 mixture. GTP hydrolysis appears as a
first order reaction for wild-type ribosomes and we 
estimated the rate of GTP hydrolysis (A:CXP) to be 
122 s -1 in this case (Materials and Methods). For 
the w .t./U 1067 mixture, the experimental data 
reflects the sum of two exponentials corresponding 
to the extent of GTP hydrolysis for wild-type and 
for U1067 ribosomes. By using the known fraction 
of U1067 in the mixture and that fcCTP =  122 s_1 for 
wild-type ribosomes, we estimated that 
kGJP =  71 s-1 for pure U1067 ribosomes (Materials 
and Methods). These two rate constants corre­
spond to average times (time =  l / k GTV) of GTP- 
hydrolysis of 8.2 ms for wild-type and 14.1 ms for 
mutant ribosomes.
The plots for dipeptide formation show a clear 
lag phase at short times (Figure 2(a) and (b)) which 
means that the reactions have several consecutive 
steps. The average time for dipeptide formation 
(xdip) is the time it takes to hydrolyze GTP on EF- 
Tu plus the time for EF-Tu-GDP release from the 
ribosome plus the peptidyl transfer time. tdip can 
be estimated by integrating the probability, P(f), 
that no dipeptides have formed from zero to infi­
nite time (Materials and Methods, Bilgin et al., 
1992). We obtained a Tdip of 22.5 ms for peptidyl 
transfer on wild-type ribosomes.
In order to calculate Tdip for pure 1067 ribo­
somes, the contribution from wild-type ribosomes 
to the dipeptide formation was subtracted. For 
this, data for wild-type ribosomes (Figure 2(a)) and 
the measured fraction (0.49) of wild-type in the 
w .t./U 1067 mixture were used (Materials and 
Methods). We estimated then, as in Figure 2(a) for 
wild-type, that t dip is 43 ms for pure U1067 ribo­
somes.
For these altered ribosomes the average time to 
hydrolyze GTP is 5.9 ms Longer than for wild- 
type ribosomes (14.1 ms — 8.2 ms =  5.9 ms). Since 
the average time for peptide bond formation
Table 1. Kinetic parameters for w ild-type and U1067 ribosomes
Ribosome
* r , l
ts"1)
EF-Tu cycle 
Fraction of w.t.a kcat/K v  
( % )  ((j M _1s _1 )
Fraction of w.t.a 
( % )
W.t.
W.t./U1067
U1067(calculated)
7.3 ±  0.7
5.4 ±0.1 
3.0 ±  0.02
1 0 0  
74 ± 8  
42 ± 4
26 ± 3  
17 ±0.1 
8.4 ±  2.2
1 0 0  
65 ± 6  
32 ±11
Ku 
(s ' )
EF-G cycle 
Fraction of w.t.* A;.lt/K M 
('" ..) ( n M - ‘s - ‘)
Fraction of w.t.a 
("/„) •
W.t.
W.t./U1067
U1067(calculated)
91 ± 3  
76 ±  1 
66 ±  4
1 0 0  
83 ± 5  
72 ± 7
66 ± 5  
59 ± 7  
55 ± 9
100 
90 ± 4  
83 ±  8
GTP hvdroivsis on EF-Tu and peptidyl transfer 
^ 7 T I '( S ~ ')  V .TI- (1 A V .T I’) ( m s )  ^ d i p ( m s )
W.t.
U1067 (calculated)
122 ±  11 
71 ± 7
8.2 ±  0.7 
14.1 ±  1.4
22.5 ±  2.1 
43.0 ±1.4
a The ratios between wild-tvpe and mutant values, obtained in parallel experiments, were averaged 
over separate experiments (two experiments for EF-Tu, and three experiments for EF-G) and 
a-values calculated.
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time (ms)
time (ms)
Figure 2. The extent of GTP hydrolysis and dipeptide 
formation for w ild-type ribosomes (a) and for w .t ./  
U1067 m ixture (b). The amount of GTP hydrolyzed ( ♦ )  
or the am ount of dipeptides formed (0 ) is plotted as a 
function of time.
includes the time to hydrolyze GTP, one would  
expect an at least 5.9 ms longer Tdip for the 1067U 
mutant than for the wild-type. Interestingly, the 
increase in Tdip is 43 -  22.5 =20.5 ms, indicating 
that other steps, in addition to GTP hydrolysis, 
are slowed down by the U1067 mutation. One 
possibility is that the peptidyl-transfer reaction 
itself is slowed down. Another is that the release 
of EF-Tu.GDP from the ribosome takes longer 
time in the U1067 case.
Accuracy
If the binding of ternary complexes to the ribo­
some gets weaker, or if the rate of GTP hydroly­
sis on F.F-Tu gets slower, a high accuracy 
phenotype may arise (Kurland & Ehrenberg, 
1984). In order to see if the observed impaired 
binding of ternary complex (kc,n /K M) to the
U1067 mutant and the observed slower rate of 
GTP hydrolysis on EF-Tu are associated with 
such an accuracy phenotype w e compared the 
wild-type ribosomes with the w .t./U 1067 mixture 
in a missense error assay (Ehrenberg et al., 1990). 
Leucine misincorporation into poly(Phe) was stu­
died and it was found that the normalized mis­
sense error frequency is 0.7 x 10-3 for both 
ribosome variants when Leu-tRNALeu4 competes 
with Phe-tRNAPhe in poly(U) reading (data not 
shown, Materials and Methods).
Proofreading of cognate aminoacyl-tRNA
The number of GTPs hydrolyzed on EF-Tu per 
cognate peptide bond ( f )  in poly(U) translation 
is near two for both wild-type and for U1067 
ribosomes in dipeptide formation (Figure 2). We 
also measured f .  for wild-type and U1067 ribo­
som es in steady-state assays by two different 
methods. In the first, the extent of polv(Phe) syn­
thesis was measured as a function of EF-Tu GDP 
in the absence of EF-Ts (Materials and Methods). 
f c was calculated by using the known exchange 
rate of GTP on EF-Tu (kd — 0.011 s _1) and well 
determined EF-Tu concentration. We obtained 
/^.-values of 1.96 and 2.08, respectively, for wild- 
type and for mutated ribosomes (data not 
shown). In the second method, the extent of GTP 
hydrolysis on EF-Tu per peptide bond formation 
was directly measured after separating the action 
of EF-Tu from that of EF-G (Ehrenberg et al., 
1990). Here, w e took advantage of the slow  
exchange rate of GTP in the ternary complex and 
used [ H]GTP to measure the extent of GTP 
hydrolysis on EF-Tu, whereas a high concen­
tration of unlabelled GTP was used to drive the 
cycle of EF-G (Ehrenberg et al., 1990, Materials 
and Methods). We obtained with this method 
similar f c values for wild-tvpe and for U1067 
ribosomes ( 1.9 and 2.3, respectively). We con­
clude from these results that U1067 ribosomes do 
not affect the proofreading of the cognate ami- 
noacyl-tRNA's.
Dissociation rate of peptidyl-tRNA from 
the A-site
In a translation system that lacks EF-G, 
dipeptidyl-tRNA remains in the A-site after pep­
tidyl-transfer, waiting to be translocated. 
Addition of EF-G after various times leads to 
completion of long poly(Phe) chains, provided 
that peptidyl-tRNA has not yet dissociated from 
the A-site during these waiting times before EF- 
G addition (Karimi & Ehrenberg, 1994). We 
compared, using this technique, the dissociation 
rates of peptidyl-tRNA from wild-type and from 
w.t./U 1067 ribosomes and found dissociation 
rates of N-acetyl-Phe-Phe-tRNA1’111- corresponding 
to 2 . 3 x l 0 ' 3 s~' for both ribosome types (data 
not shown).
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Poly(Phe)/s/EF-G/70S (pM-1 s -1 )
Figure 3. EF-G cycle. Eadie-Hofstee plots from titrations 
with w ild-type (n) or with w .t./U 1067  ribosome mixture 
( ♦ )  at a fixed and rate limiting concentration of EF-G. 
The rate of poly(Phe) svnthesis normalized to the 
am ount of EF-G (poiv(I’h e)/s/E F -G ) is plotted as a 
function of the rate of polv(Phe) svnthesis normalized to 
the am ount of EF-G and to the concentration of active 
ribosomes (p o lv (P h e)/s/E F -G /70  S). The intercept at the 
ordinate is the k .M tor the EF-G cvcle and the intercept 
at the abscissa is the ,/K M for the EF-G-ribosome 
association.
EF-G cycle
The effects of the A to U change at position 1067 
on the full cvcle of EF-G were also studied as 
described bv Ehrenberg et til. (1990). A ribosome 
titration experiment, that is principally similar to 
the one in Figure 1, was done but with EF-G, 
instead of EF-Tu, kept at a small rate limiting con­
centration with all other components in excess. 
One such experiment where wild-tvpe ribosomes 
are compared with w .t./L r1067 mixture is shown 
in Figure 3. From these Eadie-Hofstee plots kcM/ KM 
for the effective binding of EF-G to the ribosome 
was estimated to be 61 x 10h M_1s~'for wild-tvpe 
and 53 x 10h tv r 's-1 for the w .t./U1067 mixture. 
For the pure U1067 ribosome we estimated k^t/K s  ^
to be 47 x 10h M_ls “' (Materials and Methods). 
The mutation also decreased the maximal turnover 
rate for EF-G (/ctU = 87 s_l for wild-tvpe and 
k,.M =  77 s -l for w.t./U1067 mixture). For the pure 
U1067 mutant kt.M was estimated to be 70 s~'.
Discussion
We have found that a base change from A to U 
at position 1067 of 23 S rRNA from £. coli has sig­
nificant effects on both EF-Tu and EF-G function. 
The strongest effects are seen for EF-Tu. First, the 
effective association rate constant (kat/K M) for cog­
nate ternary complex binding to the ribosomal 
A-site is reduced more than a factor of two by the 
base change and, second, the average time for
GTP-hydrolvsis in a cognate ternary complex in 
the A-site is increased almost twofold (Table 1). 
Since the time for dipeptide formation increases 
more by the rRNA mutation than the correspond­
ing increase in GTP-hydrolysis time, the A to U 
change probably has multiple effects on EF-Tu 
function, and w e suggest that the release of EF- 
Tu-GDP from the ribosome is slowed down. This 
gets support from the corresponding increase in 
the average time for a full EF-Tu cycle (Figure 1, 
Table 1). It is, however, still possible that the 
U1067 mutation perturbs also the peptidvl-transfer 
reaction itself.
The A to U transversion has also a small but a 
significant effect on the effective rate of association 
(kCM/ K M) of EF-G to the ribosome as well as on the 
translocation rate, leaving the /CM unchanged 
(Figure 3, Table 1).
Our functional data confirm that the TBS region 
is important for the interaction between EF-G and 
the ribosome, but indicates that this part of 23 S 
rRNA may be even more crucial for the interaction 
between the ribosome and EF-Tu. Beside the TBS, 
both elongation factors have previously been 
shown to interact with the SRL region (Moazed 
et al., 1988), indicating that domains II and VI are 
quite close in the tertiary fold of 23 S rRNA within 
the £. coli ribosome.
The impairment of EF-Tu function, that we have 
observed in vitro , is consistent with in vivo exper­
iments by Thompson et al. (1988), demonstrating 
a growth rate deficiency of mutants containing 
U1067. This decreased growth rate is readily 
explained by the reduction in kcat/K M for the inter­
action between cognate ternary complex and the 
A-site in combination with the prolonged time for 
peptidyl transfer (T(lip; Table 1). Each of these 
defects could by themselves account for why 
U1067 bacteria grow slower than wild-tvpe 
(Kurland et al., 1996; Pedersen, 1984), while the 
reduction in /rrnt/K M for EF-G is expected to have a 
much smaller effect on growth rate.
Given the significant effect on EF-Tu function 
that is caused by the A to U transversion at 1067, 
the lack of experimental data that directly point to 
an interaction between EF-Tu and the TBS- 
sequence is surprising. There exists, however, a 
number of indirect observations that implicate inti­
mate structural and functional relations between 
TBS and EF-Tu.
Studies with thiostrepton and micrococcin (see 
Introduction) indicate that the TBS is a constitutive 
part of the ribosomal A-site (Gale et al., 1981). 
These antibiotics inhibit such ribosomal functions 
that normally are associated with the A-site. This 
may indicate that the drugs, and therefore the 
nucleotides to which they bind, may be present in 
the A-site itself. Among A-site related functions, 
the inhibition of (p)ppGpp formation, peptide 
chain termination and the binding of ribosomal 
factors IF-2, EF-Tu and EF-G to the ribosome 
are influenced bv thiostrepton (Gale et ah, 1981). 
Furthermore, thiostrepton may, depending on
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experimental conditions, stimulate ribosomal pepti­
dyltransferase (Kutay et al., 1990) and genetic evi­
dence for a functional interaction between domains
II and V of 23 S rRNA has been provided (Mankin 
et al., 1994)
A different type of experimental support to the 
idea, that the TBS might be part of the ribosomal 
A-site, comes from studies showing that enzymatic 
binding of aminoacyl-tRNA to the A-site moder­
ately protects bases G1068 and G1071 from chemi­
cal modification (Moazed & Noller, 1989).
Interestingly, the U1067 mutant does not have 
an accuracy phenotype, different from that of 
wild-type ribosomes, despite its reduced rate of 
GTP hydrolysis on EF-Tu and impaired kcat/K M 
for ribosome-ternary complex interaction. This 
means that kcM/K M for cognate and near-cognate 
ternary complex interaction with the ribosome 
must be reduced to the same extent by the base 
change. This behavior is unusual, since a reduced 
kcai/K M value for the cognate ternary complex 
normally is associated with reduced missense 
errors (Kurland et al., 1996). A similar case was 
found by Tapio et al. (1990) for an EF-Tu variant 
(Aa) with dramatically reduced kcat/K M for cog­
nate ternary complex-ribosome interaction but 
with the same missense error level as wild-type 
EF-Tu. The most likely interpretation of these 
results is that the amino acid substitution in EF- 
Tu (Tapio et al., 1990) and the base change at 
1067 both affect interactions between EF-Tu and 
rRNA in a step before codon-anticodon contact. 
We have also found that the number of GTPs 
hydrolyzed per peptide bond for cognate ternary 
complex (fc) and that the drop-off rate of cognate 
peptidyl-tRNA from the A-site, both are 
unchanged by the U1067 mutation. Since the f c- 
value is inversely proportional to the probability 
that a cognate aminoacyl-tRNA survives riboso­
mal proofreading (Kurland et al., 1996), these 
experiments also suggest that the change of base 
at position 1067 may affect a direct interaction 
between this base and EF-Tu rather than between 
rRNA and aminoacyl-tRNA.
Recent crystallographic data reveal that the the 
structure of EF-G-GDP (Czworkowski et al., 1994; 
Aevarsson et al., 1994) and of the ternary complex 
between aminoacyl-tRNA, GTP and EF-Tu (Nissen 
et al., 1995) are remarkably similar. This may mean 
that not only EF-Tu, but also EF-G, directly inter­
acts with the ribosomal A-site. It is thus conceiva­
ble that EF-G ends up in the A-site after 
translocation of peptidyl-tRNA from A- to P-site 
(Nyborg et al., 1996; R. Karimi & M. Ehrenberg, 
unpublished data). Assuming that not only EF-Tu 
but also EF-G have direct interactions with the A- 
site, w e may explain our kinetic data on the effects 
of the A to U transversion at position 1067 of 23 S 
rRNA in a unified way. If TBS in general and base 
1067 in particular are part of the ribosomal A-site, 
then it follows naturally that a base change at pos­
ition 1067 may directly affect the action of both
elongation factors by changing their binding inter­
actions with the ribosome.
With support from the present finding that the 
rate of GTP hydrolysis on EF-Tu is slowed down 
by the A to U transversion (Table 1), we also 
suggest that the TBS region is crucial for the 
activity of a common GTPase center, that stimu­
lates both EF-Tu and EF-G-dependent GTPase 
activity. Further, indirect, evidence in this direction 
is the more recent observation that GTP hydrolysis 
on EF-Tu is inhibited by thiostrepton (U. S. & N. 
B., unpublished results).
Materials and Methods
Strains and plasmids
£. coli strain pop2136, com prising a chrom osomallv 
located gene encoding for the temperature-sensitive 
lam bda repressor cJts857, w as used as a host to tranform 
the plasm ids. Plasmid p N 02680  w hich carries the £. coli 
rrnB operon under the control of lambda leftward pro­
moter w as used to derive pNO-U1067T. Both p N 02680  
and pNO-U1067T w ere transformed into pop2136 strain 
and selected on ampicillin plates (100 n g /m l).
Preparation of ribosomes
Transformants p N 02680  and pNO-A1067T of E. coli 
strain pop2136 w ere grown in TY2 m edium  sup­
plem ented with 0.4"o (w /v )  glucose and ampicillin 
(100 (ig /m l) at 30 C to =  0.14. Thereafter, expression  
of RNA from plasm ids w as induced by temperature shift 
to 42'C  and the bacteria w ere harvested after tw o hours. 
Ribosomes w ere purified by gel filtration chrom atog­
raphy on Sephacryl-S300 (Pharmacia) (for details, see 
Jelenc 1980), dialvzed and stored in polym ix buffer 
(Jelenc & Kurland, 1979, see below).
Preparation of enzymes and tRNAs
EF-Tu, EF-Ts, EF-G, Phe-tRNA synthetase and Leu- 
tRNA synthetase w ere purified from E. coli MRE600 bv 
follow ing the protocols of Ehrenberg et al. 1990). tRNA- 
hll,k w as purified from £. coli MRE600 as described bv 
Kelmers et ai. (1971). tRNA1’111' and tR NA u-u4 were puri­
fied from tRNAbu,k according to Gillam et al. (1967). 
N -acetvl-Phe-tRNA,,|lc w as prepared from purified 
tR NA 1’111’ as described by W agner et al. (1982).
tRNAs and enzym es w ere all d ialvzed and stored in 
polym ix buffer.
Analysis of rRNA content in ribosomes
rRNA w as extracted from the purified ribosom es used 
in the assays and sequenced. Purified rRNA obtained 
from w ild-tvpe and from w .t./U 1067  mixture was 
sequenced by primer extension using reverse transcrip­
tase as described by Bilgin et al. (1990). Fractions of 
mutant RNA in purified ribosomes w ere estim ated from 
the autoradiograms of the sequencing gels according to 
Bilgin & Ehrenberg (1994).
Assays
All experiments were performed at 37 C in polvmix 
buffer (5 mM magnesium  acetate, 5 mM potassium  phos­
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phate (pH 7.3), 95 mM potassium  chloride, 5 mM  
am m onium  chloride, 0.5 mM calcium chloride, 1 mM 
spermidine, 8 raM putrescine and 1 mM 1,4-dithioery- 
thritol). Steady-state experiments w ere described by 
Ehrenberg et al. (1990) and pre-steady-state assay w ith  
time resolved quench-flow  is described by Bilgin et al. 
(1992)'in detail.
Factor cycles
EF-Tu and EF-G cycle experiments w ere carried out 
as described by Ehrenberg et al. (1990) and references 
therein. The elongation factor w as kept at a rate limit­
ing concentration and the ribosome concentration was 
varied w ith  all other com ponents in excess. Cycling  
rates of elongation factors obey M ichaelis-M enten kin­
etics. kCM and KM for EF-Tu and EF-G w ere directly 
determ ined from Eadie-Hoffstee plots (Ehrenberg et al.,
1990) and parameters for pure mutant w ere calculated  
as described bv Bilgin & Ehrenberg (1994) using the 
equations:
Km /Kmi -  UK-m/Km ) -  (1 -
and
K m 2 =  s / I U / K m ) -  ( 1  -  2 ) / K , w i )]
where y. is the fraction of the mutated ribosom es in the 
w ild-type-m utant mixture, A\„,, kcM2 and kcM are the 
m axim um  elongation factor cycling rates for wild-tvpe, 
mutant and w ild-tvpe-m utant mixture, respectively. 
Similarly KNtl, KM2 and are the corresponding XM 
values.
GTP hydrolysis on EF-Tu and dipeptide formation
The experim ents w ere performed on quench-flow  
apparatus (Kin-Tec USA). EF-Tu • pH]GTP • Phe-tRNAphc 
ternary com plex w as rapidlv mixed with ribosomes, 
initiated with A/-acetvl-[;'H]Phe-tRNAl’hl’ and poly(U) in 
the absence of EF-G and EF-Ts (see Bilgin et al., 1992 for 
details).The GTP hydrolysis on EF-Tu and the appear­
ance of dipeptides w ere followed as a function of time. 
Tine extent of GTP hydrolvsis w as determ ined bv the 
G D P/(G D P +  GTP) ratio, calculated after thin-laver 
chrom atography of the quenched sam ples, multiplied by 
the total am ount of ['H]GTP initially present in the tern­
ary com plex before m ixing with ribosomes. The extent of 
dipeptide formation w as calculated by using the ratio of 
the N-acetvl-Phe-Phe dipeptides to the total N-acetvl-Phe 
plus N-acetvl-Phe-Phe dipeptides after separating the N- 
acetvl-Phe-Phe dipeptides from N-acetvl-Phe by HPLC. 
This ratio w as then m ultiplied bv the total am ount of N- 
acetvl-Phe initially present in the ribosome mix (Bilgin 
et al., 1992). The time curves were evaluated as described  
bv Bilgin et al. (1992).
In order to calculate the rate of GTP hvdrolvsis and  
the average time for peptide bond formation for pure 
mutants, contributions of the w ild-tvpe ribosomes were 
substracted from the corresponding data for the w .t ./  
U1067 mixture by taking into account the percentage of 
the w ild-tvpe ribosom es in the mixture (49%).
The apparent GTP hydrolysis for w .t./U 1067  mixture 
w as the sum  of tw o exponentials corresponding to the 
rates of GTP hydrolysis (kCTP) for w ild-tvpe and for 
1067U mutant. The known kc-JV for w ild-tvpe ribosomes 
and the fraction o f w ild-tvpe RNA in the w .t./U 1067  
mixture w as used in a MatLab program (courtesv of M. 
Pavlov) to estim ate the fcCTP for pure U1067 ribosomes.
For peptide bond formation, the reaction cannot be 
characterized by a single rate constant. D ipeptides 
appear after a lag phase indicating several steps before 
peptidyltransferase. For w ild-type ribosom es, the aver­
age tim e for d ipeptide formation w as estim ated by inte­
grating the probability that no peptide has occured from 
zero to infinite time as described bv Bilgin et al. (1992). 
In order to calculate the average tim e for d ipeptide for­
mation for pure mutant, w e first substracted the contri­
bution of the w ild-type ribosom es to dipeptides at each 
time point from the data set for vv.t./U 1067 mixture. We 
used, for this purpose, the data set for w ild-tvpe ribo­
som es and the percentage of the w ild -type ribosomes in 
the w .t./U 1067  mixture. This new  data set w as then trea­
ted as described by Bilgin et al. (1992), to calculate the 
average time for d ipeptide formation for pure U1067 
ribosom es.
Missense errors
Leu misincorporation into polv(Phe) chains was 
m easured by varying Leu-tRNALcUj concentration at a 
fixed Phe-tR N A i>hL' concentration w here EF-Tu w as in 
excess over the total tRNA (Ehrenberg et al., 1990). Leu 
misincorporation increases linearly with Leu-/Phe-tRNA  
ratio. W e plotted Leu/(Leu +  Phe) incorporation against 
L eu-/Phe-tR N A  ratio. The norm alized m issense error 
frequency (PE) w as obtained from the slope of this line 
(Ehrenberg et al., 1990).
Number of GTP molecules hydrolyzed per correctly 
formed peptide bond (fc) in steady-state
In the absence of EF-Ts, the rate of GTP exchange on 
EF-Tu is very slow  (kd =  0.011 s" 1). In an elongation  
burst assay, w ith an exception that EF-Tu GDP is added 
with the ribosomes and EF-Ts is excluded, the extent of 
polv(Phe) elongation depends on the concentration of 
EF-Tu w hich is exclusively in the EF-Tu-GDP form and 
the rate o f exchange of GDP to GTP on EF-Tu. Polv(Phe) 
synthesis is then given by the equation:
poh/{Phe)/s = \EF -  Tu] ■ k ,,/ f
Polv(Phe) synthesis was m easured at varving EF-Tu con­
centrations a n d /’, w as calculated bv taking kd =  0.011 s 1 
(Ehrenberg et al., 1990).
/  w as also determined bv directly measuring the 
pH]GTP hydrolysis on EF-Tu in the absence of EF-Ts 
w hile EF-G w as driven by high concentration of 
unlabelled GTP. The am ount of GTP hvdrolvzed w as 
obtained by isotope dilution. This assav w as described 
by detail by Ehrenberg et al. (1990).
Peptidyl-tRNA stability at the A-site
Stability of the N-acetvl-Phe-Phe-tRNA in the A-site 
w as m easured as described bv Karimi & Ehrenberg 
(1990).
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Abstract
Previous experiments have shown that the top of helix 90 of 23S rRNA is 
highly important for the ribosomal peptidyltransferase activity and might be 
part of the donor (P) site. Developing on these studies, mutations in the 23 S 
rRNA at the highly conserved positions G2505, G2582 and G2583 were 
investigated. None of the mutations affected assembly, subunit association or 
the capacity of tRNA binding to A and P sites. A "selective transpeptidation 
assay" revealed that the mutations specifically impaired peptide bond for­
mation. Results with a modified "fragment” assay using the minimal donor sub­
strate pA-fMet are consistent with a model where the nucleotides ¥ 0 0 2 5 8 2  
form a binding pocket for C75 of the tRNA.
Introduction
Peptide-boind formation is the central enzymatic activity of the ribosome. The 
underlying biochemical reaction is the transfer of the peptidyl residue from a 
peptidyl-tRNA in the P site to the a-amino group of an aminoacyl-tRNA at the 
A site. The peptidyltransferase (PTF) is an integral activity of the large riboso­
mal subunit (Monro, 1967) and is localized at the base of the central protube­
rance of the 50S ribosomal subunit (Stöffler & Stöffler-Meilicke, 1986; Oakes 
e t a l, 1986). It has been demonstrated with ribosomes from Escherichia coli 
that the 23 S rRNA and the large subunit proteins L2, L3 and L4 are possibly in­
volved in this catalytic activity (Hampl e t a l, 1981; Franceschi & Nierhaus,
1990). The importance of the 23 S rRNA in the PTF activity has been shown by 
several independent methods. A complex derived from the large subunit of 
Thermus aquaticus ribosomes consisting of 23 S rRNA and only up to 8 pro­
teins has significant PTF activity (Noller et a l, 1992; Noller, 1993). Using 
footprinting and cross-linking techniques, substrates specific for both the A and 
the P site have been demonstrated to interact with domain V (reviewed in Gar­
rett & Rodriguez-Fonseca, 1995). Antibiotics, known to inhibit PTF, have been
extensively used to map the ribosomal PTF centre and the majority of inhibitors 
have also been shown to interact with domain V (Cundliffe, 1990; Rodriguez- 
Fonseca et a l, 1995; Spahn & Prescott, 1996 and references therein).
Site directed mutagenesis is a powerful method for the identification of 
nucleotides and amino acid residues that are important for the PTF activity. 
Using this method, two regions of the 23 S rRNA have been shown to be 
particularly important for peptide bond formation. Mutations at G2252 and 
G2253 interfere with PTF activity (Lieberman & Dahlberg, 1994; Samaha et 
al, 1995; Porse et a l, 1996). Moreover, the partial restoration of activity by a 
combination of a 23 S rRNA mutation and a compensating tRNA mutation 
established a Watson-Crick base-pair in the ribosomal donor site between 23 S 
rRNA nucleotide G2252 and tRNA nucleotide C74 within the 3’ CCA end 
(Samaha et a l, 1995; Porse et a l, 1996). However, the neighboring nucleotides 
G2251 and G2253 do not interact with the adjacent C75 of the 3’ CCA end 
(Samaha et a l, 1995; Green et a l, 1997). Therefore, a complete set of inter­
actions between the 3’ CCA end of tRNA and ribosomal the PTF centre, as 
well as the nucleotides or aminoacyl residues involved in the enzymatic ac­
tivity, are yet to be identified.
The second most sensitive region with respect to peptide bond formation has 
been identified around the top of helix 90 of 23S rRNA shown in Fig. 1 
(Saarma & Remme, 1992; Porse & Garrett, 1995; Porse et a l, 1996; Spahn et 
a l, 1996a; Spahn et a l, 1996b; Green et a l, 1997). We have previously 
analysed the involvement of two highly conserved UGG sequences in binding 
the 3’ CCA end of tRNA (Spahn et a l, 1996a; Spahn et al., 1996b). Although 
no evidence for a canonical base pair interaction was found, the results sug­
gested that G2581 and ¥2580 might participate in the fixation of C75 of the 
CCA 3’ end of peptidyl-tRNA in the ribosomal P site.
In this study we extend our analysis to mutations of the three universally 
conserved nucleotides G2505, G2582 and G2583 in the putative PTF centre of 
E. coli 23 S rRNA. Cross-linking and footprinting experiments mapped the 
binding sites of the substrates of the PTF centre close to these nucleotides 
(Garrett & Rodriguez-Fonseca, 1995). In order to distinguish between the acti­
vities of chromosome-encoded wild-type ribosomes and the plasmid-borne mu­
tant ribosomes, a ‘selective transpeptidation assay’ has been used with 
thiostrepton as the selective agent. We show that mutations at all three posi­
tions severely inhibit peptide bond formation. Furthermore, experiments with 
pA-fMet as minimal donor of the PTF centre suggest that G2582 in addition to 
¥2580 and G2581 might interact with C75 of a tRNA located at the P site.
2
Results
Mutations of E. coli 23 S rRNA in the peptidyltransferase centre have a high 
probability to give a lethal phenotype. Indeed, the G2505C and G2583A/C 
mutations caused a lethal phenotype in combination with A1067U (Saarma et 
al., 1992) like many other mutants in the centre of domain V of 23 S rRNA 
(Lieberman & Dahlberg, 1994; Porse & Garrett, 1995; Porse et al., 1996; Spahn 
et al., 1996a). Furthermore, G2582A and G2582U linked to A1067U have a 
dominant lethal phenotype (not shown). In order to allow expression and isola­
tion of mutant ribosomes, a conditional expression system has been used.
In addition to the plasmid borne mutant rRNA, transcription occurs also 
from seven chromosomal 23 S rRNA genes. Following expression of the mutant 
RNA and isolation of the ribosomes, we determined the fraction of plasmid- 
derived 23S rRNA with the primer extension method (Sigmund et a l, 1988, see 
materials and methods) using the A1067U mutation as a marker. All mutant 
23S rRNA species characterized in this paper (G2505C, G2582A, G2582U, 
G2583A, and G2583C) were readily incorporated into 70S ribosomes and poly­
somes, indicating that the base substitutions did not cause any assembly defect. 
The expression system produces a mixed ribosome population, approximately 
half of which was of plasmid origin (data not shown).
It is difficult to distinguish the kinetics of peptidyl transfer of wild-type and 
mutant ribosomes in a mixed ribosome population. Therefore, a ‘selective 
transpeptidation assay’ has been employed which depresses the activities of the 
wild-type (chromosome-encoded) ribosomes almost completely (Spahn et al., 
1996b). The method exploits a second mutation in the plasmid-borne 23 S 
rRNA, i.e. A1067U that renders the ribosomes resistant towards the antibiotic 
thiostrepton, whereas chromosome-borne ribosomes will be blocked by the anti­
biotic. The combination of a ‘peptidyl transfer’ mutations with the thiostrepton 
resistance mutation on one and the same 23 S rRNA gene enables the measure­
ment of the peptidyl transfer kinetics exclusively of the mutant ribosomes.
In the presence of the heteropolymeric MF-mRNA (coding for Met and Phe) 
the ribosomal P site was filled with tRNAfMet, followed by the binding of 
AcPhe-tRNAphe to the ribosomal A site. Thiostrepton trapped the chromosome- 
derived ribosomes in the pre-translocational state. Translocation of AcPhe- 
tRNAphe to the ribosomal P site on ribosomes containing plasmid borne 23 S 
rRNA was triggered by EF-G, thus leading to a puromycin reaction specific for 
mutant ribosomes.
The amounts of AcPhe-tRNA bound to the A and P sites were determined 
before and after translocation, respectively (for details, see Spahn, et a l, 
1996b). The overall tRNA binding to both the ribosomal A and P sites was 
about the same for all mutants (not shown).
Fig. 2A demonstrates that A1067U ribosomes are fully active in the puro­
mycin reaction. In the presence of thiostrepton, half of the ribosomes can carry 
out peptidyl transfer as compared with the minus-drug control. The result
3
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correlates well with the sequencing data that revealed a fraction of about 50% 
of ribosomes containing plasmid-borne 23 S rRNA. The curve minus-EF-G 
represents the background of the reaction. In contrast to the resistant ribosomes, 
the activity of wild type ribosomes is blocked in the presence of thiostrepton 
(see Table).
Figs. 2B, C, and D demonstrate the consequences of the nucleotide substitu­
tions at position 2505, 2582 and 2583. In all cases the level of peptidytrans- 
ferase activity is severely reduced. In the presence of thiostrepton, only little 
activity is seen with the mutants G2505C (Fig. 2B), G2582A (Fig. 2C), 
G2582U (Table 1), and G2583A (Fig. 2D). Ribosomes containing the G2583C 
mutation in 23 S rRNA have practically no peptidyltransferase activity under 
conditions used (Table 1).
The Table 1 summarizes the peptidyl transferase activity of ribosomes con­
taining mutations around helix 90 determined in this study and in Spahn, et a l, 
1996b according to the test system shown in Fig. 2. The results indicate that a 
cluster of nucleotides at the top of helix 90 is of pivotal importance for the PTF 
reaction (Fig. 1).
pA-fMet is the minimal donor for the ribosomal peptidyltransferase 
reaction, but it’s donor activity is significantly lower than that of pCA-fMet 
(Cerna, et a l, 1973). Intriguingly, the donor activity of pA-fMet becomes 
strongly stimulated by CMP (Cerna, 1973), whereas for pCA-fMet activity, 
CMP even shows a small inhibitory effect (Cerna, 1975). The interpretation of 
this findings is that binding of nucleotide C75 of the tRNA 3’ end in the 
ribosomal donor site is important for the PTF activity and that CMP stimulates 
the donor activity of pA-fMet by taking the place of C75 (Cerna et a l, 1973; 
Cerna, 1975). Previously, we have detected that CMP stimulation is lost with 
mutations *F2580C and G2581A (Spahn et a l, 1996b). A similar assay was 
performed with ribosomes containing mutations at the positions G2505, G2582, 
and G2583.
We have tested the transpeptidation reaction from pA-fMet to Phe-tRNAPhe 
in the presence and absence of CMP. Mutant ribosomes G2505C and G2583A 
exhibited similar stimulation by CMP as the wild-type (A1067U). In contrast, 
CMP stimulation was reduced by a factor of 2 in the presence of ribosomes 
containing the mutations G2582A or G2582U (stimulation factors in Table 2). 
In this assay, both wild-type and mutant ribosomes can participate in peptide 
bond formation. If the mutant ribosomes are inactive, i. e. only the wild-type 
ribosomes participate in the catalysis, the stimulation factor should be the same 
as that observed with wild-type ribosomes. A twofold decrease in the stimu­
lation factor observed with G2582 mutants indicates that the mutant ribosomes 
were active in this assay. Consequently, transfer of the fMet residue from pA- 
fMet to Phe-tRNA was not stimulated by CMP on the mutant ribosomes 
containing the mutations G2582A/U.
4
The relative CMP stimulation of the mutations at G2505, G2582, and G2583 
compared with our previous results are shown in Fig. 3. The mutations at 
G2582 cause a loss of the CMP stimulation as reported earlier for mutations at 
positions ¥2580 and G2581 (Spahn et al., 1996b), whereas the mutations at the 
adjacent G2583 or G2505 showed a full stimulation effect of CMP.
Discussion
Transpeptidation reaction takes place in close proximity to the location of the 
3’ CCA ends of the tRNAs at the donor and acceptor sites. The region of 23 S 
rRNA around the top of helix 90 has been implicated in binding of the donor 
substrate. In footprinting experiments, peptidyl-tRNA analogues protect the 
bases U2506, U2584 and U2585 (Moazed & Noller, 1989; Moazed & Noller,
1991). These protections disappeared after the removal of 3’ terminal A of P 
site bound tRNA. G2505 is protected by a tRNA that lacks the 3’ terminal CA. 
G2583 and the nucleotides in the helix 90 were not accessible for chemical 
modificators (Moazed & Noller, 1989). In a recent cross-linking study with 
[2N3A76]tRNAphe derivatives, the 23S rRNA segments 2500-2520 and 2570- 
2590 were labeled from A and P sites, respectively, showing direct proximity of 
helix 90 of 23S rRNA to the PTF centre (Wower et al., 1995). Further support 
comes from a mutation (lack of methylation) at position U2584 of 23 S rRNA 
from Halobacterium salinarium that renders the ribosomes resistant to sparso- 
mycin, an antibiotic that stabilizes the binding of the 3’-terminal fragments of 
peptidyl-tRNA analogues to the P site (Lazaro et al., 1996).
In this paper we are extending our study of the effects of mutations at the 
peptidyltransferase region of 23S rRNA (Saarma & Remme, 1992; Spahn et al., 
1996a; Spahn et al., 1996b). Mutations at the highly conserved positions G2505 
(to C), G2582 (to A, U) and G2583 (to A, C) show a dominant lethal pheno­
type. An equal distribution of the mutated 23 S rRNA in the polysomal fraction 
the 70S ribosomes and the 50S subunits shows that the mutations did not cause 
an assembly defect and that the mutant 50S subunits are not impaired in subunit 
association. Since the efficiencies of tRNA binding to the A and P sites are not 
affected, the mutations do not seem to induce a gross-conformational change.
A ‘selective transpeptidation assay’ (Spahn et al., 1996b) was used to study 
the effects of the mutations on the formation of AcPhe-puromycin. All studied 
mutants were drastically repressed with respect to peptidyltransferase activity 
(Table 1). The fact that the impairments are restricted to the PTF activity 
suggests the involvement of the nucleotides G2505 G2582 and G2583 in the 
ribosomal peptidyltranferase. The severely reduced PTF activity might explain 
the dominant lethal phenotype of these mutations (Saarma & Remme, 1992).
While our experiments were in progress a similar analysis concerning the 
effect of mutations around helix 90 on PTF activity was presented (Porse & 
Garrett, 1995). A different method for assaying PTF activity was used as well
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as a different combination of antibiotic and resistance mutation in order to 
measure exclusively the peptide bond formation with mutant ribosomes. Both 
studies are in quite good agreement and imply an important role of this rRNA 
region for the PTF activity. Porse et al. 1996 propose a role in the donor 
substrate binding for the region around helix 90 in agreement with our previous 
analysis (Spahn et a l, 1996a). Based on the fact that significant activity of the 
U2585G mutation was found in contrast to the A and C mutations at the same 
position, the possibility of a Hoogsteen pair between the 3’ terminal A of the 
donor substrate and U2585 of 23S rRNA was suggested (Porse et al., 1996). 
However, using a chimeric reconstitution approach Green et al. found similar 
activity for U2585G and U2585C, rendering a Hoogsteen pair at this position 
unlikely (Green et al., 1997).
Previously, we have shown that the pA-fMet reaction of ribosomes carrying 
the mutations ¥25800 and G2581A cannot be stimulated by CMP (Spahn et 
a l, 1996b). The CMP stimulation was interpreted as an indication for the 
importance of C75 fixation of the tRNA at the donor (P) site of the PTF center 
(Cerna, 1975; Quiggle & Chladek, 1980). Here we extend this effect to muta­
tions at G2582 (to A, C). The loss of CMP stimulation seems to be restricted to 
mutations within the ¥ 0 0 2 5 8 2  sequence. Mutations at the directly adjacent 
G2583 show a full response to CMP, as well as mutations at G2505 and C2507 
which are neighboured in the secondary structure (Fig. 1). Interestingly, the 
mutation ¥25800 does not abolish ribosomal peptidyltransferase activity in 
puromycin reaction (Spahn, et al., 1996b). In contrast, mutations at G2505 and 
G2583 are inactive in puromycin reaction but are stimulated by CMP.
There is an apparent contradiction between the results obtained in two 
different assay systems. In the ‘puromycin reaction’ G2582 mutants were found 
to be inactive. In contrast, the loss of CMP stimulation can be explained only if 
these mutant ribosomes were active in the pA-fMet reaction. The problem is 
solved, if we assume that G2582 is invovled in an interaction with C75 of a 
tRNA. This interaction can take place only in the ‘puromycin reaction’, since 
pA-fMet is a ‘minimal donor’ and does not have the corresponding nucleotide 
C75. Therefore, inactivity of the G2582 mutants in the puromycin reaction can 
be due to a disturbance of the G2582-C75 interaction. Likewise, the lack of the 
CMP stimulation is also explained by such a disturbance. The loss of CMP 
stimulation and the restriction to mutants of the triplet ¥GG2582 has a clue for 
a direct involvement of this sequence in binding C75 of the P site located 
peptidyl-tRNA. The fact that CMP stimulation cannot be compensated with 
other nucleoside phosphates indicates that the sequence ¥GG2582 forms a 
binding pocket for C75 of tRNA instead of Watson-Crick base-pairing. 
However, indirect effects cannot be ruled out.
C74 of the 3’ terminal end of peptidyl-tRNA is base-paired with G2252 
within the helix 80 region of 23S rRNA (Samaha et al., 1995; Porse et al.,
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1996). If the remaining 3’ CCA end would be bound by the helix 90 region, 
both 23 S rRNA regions have to be in close proximity. 3’ CCA dependent foot­
prints can be found in both regions (Moazed & Noller., 1989; Moazed & 
Noller, 1991). Moreover, a functional coupling between both regions has been 
shown: mutations in the helix 80 region change the reactivity of bases in the 
helix 90 region (Samaha et a l, 1995; Green et al., 1997).
Materials and Methods
Preparation o f ribosomes
23S rRNA mutants were constructed and cloned into the expression plasmid 
ptac-2, that contains the thiostrepton resistance mutation A1067U in its 23S 
rRNA gene (Saarma & Remme, 1992). E. coli strain XL-1 was used to express 
the mutant genes.
The isolation of ribosomes was performed in two steps: (i) crude ribosomes 
were pelleted from a S30 lysate through a 20% sucrose cushion, (ii) 70S ribo­
somes were fractionated and collected from a 10%-30% (w/v) sucrose gradient 
(for details see Spahn et al., 1996a).
The relative amount of mutant 23S rRNA was determined by the primer 
extension method (Sigmund et al., 1988) using 5’-[32P]-labeled primer com­
plementary to bases 1069-1087 of23S rRNA.
Selective transpeptidation assay
The assay was performed under the following buffer conditions: 20 mM Hepes, 
pH 7.6; 6 mM MgCl2; 150 mM NH4C1; 4 mM (3-mercaptoethanol; 2 mM sper­
midine and 0.05 mM spermine. 70S ribosomes were programmed with MF- 
mRNA (Triana-Alonso et a l, 1995) that contains the codons AUG (Met) and 
UUC (Phe) in the middle. The ribosomal P site was occupied with tRNAfMet 
(1.5 fold molar excess over 70S ribosomes, incubation at 37°C for 20 min), 
followed by filling the A site with Ac[14C]Phe-tRNApl,e (1030 dpm/pmol,
1.1 tRNA/70S). After incubation for 30 min at 37°C, two aliquots were taken to 
determine the levels of binding and the remaining reaction mixture was divided 
into three aliquots. Thiostrepton (1 j^M f. c.) and EF-G were added to one ali­
quot, and the incubation was continued for 10 min at 37°C. The puromycin 
reaction was performed at 0°C. EF-G only was added to the second aliquot. The 
third aliquot served as a mock control and neither thiostrepton nor EF-G were 
added to check whether the pre-translocational state was established.
Fragment reaction with pA-fMet
The conditions used were essentially as described previously (Spahn et a l, 
1996b). 25 |il of the reaction mixture contained 50 mM Tris-HCl, pH 7.4, 
400 mM KC1, 20 mM Mg(COO)2, 1 pmol 70S, 1.5-2 pmol [3H]Phe-tRNApl,e
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(-80 000 dpm/pmol) 1 mM pA-fMet and when indicated 1 mM CMP. The 
reaction was initiated by the addition of 25 \i\ methanol; incubation was for 
60 min at 0°C. The reaction was terminated by addition of 25 \i\ 3 M NaOH 
followed by an incubation for 30 min at 37 °C to hydrolyse the ester bonds. 
100 1^ 10 M HC1 was added and the fMet-Phe was extracted with ethyl acetate. 
The ethyl acetate phase was washed successively with 100 |il 1 M HC1 and 100 
jiil water before counting in order to decrease the background. Blank values 
were obtained by omitting pA-fMet, ribosomes or methanol.
The data were processed in the following way: the activity stimulated by 
CMP (pA-fMet formed in the presence of CMP minus pA-fMet formed without 
CMP) was divided by the reactivity without CMP. This relative stimulated 
activity was compared with the corresponding value of the A1067U control 
ribosomes. A 50% relative stimulated activity caused by CMP stimulation 
reflects the presence of the 50% ribosomes containing chromosomal-borne 23 S 
rRNA. This case, where the fraction of ribosomes with plasmid-borne 23 S 
rRNA cannot be stimulated, was scaled to one. These values are given in Fig. 3.
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Figure 1. Secondary structure of helix 90 in domain V of E.coli 23 S rRNA according to 
Gutell et a l, 1993. Positions where mutations impair peptide bond formation 
are encircled (data from refs. Porse et a l, 1996, Spahn et al., 1996b, and this 
paper). Arrows indicate positions where a mutation interferes with the CMP 
stimulation o f the pA-fMet (Spahn et a l, 1996b and this paper). These 
nucleotides might interact (directly or indirectly) with C75 of the P site bound 
tRNA.
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Figure 2. Kinetics o f the puromycin reaction. The puromycin reaction of the pre­
translocational ribosomes (minus EF-G, open circles) represents the 
background, whereas the puromycin reaction of the mixed population is 
shown after an EF-G dependent translocation (filled circles). The curve after 
an EF-G dependent translocation in the presence of thiostrepton (filled 
triangles) indicates the puromycin reaction of ribosomes exclusively with 
plasmid-derived 23S rRNA. For details see text.
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Figure 3. Relative stimulation of the pA-fMet reaction by CMP. A relative stimulation 
of one indicates that the fraction of ribosomes with plasmid-derived 23 S 
rRNA within the mixed population cannot be stimulated (for details see 
material and methods). The data for the C2507U, H^SOC, G2581A and 
C2254U mutants are taken from Spahn et al, 1996b.
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Table 1. Relative puromycin reaction of ribosomes with plasmid-borne 23S rRNA.
After establishing a pre-translocational state, an EF-G dependent trans­
location was performed in the presence and absence of thiostrepton and a 
puromycin reaction was performed. To calculate the relative activity the 
values in the saturation phase of the puromycin reaction (incubation time 3h- 
24h) were taken. The background values (minus EF-G) were subtracted and 
the values in the presence of thiostrepton (plus EF-G, plus thiostrepton) were 
divided by the values minus thiostrepton (plus EF-G). The ratio for the 
A1067U ribosomes, 0.47, correlates well with approximately 50% of ribo­
somes with plasmid-derived 23S rRNA and was set to 100%.
Ribosomes Relative puromycin reaction [%] A1067U= 100%
wild type (background) 4
A1067U 100
G2505C 9
C2507U 56a
¥2580C 38a
G2581A 5 a
G2582A 8
G2582U 8
G2583A 12
G2583C 1
C2507U/G2581A 6 a
C2507A/G2581A 0 a
a Data taken from Spahn et al., 1996b.
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Table 2. Stimulation of dipeptide bond formation with CMP on mutant ribosomes. The 
fMet-Phe synthesis is shown in the presence and absence of CMP using 
[3H]Phe-tRNAphe as the acceptor substrate and pA-fMet as the donor. Back­
ground values (35-62 DPM in different experiments) are substracted.
Ribosomes DPM
(-CMP)
DPM
(+CMP)
Stimulation factor
A1067U (wt) 758 3713 4.9
G2505C 406 1929 4.75
G2582A 435 898 2.07
G2582U 828 1515 1.83
G2583A 501 2415 4.82
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